Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	7.6	7.7	4.0	2.9	4.2	6.4	12.2	25.9	9.8	7.9	10.2	9.4	9.5	5.4	7.0	7.0	6.1	4.2	4.7	5.4	9.9	7.0	21.4	3.9	3.4	6.6	3.8	5.7	17.9	11.4	12.5	3.4	7.3	6.0	10.0	27.3	6.7	6.3	33.4	23.6	13.6	3.1	5.3	3.9	8.6	9.1	7.0	5.8	7.4	13.8	3.9	3.5	6.9	6.8	5.1	2.3	1.8	2.8	8.7	6.3	0.6	5.1	5.6	5.3	7.8	0.7	1.8	0.0	2.7	4.5	4.2	7.3	1.2	4.3	5.9	0.1	3.4	0.0	6.0	3.4	11.6	0.0	3.1	6.2	5.2	2.2	6.0	1.1	11.7	1.8	0.0	1.9	0.5	4.3	3.2	0.0	1.8	1.9	3.4	0.4	0.1	0.4	1.0	8.3	10.0	1.5	18.6	8.4	5.0	1.6	8.7	3.2	8.6	6.0	1.7	5.6	1.1	10.3	0.3	0.4	2.4	0.0	5.5	0.3	0.3	2.1	1.3	0.0	1.8	1.1	1.7	1.5	0.2	2.3	0.9	1.4	0.9	1.5	0.0	1.8	1.2	0.6	4.0	4.2	25.9	9.8	5.4	9.9	6.6	3.8	7.3	5.3	7.0	6.8	17.7	19.2	20.3	14.4	12.5	65.4	34.9	35.1	31.3	122.3	33.9	42.8	26.4	30.0	27.8	38.6	116.7	17.3	17.7	126.7	5.9	15.6	18.9	38.6	17.4	18.3	112.7	8.4	143.1	9.8	6.0	33.1	32.6	61.8	14.0	90.3	17.2	94.4	7.4	106.0	184.6	73.7	32.6	3.7	24.4	14.4	63.6	7.0	101.4	20.6	29.9	45.6	11.3	79.9	105.3	9.3	45.6	45.9	23.4	32.1	151.1	9.4	66.0	113.4	92.1	28.7	30.3	200.8	78.1	33.8	53.6	23.7	18.2	80.7	30.4	41.8
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
AC006486.1		ENSG00000268643	"Novel protein"		19	42234583-42255132	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"retina: 10.8"	"Cell type enhanced"	"Detected in single"		"Suprabasal keratinocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 31.6"															NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"								"unprognostic (2.11e-1)"													2.5	1.0	0.4	1.2	0.7	0.9	1.0	1.0	1.6	0.0	0.6	3.9	1.8	4.2	0.0	1.6	0.1	0.1	0.0	0.8	0.8	4.3	1.6	1.1	0.9	0.5	0.3	0.0	0.0	0.6	0.1	0.5	0.7	0.2	0.8	10.8	0.0	0.3	4.1	0.0	2.1	0.0	0.3	1.7	2.2	1.9	0.4	0.4	0.6	1.1	0.9	0.9	0.0	1.5	13.6	17.0	8.7	5.0	0.0	0.5	1.1	18.3	1.2	0.0	3.1	3.6	1.8	3.8	6.6	1.6	12.3	5.2	3.8	0.0	19.9	7.7	2.6	5.8	12.7	4.6	0.7	19.3	4.6	0.0	0.0	3.1	0.0	6.9	1.2	5.7	2.3	6.8	0.0	2.3	1.8	0.0	8.3	18.1	2.9	6.0	8.0	0.0	0.0	31.6	4.4	5.9	16.0	0.3	3.5	20.9	3.1	0.0	0.0	5.1	7.0	2.9	17.1	7.6	24.7	10.6	5.9	5.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	1.6	0.8	0.8	0.5	0.3	0.7	0.3	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0
AC019117.1		ENSG00000283321	"Novel protein"		7	17299295-17467234	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"cervix: 8.4;urinary bladder: 15.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 1.1;Early spermatids: 2.1;Endometrial ciliated cells: 1.4;Late spermatids: 1.2;Theca cells: 1.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 55.3"									HPA029722	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA029722: AB_10599189"																		0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.0	0.1	8.4	0.0	0.1	0.3	1.6	0.4	0.2	2.0	0.8	0.0	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.3	0.7	0.9	0.3	0.0	0.5	0.1	0.4	0.0	0.2	1.1	0.4	0.1	0.1	0.1	0.0	0.1	15.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	11.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.1	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0
AC022150.4		ENSG00000269825	"Novel zinc finger protein"		19	52650447-52690533	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 15.0"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 15: RT4 - Unknown function"		"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (2.33e-3)"	"unprognostic (9.06e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.55e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-3)"	"unprognostic (3.17e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.89e-1)"	1.1	1.1	1.7	2.0	4.9	3.1	1.6	5.2	2.1	1.0	2.2	0.7	0.8	1.4	2.1	1.1	0.8	1.6	0.8	1.1	2.1	1.4	0.3	1.2	1.6	3.8	2.4	1.2	1.1	1.2		2.8	4.0	1.4	0.9	3.1	0.9	2.0	0.5	2.1	0.6	1.2	2.5	1.8	1.3	1.8	2.6	2.1	1.5	0.6	1.9	1.1		3.2	5.0	0.0	2.6	6.4	0.6	1.4	6.1	5.1	3.0	3.7	4.5	4.3	2.9	4.1	1.4	2.8	2.5	1.8	4.6	2.4	5.7	0.1	0.4	2.5	14.3	0.8	0.5	3.1	4.0	1.6	0.3	5.4	6.4	1.2	4.0	4.4	4.5	1.7	3.5	2.1	4.4	2.3	1.6	0.0	7.1	6.9	4.7	2.2	2.4	15.0	2.9	1.8	6.4	2.7	0.5	6.4	7.3	2.1	5.7	9.6	4.2	1.8	7.8	0.1	3.0	5.7	0.1	1.5	5.1	0.8	0.3	0.2	0.7	0.3	0.5	0.5	0.5	0.8	0.2	0.5	0.5	0.7	0.7	0.9	0.3	0.4	0.5	0.3	1.7	4.9	5.2	2.1	1.1	2.1	3.8	2.4	4.0	2.5	2.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409009-19452505	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"stomach 1: 61.8;urinary bladder: 39.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.7;Gastric mucus-secreting cells: 21.9;Inhibitory neurons: 10.3;Microglial cells: 26.2;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 29.7;RT4: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	6.9	1.4	4.5	1.1	3.4	0.6	5.0	2.7	5.0	1.7	2.0	3.3	4.5	1.4	4.2	2.2	3.7	1.7	2.9	4.4	3.1	1.9	2.4	2.2	1.0	3.2	3.1	1.0	6.8	2.5	1.1	9.7	4.3	3.7	4.3	3.8	1.9	4.5	1.2	5.9	2.7	1.3	2.8	1.4	61.8	1.9	5.9	2.4	2.5	1.0	1.3	39.2	1.7	3.7	1.2	2.0	3.9	2.0	6.2	0.5	29.7	2.1	1.4	0.7	1.0	0.6	1.9	1.3	0.7	0.3	0.4	4.5	0.8	5.8	1.5	2.4	1.1	2.1	1.6	3.0	1.3	0.5	2.0	1.8	5.6	2.2	2.4	0.6	6.2	2.1	3.1	3.8	2.0	1.7	3.6	1.8	3.1	11.1	0.9	3.2	1.0	0.7	0.6	73.6	6.9	1.8	0.4	2.2	0.5	9.3	2.7	2.5	3.1	0.5	1.5	0.6	0.9	1.4	1.7	1.4	0.6	1.5	1.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.5	3.4	2.7	5.0	4.4	3.1	3.2	3.1	4.3	2.8	5.9	3.7	3.2	0.0	0.0	1.0	0.7	0.3	0.4	0.1	0.6	1.0	0.3	0.4	0.1	0.0	0.1	0.0	2.1	0.5	0.4	0.0	0.0	0.1	2.6	0.3	0.2	0.8	0.0	0.8	19.7	0.0	0.6	0.3	21.9	0.4	0.0	0.0	1.4	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.3	0.2	0.0	26.2	0.0	0.6	0.0	5.5	7.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.6	0.0	0.6	0.4	0.4	0.4	0.8	0.0	4.0	0.3	0.0	0.0	1.1
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 44.4;intestine: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Distal enterocytes: 71.3;Late spermatids: 150.6;Proximal enterocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 18.9;OE19: 27.3;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.4	3.4	4.6	2.4	5.9	3.7	1.1	7.0	5.2	3.8	44.4	13.8	36.0	2.6	3.1	15.9	3.0	2.4	30.4	5.4	4.9	16.3	1.2	1.9	1.7	7.1	12.3	5.2	3.1	21.2	8.0	1.5	6.1	3.5	11.6	7.9	9.4	3.4	9.2	2.8	29.3	2.5	3.6	1.5	11.1	2.5	7.6	0.6	10.1	10.6	3.3	6.5	6.3	3.9	6.7	4.2	2.0	1.2	0.8	1.9	3.4	3.7	0.2	1.1	0.8	6.4	16.9	1.4	5.6	3.0	4.0	18.9	0.8	3.3	0.6	3.9	1.4	16.0	6.2	2.7	0.3	1.8	2.1	2.0	3.7	0.4	1.6	1.7	3.4	1.1	0.9	1.9	4.0	2.0	0.7	2.4	3.3	27.3	0.9	1.2	11.1	1.5	0.7	40.1	4.2	4.2	1.8	1.2	0.8	6.8	1.6	5.1	3.5	2.5	2.4	1.7	1.4	1.9	1.0	1.5	1.2	11.7	1.3	1.1	0.6	4.6	0.3	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.4	1.3	0.4	0.5	0.4	0.3	0.3	4.6	5.9	7.0	5.2	5.4	4.9	7.1	12.3	6.1	3.6	7.6	3.9	0.5	0.0	7.8	134.8	1.4	4.8	16.6	7.3	2.8	46.4	3.4	0.9	24.7	10.0	7.2	25.8	0.0	2.0	0.2	71.3	11.7	4.4	22.6	11.4	1.7	2.1	47.5	3.0	11.7	2.6	6.2	3.5	33.6	14.1	15.2	3.3	3.9	0.4	8.3	15.2	6.0	38.8	10.2	8.0	7.4	150.6	13.7	6.1	8.8	10.3	2.9	46.4	0.0	19.6	3.9	4.7	37.0	17.7	0.5	6.6	106.1	48.0	8.5	5.3	0.0	19.1	2.5	0.6	1.0	5.3	2.8	2.5	1.2	16.4	44.8	26.3
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979177	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 191.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 199.8;Hepatocytes: 287.4;Proximal enterocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 77.2;neutrophil: 113.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 113.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 96.9;RT4: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		96000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	37.8	18.1	16.1	10.6	18.2	8.8	17.1	17.4	15.1	11.0	21.3	40.9	62.5	9.3	9.8	30.4	9.9	14.9	23.0	14.3	17.5	40.3	191.5	13.6	6.2	16.6	17.9	9.5	39.7	18.8	12.6	17.3	15.9	18.4	27.1	16.1	15.4	11.8	30.1	24.8	51.4	11.1	17.5	10.5	27.4	9.3	20.6	8.3	17.0	29.2	12.1	19.5	12.7	18.9	16.3	24.5	7.2	9.9	34.0	14.4	96.9	11.8	11.3	12.9	14.8	16.4	24.0	9.1	14.0	17.9	12.5	9.9	28.7	12.4	19.2	10.0	9.5	10.9	13.1	47.2	19.4	9.7	7.8	24.0	9.4	15.7	9.2	13.1	32.3	13.6	12.3	8.9	14.0	45.3	26.3	7.0	4.9	36.8	19.8	13.4	21.3	10.2	20.7	129.1	8.7	12.6	30.6	46.5	11.4	21.2	32.6	11.3	20.9	18.2	13.4	15.2	11.5	14.4	11.0	4.0	10.0	9.7	11.4	77.2	18.3	5.2	6.9	14.2	8.2	5.4	6.6	8.8	10.3	4.5	7.2	7.1	113.7	7.2	9.4	9.4	9.3	8.0	16.1	18.2	17.4	15.1	14.3	17.5	16.6	17.9	15.9	17.5	20.6	18.9	28.0	28.9	25.0	25.1	10.8	13.5	15.9	26.1	21.1	27.4	19.4	13.5	47.4	51.5	23.4	23.9	22.9	37.7	12.1	199.8	21.5	22.9	11.6	18.1	16.7	18.8	34.4	21.5	17.8	40.6	46.5	19.8	88.7	24.1	17.1	21.4	21.8	287.4	25.4	18.5	18.8	44.5	24.4	35.4	14.1	7.1	29.8	23.7	14.2	15.0	36.3	61.9	9.2	22.1	18.2	34.2	100.0	47.0	18.3	24.0	238.7	107.8	17.4	28.4	0.0	18.4	17.2	5.5	11.0	28.5	30.3	43.2	13.2	17.1	41.9	31.7
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 142.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 97.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Uncertain	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Microtubules, Cytosol"		"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.41e-4)"	24.8	71.9	7.6	5.7	8.5	3.3	21.0	7.7	10.1	18.9	8.6	26.9	22.1	6.7	15.8	7.7	9.7	10.8	25.9	7.1	7.0	142.1	36.4	17.8	8.5	8.5	7.3	19.3	6.8	9.9	2.9	15.4	8.0	15.0	17.5	1.1	15.8	16.0	41.3	22.5	20.2	5.4	8.2	8.4	18.8	4.9	7.9	5.6	42.5	25.8	8.2	17.8	13.4	7.7	24.8	8.1	6.6	15.8	68.1	12.1	38.1	5.9	8.6	12.6	24.5	32.1	47.2	15.7	12.6	7.3	11.5	14.7	4.7	29.2	15.3	19.5	11.2	27.3	3.9	58.5	11.4	3.3	24.3	54.9	44.4	15.8	2.1	45.4	17.4	20.3	3.2	8.8	13.7	31.3	8.8	11.1	1.1	47.5	11.9	20.6	4.8	41.2	4.2	97.2	21.6	11.3	11.8	17.3	12.3	13.7	15.5	22.8	12.7	22.5	6.8	3.5	1.9	15.4	3.1	8.2	9.3	17.1	1.4	0.0	2.9	15.3	2.0	7.7	1.7	8.6	1.5	2.1	16.1	2.0	0.7	0.9	0.5	1.6	7.0	6.3	5.5	2.7	7.6	8.5	7.7	10.1	7.1	7.0	8.5	7.3	8.0	8.2	7.9	7.7	3.2	28.9	24.3	27.1	7.3	6.0	23.3	17.0	25.0	0.0	20.8	16.0	25.9	11.5	19.9	3.7	0.0	85.8	1.7	59.5	11.7	13.5	0.4	4.9	3.5	4.9	10.2	1.3	0.3	4.3	11.7	6.5	21.9	7.7	22.2	24.5	4.2	44.4	21.9	0.0	0.3	20.6	2.0	9.8	11.0	1.6	26.8	11.0	3.6	17.8	12.7	6.1	5.2	3.5	0.5	5.7	53.1	14.3	2.6	3.5	78.2	128.4	14.6	0.2	0.0	2.7	5.9	0.2	2.2	5.4	7.0	81.0	4.1	12.1	25.8	14.0
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.6;pancreas: 4.0;skin 1: 1.9;stomach 1: 1.9;urinary bladder: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.0;Cone photoreceptor cells: 2.1;Early spermatids: 2.4;Excitatory neurons: 3.8;Inhibitory neurons: 3.4;Oligodendrocytes: 2.1;Rod photoreceptor cells: 5.3"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"RT4: 3.7"									HPA044593	Uncertain					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.71e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.9	0.1	0.1	3.6	0.4	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	2.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.4	0.6	1.2	0.6	0.0	0.0	3.8	0.0	0.0	0.1	1.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1G2	G2AD	ENSG00000213983	"Adaptor related protein complex 1 subunit gamma 2"	O75843	14	23559565-23568070	"Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 108.3;RT4: 151.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004106	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004106: AB_1078172"	"unprognostic (1.94e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.85e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-3)"	15.3	18.0	31.3	23.3	35.5	30.5	20.0	34.0	40.5	22.5	27.8	27.2	28.7	11.7	14.3	35.5	19.8	18.2	6.1	32.8	30.7	26.7	15.1	18.9	39.1	29.7	28.7	23.0	36.2	24.9	67.4	12.9	29.9	33.8	23.0	9.8	29.7	15.9	2.2	45.2	37.5	10.3	27.5	45.7	35.2	7.5	30.2	30.1	27.2	1.6	42.9	26.3	26.2	30.1	29.1	30.4	0.8	3.1	4.5	7.2	45.5	3.5	8.3	10.3	13.5	28.6	64.8	53.8	15.6	2.8	0.1	53.5	16.2	45.4	7.0	30.0	9.2	20.8	14.5	67.7	16.9	31.6	108.3	20.9	66.0	7.0	24.1	11.2	6.1	37.5	9.2	22.3	4.4	70.8	26.3	28.8	6.9	59.2	11.1	38.9	0.2	16.7	41.3	151.2	8.2	11.5	15.0	68.0	5.6	17.9	40.4	7.8	5.3	2.7	20.2	2.6	0.2	16.2	9.2	21.3	1.2	21.3	3.3	40.6	25.4	43.8	29.5	35.2	28.0	30.7	31.5	31.5	42.5	28.1	25.4	24.8	10.2	38.7	37.0	22.2	42.2	35.6	31.3	35.5	34.0	40.5	32.8	30.7	29.7	28.7	29.9	27.5	30.2	30.1	9.1	19.2	21.7	6.2	31.4	13.5	18.9	33.1	29.0	31.1	23.7	21.8	0.5	17.2	38.2	12.9	2.1	22.8	23.7	38.7	5.9	30.4	1.1	9.7	4.7	9.7	32.4	9.9	21.5	29.4	24.1	7.1	64.2	15.6	31.7	22.0	6.4	2.5	15.2	72.3	15.7	29.4	42.7	15.2	21.0	1.2	9.3	15.1	10.6	6.5	27.5	8.6	12.3	4.0	4.7	26.6	53.1	6.0	14.0	11.0	33.1	9.6	24.3	6.2	0.0	1.6	5.0	5.8	3.9	16.4	9.8	24.5	30.9	13.9	34.6	23.3
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343781	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavorable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	11.4	10.3	5.6	14.6	5.3	27.5	13.6	8.2	6.8	14.2	10.1	19.2	16.9	10.5	11.0	15.2	11.8	12.5	9.6	4.6	5.5	22.8	15.2	13.8	15.4	6.2	6.5	10.3	17.5	28.0	5.4	14.4	6.7	13.0	17.2	36.5	14.8	12.1	12.8	13.7	17.5	10.8	5.2	13.8	19.6	28.3	6.4	22.2	22.4	14.0	17.2	19.7	7.9	7.3	31.8	20.4	19.3	7.3	21.9	29.8	22.5	21.4	24.3	21.7	22.0	12.6	30.0	23.9	8.9	27.6	26.2	22.2	23.5	30.4	26.6	28.3	16.0	40.2	12.0	13.5	18.6	20.9	37.3	18.4	21.6	19.2	31.8	22.3	31.5	24.6	24.5	25.3	25.5	7.2	48.1	9.7	42.5	34.5	18.5	22.4	13.9	4.8	35.8	58.2	7.6	14.9	14.1	33.9	19.5	29.5	58.5	18.3	38.6	14.4	19.3	19.5	16.4	20.4	22.6	17.5	23.6	20.8	14.2	6.1	1.6	4.3	2.8	2.3	3.6	1.2	1.8	2.3	1.6	1.3	3.0	2.6	5.1	2.5	0.9	2.2	3.9	0.9	5.6	5.3	8.2	6.8	4.6	5.5	6.2	6.5	6.7	5.2	6.4	7.3	38.5	44.8	23.1	73.1	32.7	23.7	34.0	23.8	19.9	36.8	32.7	18.9	33.1	18.6	31.9	38.6	139.7	20.0	47.0	43.2	11.7	29.7	25.4	42.5	34.7	28.5	29.4	16.2	119.0	25.6	15.4	22.9	57.6	53.0	15.2	40.0	23.2	19.6	15.8	43.7	146.3	27.9	14.2	31.3	20.4	36.0	40.0	35.2	17.8	105.9	47.1	22.9	46.4	151.8	126.6	40.1	25.7	30.1	29.8	38.2	30.8	24.7	33.9	100.8	6.6	23.6	26.5	69.4	50.7	26.0	29.5	24.9	42.4	32.1	28.0	60.4
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.1;Paneth cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;OE19: 20.5;RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023919, HPA053053"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.21e-4)"	16.2	7.3	4.3	8.6	6.7	11.6	15.8	4.0	4.8	27.1	3.1	39.6	10.5	8.7	1.7	98.0	11.7	3.2	22.7	3.7	4.0	20.4	6.5	28.4	9.1	5.4	4.5	3.6	7.7	3.1	10.4	4.0	4.7	17.0	8.9	0.5	37.7	1.5	4.4	27.3	51.6	2.4	4.4	63.0	12.7	8.9	5.5	6.3	16.7	1.8	6.7	17.6	44.2	4.3	6.1	6.0	0.1	1.7	0.8	0.4	16.7	0.0	0.3	0.4	0.1	5.3	11.9	5.5	11.4	0.4	2.6	3.8	0.8	1.1	0.2	11.3	3.7	0.3	2.7	3.5	0.1	0.0	15.7	0.8	4.7	0.0	1.7	0.5	3.6	5.9	1.5	9.8	0.5	4.2	5.3	1.9	0.3	20.5	4.9	4.4	0.2	1.9	3.9	26.1	0.8	0.5	0.7	5.0	0.3	2.0	3.9	10.2	5.6	0.0	1.4	0.1	0.5	12.0	8.4	1.2	0.3	1.5	0.1	1.0	5.2	4.4	2.4	8.6	1.5	3.6	1.5	2.7	4.3	2.7	1.2	1.3	10.0	1.8	11.4	7.2	2.1	4.0	4.3	6.7	4.0	4.8	3.7	4.0	5.4	4.5	4.7	4.4	5.5	4.3	19.9	6.4	17.8	2.9	23.1	10.3	15.2	9.3	2.8	3.3	11.4	7.4	10.6	15.7	13.0	18.4	4.2	7.7	38.0	99.1	3.9	6.0	1.1	11.0	2.5	20.8	19.2	1.7	3.6	3.4	11.5	3.1	31.6	18.4	4.5	0.5	17.5	2.1	15.0	1.7	8.8	34.2	10.2	47.1	13.4	1.1	0.3	33.1	7.2	19.7	26.0	1.6	23.7	3.0	2.5	19.1	79.6	0.0	15.9	28.3	57.0	6.4	11.7	1.6	0.0	3.0	2.9	6.7	2.0	9.7	8.7	14.1	14.2	1.0	43.4	57.4
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46860997-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 186.4;Late spermatids: 651.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142"	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	13.6	10.1	35.7	8.0	31.5	5.3	16.1	16.8	31.1	12.9	9.2	14.8	12.9	12.8	10.6	15.7	12.8	9.1	25.8	37.0	27.3	19.1	22.3	14.9	8.7	26.0	32.3	17.3	13.6	31.3	14.1	7.8	34.5	13.4	12.3	16.6	15.7	15.7	29.4	11.6	16.3	12.9	19.8	8.8	10.9	40.3	33.3	10.8	20.2	24.2	9.0	13.1	9.0	25.1	52.0	56.7	37.9	34.0	33.9	27.9	6.4	27.3	38.7	27.1	31.0	30.6	18.0	27.4	19.1	112.0	41.2	30.8	34.8	35.3	36.9	19.3	14.7	37.2	40.1	24.1	31.7	22.3	30.4	28.3	35.1	30.6	32.5	37.9	24.7	18.2	25.2	9.9	31.4	30.3	21.8	35.4	19.9	37.4	20.8	24.1	26.0	8.5	23.0	100.0	37.9	36.1	50.5	47.5	20.0	23.4	44.6	27.1	31.3	23.9	18.9	26.2	33.0	10.1	19.6	21.7	53.6	22.8	59.7	0.3	0.2	0.2	0.6	0.2	0.6	0.1	0.6	0.7	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.3	35.7	31.5	16.8	31.1	37.0	27.3	26.0	32.3	34.5	19.8	33.3	25.1	15.7	44.8	38.4	47.7	8.6	15.2	13.9	20.1	19.4	31.9	35.2	23.0	58.2	27.1	21.4	25.8	25.0	3.7	14.8	61.0	7.9	14.6	186.4	17.8	19.0	19.5	31.2	16.6	42.4	20.0	1.0	19.1	19.9	34.1	9.5	30.9	27.8	89.7	15.0	69.0	48.8	18.5	14.2	19.5	7.8	651.3	23.3	11.0	21.4	32.8	14.2	28.2	18.6	37.2	58.2	20.9	21.4	25.6	6.7	23.3	44.5	22.6	10.4	22.0	19.7	22.6	24.9	45.9	23.5	24.4	16.6	1.6	16.1	29.5	25.7	17.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151586-160186980	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 6.3;testis: 16.3;urinary bladder: 5.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 26.1;Early spermatids: 87.4;Extravillous trophoblasts: 14.4;Syncytiotrophoblasts: 38.2"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"BEWO: 18.4;HDLM-2: 49.0;RT4: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favorable (2.20e-4)"	0.2	0.1	0.1	0.4	0.1	0.0	1.6	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.7	0.3	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.1	0.0	0.0	0.4	0.0	6.3	0.1	0.3	0.1	2.4	0.3	1.3	3.0	0.0	0.2	0.1	0.1	1.0	0.1	16.3	0.1	0.4	0.0	0.0	1.3	5.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.6	1.6	0.0	0.3	7.3	0.0	0.0	0.0	2.2	1.7	0.9	0.0	0.0	1.8	0.0	26.1	0.1	0.0	0.0	0.0	87.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	14.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	6.5	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	2.2	0.0	1.4	0.3	2.8	0.2	0.0	0.0	38.2	0.7	0.1	0.0	10.4
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	60.4	49.6	26.2	57.8	34.6	46.0	34.1	36.0	28.0	43.4	23.2	64.2	47.5	46.6	39.0	181.2	67.0	60.5	1005.8	39.0	28.8	34.4	54.7	49.0	36.0	32.5	46.3	42.0	38.1	56.1	24.5	55.4	29.8	93.4	69.0	19.1	92.2	70.0	2856.8	46.5	56.4	74.4	29.8	30.5	47.2	74.1	57.6	36.2	73.3	2768.8	48.1	90.9	57.9	36.1	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	26.2	34.6	36.0	28.0	39.0	28.8	32.5	46.3	29.8	29.8	57.6	36.1	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105411	"Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cardiomyocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 8.8;NK-cell: 22.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.8;NK-cells: 22.1"	"Cell line enhanced"	"Detected in many"		"RT4: 128.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041204			Approved	Vesicles		NA	NA		400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	5.3	7.2	20.7	3.9	21.5	4.8	9.8	14.7	19.6	20.1	8.0	2.7	1.9	9.9	8.5	6.8	14.2	9.9	53.3	21.7	26.7	19.4	1.2	14.6	4.9	12.8	21.7	18.8	11.1	8.6	9.8	13.9	18.0	11.6	2.4	26.6	22.3	8.5	1.4	2.5	2.4	9.9	14.1	6.2	10.7	8.4	25.7	2.8	27.0	3.2	5.4	12.3	5.4	13.0	17.3	0.3	7.5	0.1	1.0	2.8	0.1	9.3	8.7	22.3	7.3	11.3	13.2	0.0	35.7	8.0	12.7	3.9	0.0	16.9	7.5	0.0	0.0	9.0	5.7	0.0	11.2	0.2	0.0	23.3	5.4	6.1	1.4	15.6	31.6	0.0	0.0	0.0	8.3	29.4	0.1	0.0	17.4	0.2	38.9	0.1	0.0	0.2	9.3	128.3	15.1	0.1	23.7	8.8	6.3	3.0	35.6	13.3	0.0	0.2	15.5	0.5	0.2	3.6	0.1	0.2	14.7	0.0	0.0	8.8	0.2	0.0	0.4	0.2	0.4	2.3	0.2	0.4	1.7	0.2	0.4	0.9	0.4	22.1	0.1	1.1	0.0	0.7	20.7	21.5	14.7	19.6	21.7	26.7	12.8	21.7	18.0	14.1	25.7	13.0	5.0	19.2	2.2	10.1	2.1	5.0	5.2	5.7	6.2	56.3	7.5	6.2	56.9	0.0	8.0	14.7	12.5	21.2	1.2	0.1	11.7	3.5	0.7	4.9	5.8	7.7	1.8	17.0	22.3	8.5	13.0	13.3	4.6	8.7	10.2	13.0	6.1	0.2	9.8	6.7	27.5	0.1	6.1	2.1	6.8	2.2	7.2	3.4	10.6	9.4	4.3	12.6	1.0	14.6	3.2	9.8	0.1	5.3	0.2	6.2	0.1	15.8	3.1	8.4	0.0	5.3	13.2	6.5	20.7	8.4	2.6	5.1	1.2	4.6	0.7	4.5
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 254.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	27.2	85.4	27.5	11.4	27.8	6.1	25.2	34.6	34.5	29.7	72.3	38.8	14.8	27.0	5.3	33.7	30.2	10.7	63.4	29.0	26.5	40.5	22.1	30.4	14.0	28.2	29.7	53.3	76.7	20.1	30.7	12.4	27.8	38.4	17.4	5.6	29.1	17.0	58.7	28.0	23.7	13.5	26.1	19.7	66.4	20.2	30.8	12.0	28.9	29.4	16.5	56.6	29.0	29.2	62.9	73.3	19.3	40.6	78.1	26.3	34.2	27.3	13.8	32.7	31.7	74.5	37.4	73.3	30.2	24.3	10.1	28.8	29.8	47.4	16.5	46.0	76.0	27.0	32.7	5.0	75.3	36.9	24.2	38.5	29.8	24.2	35.0	31.8	45.5	55.3	34.9	43.8	12.2	74.8	50.4	38.9	16.9	98.5	35.7	75.2	33.1	80.8	30.8	254.3	102.6	29.4	41.0	66.7	20.7	13.3	42.3	17.9	25.9	31.5	30.3	37.6	34.3	40.8	58.4	35.8	17.2	56.7	21.0	0.0	14.4	3.0	14.3	16.1	20.1	23.5	17.5	18.8	25.6	20.3	15.7	14.1	0.6	14.8	6.2	28.9	24.9	12.3	27.5	27.8	34.6	34.5	29.0	26.5	28.2	29.7	27.8	26.1	30.8	29.2	13.1	28.9	44.8	59.7	14.1	6.0	28.3	32.3	14.2	10.4	23.5	17.9	25.5	31.5	20.6	12.9	20.9	67.6	11.0	28.8	72.4	38.6	8.0	16.2	22.4	13.5	19.9	6.3	11.2	21.3	25.2	15.3	32.6	23.8	23.5	18.3	12.8	11.2	26.2	1.7	10.6	30.4	38.7	7.9	10.5	10.2	17.4	7.5	24.9	8.4	21.6	7.3	7.2	9.0	11.2	15.8	17.7	30.1	15.1	16.1	13.9	39.4	13.2	13.4	19.7	9.9	17.3	8.0	19.5	32.6	7.1	45.8	9.5	21.9	33.9	47.7
BHLHE41	"BHLHB3, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120030-26125037	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 122.4;skeletal muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 78.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	10.6	14.6	35.4	7.4	46.7	0.5	13.6	52.5	35.2	38.8	11.8	9.5	2.7	8.1	19.3	3.2	45.5	18.3	20.0	30.5	39.5	3.8	0.7	11.6	7.9	58.1	48.7	12.9	7.7	6.5	16.7	10.5	62.3	9.7	11.1	122.4	18.4	14.0	92.5	5.6	6.3	4.1	60.2	9.1	4.9	4.3	49.8	6.3	57.8	12.9	17.9	21.3	9.9	67.1	11.4	0.1	0.3	0.0	20.4	9.4	4.7	2.2	3.8	0.4	1.4	0.0	13.4	0.0	1.9	4.4	31.4	11.3	0.4	1.9	1.1	0.1	1.7	1.0	0.2	0.0	0.9	5.7	0.3	1.5	1.1	7.8	15.0	92.4	0.0	0.1	0.0	39.6	2.4	1.3	0.0	3.9	10.4	3.7	7.8	0.0	1.9	31.6	4.9	126.6	0.2	0.2	1.4	0.6	29.7	0.6	0.0	0.2	6.7	7.1	8.2	0.8	5.9	52.6	32.3	0.1	44.9	4.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	46.7	52.5	35.2	30.5	39.5	58.1	48.7	62.3	60.2	49.8	67.1	1.6	0.0	1.1	46.0	25.0	6.0	59.8	34.1	10.8	347.5	9.2	56.0	46.7	37.1	11.2	29.5	183.5	26.6	0.2	55.0	0.0	40.6	0.6	78.5	27.1	12.0	13.1	0.0	10.1	21.9	3.6	22.7	3.1	60.8	5.7	0.2	2.5	0.1	91.1	250.7	12.4	4.4	0.0	4.0	4.4	1.3	30.1	39.8	14.2	120.9	27.4	239.8	0.0	22.1	56.2	21.9	12.0	26.7	61.8	49.0	0.4	2.3	34.8	309.5	6.6	13.0	7.5	0.5	3.7	3.5	3.3	7.1	2.4	2.3	5.0	83.8
BLCAP	BC10	ENSG00000166619	"BLCAP apoptosis inducing factor"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 466.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 358.9"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	65.3	56.2	161.7	27.2	189.7	35.9	59.5	106.0	147.2	49.3	159.6	54.9	51.1	34.5	52.5	86.3	141.0	29.0	75.7	147.4	163.5	60.5	101.0	37.3	40.0	123.5	137.6	40.8	27.3	50.8	149.1	76.0	145.4	59.5	52.2	70.9	57.2	56.3	466.4	88.3	48.0	34.0	108.3	46.8	39.2	30.6	197.8	41.6	45.5	120.2	53.1	72.5	60.0	117.3	138.0	38.8	45.8	48.6	86.2	66.0	63.8	64.3	62.2	56.4	45.5	137.9	109.3	70.7	62.1	90.1	53.7	259.1	34.4	268.1	57.5	14.7	31.5	23.2	94.0	130.5	55.8	46.5	29.9	84.8	283.9	54.3	101.0	46.1	79.6	51.3	22.7	51.9	114.1	77.0	39.0	37.1	36.9	77.6	109.6	36.6	171.0	47.2	64.6	358.9	41.8	50.2	77.3	221.2	54.7	46.5	73.6	44.4	75.2	144.6	37.2	51.3	28.2	28.1	37.5	34.2	60.4	42.4	26.5	74.9	56.6	69.9	45.2	56.0	49.6	93.9	51.3	48.4	52.8	113.6	67.1	52.6	59.3	48.2	53.8	22.6	55.4	52.8	161.7	189.7	106.0	147.2	147.4	163.5	123.5	137.6	145.4	108.3	197.8	117.3	24.4	80.1	31.0	14.0	38.4	147.0	97.3	135.9	137.1	43.0	29.0	60.8	56.8	30.0	68.7	40.5	22.9	115.1	25.5	72.4	82.2	35.7	73.7	58.8	26.3	54.0	40.9	15.6	26.8	33.9	84.8	29.5	17.9	18.1	29.2	32.1	89.6	81.0	55.8	42.1	29.8	58.8	52.9	41.9	36.2	161.7	29.8	29.1	35.6	13.1	30.1	64.0	24.7	16.6	11.4	54.0	31.4	59.5	16.5	88.6	69.9	55.7	63.2	36.2	32.9	28.6	27.0	30.8	27.1	66.8	122.9	65.0	26.1	54.0	33.3	133.4
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646811-134679816	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.3"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 118.2;RT4: 186.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		81000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	11.4	12.6	16.3	9.1	17.1	87.3	12.4	17.9	20.5	12.5	15.8	12.9	8.4	9.6	18.5	26.9	8.5	12.9	13.5	16.5	19.0	35.1	13.1	14.0	11.1	17.9	17.8	7.1	8.4	35.3	18.1	47.0	18.2	13.5	10.0	19.9	17.8	17.9	37.8	10.7	8.0	12.1	19.6	12.5	11.9	14.7	17.7	16.3	11.9	27.0	26.2	39.0	17.2	18.5	14.0	16.3	21.7	29.6	24.3	14.4	21.9	41.3	49.9	15.7	23.2	6.5	18.5	17.1	12.0	23.2	30.9	11.2	23.3	22.7	27.6	118.2	19.9	9.8	15.4	7.8	16.7	18.8	12.4	14.2	20.0	29.7	16.0	24.0	58.0	20.8	28.8	20.9	37.8	6.6	30.7	26.0	22.7	27.7	15.3	23.2	15.5	12.4	36.1	186.8	18.7	31.1	19.3	23.1	21.7	23.1	15.1	11.8	44.7	25.1	6.0	33.7	33.9	33.9	41.2	21.5	43.3	17.7	43.7	61.1	16.4	48.9	23.3	22.2	16.7	19.3	15.0	20.7	17.5	18.9	20.7	21.1	30.2	18.5	23.0	11.4	21.1	23.6	16.3	17.1	17.9	20.5	16.5	19.0	17.9	17.8	18.2	19.6	17.7	18.5	17.6	9.6	25.5	6.5	15.7	39.0	18.5	60.6	10.8	19.2	15.9	18.7	25.0	18.6	52.3	27.6	2.1	44.5	43.0	5.0	129.1	45.9	3.4	10.0	7.0	18.8	13.1	456.6	8.0	18.2	32.7	17.0	4.1	8.5	24.7	6.6	10.0	4.7	15.1	20.2	9.3	4.6	36.7	11.7	10.5	7.2	10.2	11.8	23.2	5.6	15.7	25.6	47.4	7.5	11.6	49.0	4.6	12.0	14.2	26.0	5.5	68.8	50.5	13.5	6.6	12.0	22.1	33.9	21.8	13.5	13.2	368.9	25.0	7.8	4.8	19.2
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271296-122338159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 8.3;testis: 7.8;urinary bladder: 20.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 123.2;Late spermatids: 69.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 33.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoli	Cytosol	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.1	0.0	1.0	0.0	1.4	0.0	0.5	1.2	2.3	0.3	0.7	0.5	0.0	0.1	0.3	0.1	0.4	0.2	0.0	1.1	1.2	0.3	4.0	0.2	0.0	1.4	1.4	0.0	0.1	0.0	0.4	0.1	1.4	0.8	0.0	0.0	0.4	0.0	0.3	8.3	0.1	0.1	1.3	0.0	0.1	7.8	1.2	0.0	0.4	0.0	0.1	20.2	0.5	2.1	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.5	33.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	1.4	1.2	2.3	1.1	1.2	1.4	1.4	1.4	1.3	1.2	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	123.2	0.6	0.0	0.2	0.0	0.0	0.9	0.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.4	69.9	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.5	9.8	1.1	3.8	0.4	0.0	0.1	0.2	1.0	3.1	0.0	0.0	0.4	0.2	10.0	0.8	0.0	3.1	0.1	0.4	0.0	0.0	2.9
BTBD7	"FLJ10648, FUP1"	ENSG00000011114	"BTB domain containing 7"	Q9P203	14	93237550-93333092	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049926, HPA053406"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"HPA049926: AB_2680956, HPA053406: AB_2682137"	"unprognostic (3.36e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.69e-6)"	"unprognostic (7.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.52e-2)"	3.9	2.7	1.2	2.2	2.1	5.6	3.4	3.6	1.8	3.4	0.0	3.3	1.8	3.5	1.5	4.5	3.4	2.0	3.1	1.2	2.7	3.9	2.9	3.8	1.2	3.0	3.1	3.5	3.4	4.0	1.9	2.6	2.6	2.9	2.3	2.5	3.6	1.7	4.7	4.1	3.3	2.1	1.7	2.3	3.0	8.0	3.6	1.2	3.5	1.6	1.4	3.5	3.9	4.1	6.6	4.0	5.2	1.8	2.9	2.5	9.0	6.0	3.8	5.0	3.0	4.5	4.9	4.3	4.9	6.5	3.6	6.1	4.6	10.4	7.7	5.1	3.5	2.9	2.5	3.3	1.7	7.6	3.6	3.6	2.0	5.1	7.3	3.8	7.5	1.7	3.1	3.5	5.2	7.2	2.0	2.9	3.2	3.3	11.2	5.9	7.6	0.9	6.1	15.5	6.7	6.2	7.9	3.0	2.1	5.6	5.3	5.4	8.9	4.2	4.3	3.0	5.3	2.5	3.5	3.9	2.1	2.1	3.0	0.8	0.1	1.3	0.3	0.2	0.1	0.6	0.2	0.3	0.1	0.4	0.1	0.2	0.5	0.1	0.3	0.4	0.4	0.0	1.2	2.1	3.6	1.8	1.2	2.7	3.0	3.1	2.6	1.7	3.6	4.1	53.6	51.3	27.7	76.4	29.0	32.4	29.0	18.1	26.7	27.9	31.9	23.9	20.9	30.0	19.6	55.2	37.5	24.2	31.6	34.5	13.7	32.3	47.9	58.2	55.7	48.5	28.8	23.4	80.2	24.6	22.5	35.6	29.0	75.5	24.7	33.3	51.4	18.6	17.8	26.9	81.6	26.2	14.2	27.7	39.5	45.7	23.6	36.1	10.6	99.3	39.5	23.9	26.8	89.0	175.7	45.2	22.0	39.5	36.0	45.8	22.1	39.3	22.9	30.4	13.1	58.3	56.4	23.7	36.6	32.9	36.9	30.6	28.2	33.1	27.7	64.5
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173801-84185294	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 193.2;intestine: 274.9;vagina: 115.3"	"Group enriched"	"Detected in some"	11	"Distal enterocytes: 853.2;Intestinal goblet cells: 267.6;Paneth cells: 815.9;Proximal enterocytes: 364.8;Undifferentiated cells: 402.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 91.5;head and neck cancer: 102.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 52.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.4	0.0	0.0	16.8	0.0	0.0	0.5	0.0	0.0	46.7	0.0	268.5	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	274.9	0.1	21.7	2.6	0.0	38.5	21.5	13.1	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	17.4	33.5	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	853.2	0.0	0.0	0.4	3.3	0.8	0.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	267.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	815.9	0.0	0.0	1.0	364.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.0	2.3	0.0	1.4	0.0	402.8	46.4
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 35.8"	"Group enriched"	"Detected in some"	18	"Early spermatids: 129.6;Late spermatids: 35.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022029			Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.3	0.2	0.8	0.5	0.8	2.6	0.7	6.3	2.2	1.3	0.3	0.6	0.3	2.7	1.3	0.2	0.1	2.1	0.4	1.3	1.0	0.4	0.7	0.2	0.8	0.8	0.1	0.2	0.2	0.4	0.1	0.5	0.8	0.2	0.7	1.4	0.1	0.1	1.3	1.1	0.3	0.2	0.0	0.5	0.4	35.8	1.1	0.1	0.7	0.0	0.2	0.5	0.0	1.8	2.0	0.3	0.2	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.6	1.2	0.4	0.2	0.0	0.7	1.4	0.0	0.0	0.2	0.3	0.3	0.8	2.0	0.5	0.0	0.3	0.7	0.0	0.3	0.0	0.0	0.0	0.3	0.7	1.8	1.6	0.0	0.4	0.3	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.2	9.1	0.2	0.0	0.5	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.8	0.0	0.1	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.8	6.3	2.2	1.3	1.0	0.8	0.1	0.8	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	129.6	0.5	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	35.7	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	4.4	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444064	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 200.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 41.8;RT4: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954, HPA076632"	Approved		Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.91e-4)"	"prognostic favorable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	23.7	37.4	25.0	4.4	26.4	2.2	37.3	21.0	20.7	14.5	68.2	57.7	6.0	15.3	16.3	31.2	18.3	16.5	22.0	24.6	38.7	14.0	5.3	19.5	4.2	24.6	35.0	21.5	12.0	29.2	8.4	12.4	25.1	41.4	11.6	14.8	16.9	22.5	7.5	16.1	12.5	11.5	27.4	4.0	27.1	33.4	31.4	9.4	9.7	13.0	5.2	26.5	17.3	28.4	1.6	1.7	9.8	2.8	9.3	8.7	14.8	9.3	17.9	5.9	4.1	41.8	6.0	14.2	1.2	6.5	6.5	3.4	5.4	6.2	10.2	4.7	4.5	3.7	2.0	2.6	5.2	3.3	1.6	6.4	4.8	4.4	6.8	7.3	8.0	2.2	0.7	3.2	8.1	2.8	3.2	2.4	7.6	5.4	2.7	2.8	1.3	2.3	8.3	43.4	1.2	3.7	5.1	11.8	12.1	11.8	18.4	4.9	7.6	2.5	2.7	5.3	7.6	2.5	2.3	16.3	2.8	2.5	5.7	6.7	2.6	5.4	2.6	2.4	2.0	2.7	3.2	3.4	2.6	1.6	2.3	2.3	5.6	1.9	2.1	0.4	3.6	2.3	25.0	26.4	21.0	20.7	24.6	38.7	24.6	35.0	25.1	27.4	31.4	28.4	6.9	16.0	11.9	52.2	2.4	3.1	12.6	6.6	7.4	6.4	27.1	14.4	14.5	4.3	13.4	11.0	6.2	26.4	3.1	3.9	11.7	10.1	200.0	8.3	9.2	5.4	2.4	1.7	45.0	10.6	14.0	42.5	5.6	3.7	4.5	4.2	3.9	1.9	6.4	1.7	32.4	2.4	16.2	3.5	4.7	32.1	15.5	5.0	12.4	24.4	5.6	14.9	7.2	50.3	43.3	10.3	2.0	11.7	4.6	16.7	0.8	5.0	17.7	5.2	6.6	9.4	16.8	46.0	5.0	16.0	4.4	29.0	3.6	3.9	2.3	21.7
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CCN6	"WISP-3, WISP3"	ENSG00000112761	"Cellular communication network factor 6"	O95389	6	112054075-112069686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 10.2"	"Cell type enriched"	"Detected in single"	7	"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"RT4: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	10.2	0.0	2.3	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CDH23	"CDHR23, DFNB12, USH1D"	ENSG00000107736	"Cadherin related 23"	Q9H251	10	71396920-71815947	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6;ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.4;Late spermatids: 67.7;Microglial cells: 33.7;Muller glia cells: 90.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 26.8;non-classical monocyte: 38.1;plasmacytoid DC: 9.5"	"Lineage enhanced"	"Detected in many"		"monocytes: 38.1"	"Group enriched"	"Detected in some"	4	"RT4: 13.4;SCLC-21H: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017232	Approved					NA	NA		950000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017232: AB_1845903"	"unprognostic (6.76e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.40e-4)"	11.3	3.3	9.6	2.1	11.6	2.2	6.2	10.6	7.9	3.3	10.2	1.7	1.1	4.9	1.6	1.8	8.9	2.2	5.4	6.3	16.2	0.9	14.4	7.8	1.7	35.6	18.5	35.3	8.4	9.9	1.2	0.5	34.7	3.7	1.2	14.4	1.2	0.7	2.7	1.6	2.3	2.1	8.6	7.0	1.7	11.0	23.6	5.3	1.8	2.5	1.4	4.2	2.6	8.8	0.0	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.9	0.4	1.3	0.0	0.0	0.1	1.2	1.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.1	1.5	0.4	0.0	1.1	0.0	0.1	0.0	13.4	5.3	1.1	0.8	0.2	0.1	1.1	0.1	2.2	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.2	1.5	1.0	0.0	0.0	6.0	5.1	0.1	26.8	0.4	0.0	0.2	0.1	4.9	0.0	0.2	0.6	6.1	0.0	38.1	9.5	0.0	2.9	9.6	11.6	10.6	7.9	6.3	16.2	35.6	18.5	34.7	8.6	23.6	8.8	8.2	0.0	0.6	9.4	1.1	0.8	4.1	0.3	0.6	1.9	0.2	1.1	4.7	0.0	1.0	1.8	0.0	1.5	11.5	0.9	0.0	0.4	78.4	1.9	0.7	10.0	7.2	0.0	1.1	0.4	4.4	3.4	1.1	0.3	0.0	0.4	7.9	20.4	2.2	0.0	2.7	1.1	0.0	12.2	11.6	67.7	2.5	15.0	7.2	33.7	10.6	90.7	3.1	1.5	8.5	0.2	7.5	0.7	0.4	2.6	1.6	0.8	0.7	4.2	6.6	5.1	1.7	3.4	1.0	0.0	1.1	0.3	1.0	0.2	0.7	3.6
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958423-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 36.4"	"Low region specificity"	"Detected in some"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.9	0.4	1.0	0.3	1.5	1.0	0.8	1.2	2.0	2.0	0.3	0.7	0.4	0.6	0.4	3.4	2.0	0.4	0.7	0.9	1.8	0.5	0.3	2.1	0.4	1.6	1.7	0.3	0.5	0.3	1.7	0.4	1.5	8.0	0.3	0.4	2.0	0.5	1.0	0.6	0.8	0.4	0.6	0.8	1.2	0.7	1.9	0.9	0.6	0.3	3.0	2.7	1.3	2.6	0.0	0.7	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.1	0.0	0.8	0.8	0.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.1	7.9	0.1	0.1	0.0	0.3	0.3	0.1	1.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.7	0.1	36.4	0.8	0.1	0.4	0.2	0.1	0.4	0.2	0.4	0.2	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	1.2	2.0	0.9	1.8	1.6	1.7	1.5	0.6	1.9	2.6	4.3	6.4	6.1	17.9	0.1	0.1	1.2	6.6	0.0	0.5	1.6	0.5	0.7	0.0	18.7	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.2	2.1	0.4	2.1	0.0	2.5	9.3	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.7	0.1	0.6	0.0	8.4	0.0	6.1	1.3	0.4	1.7	0.0	1.4	0.0	7.5	0.6	0.2	1.0	7.1	14.9	0.0	0.0	0.0	0.4	10.9	0.2	0.1	39.6	0.0	0.0	0.5	2.4	0.9	0.2	0.2	0.0	14.9	0.2	0.1	0.2	7.4
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: AB_2732242"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	9.8	8.1	7.8	15.6	7.9	22.0	9.1	7.1	9.1	9.8	6.0	12.4	15.9	10.7	3.3	15.6	8.7	9.9	10.7	6.9	7.0	8.6	9.0	12.2	20.9	7.9	7.3	6.2	11.9	7.6	9.4	17.7	7.9	9.9	8.5	6.3	9.4	9.6	8.0	12.3	15.0	12.6	6.0	17.5	12.9	15.4	8.6	25.2	9.1	9.2	13.8	14.4	10.8	9.1	11.0	24.1	19.3	1.6	16.8	21.3	41.0	23.4	17.9	23.7	22.7	20.6	8.7	0.2	21.6	25.3	16.7	18.6	2.1	21.5	12.2	1.3	21.0	36.5	16.7	24.4	42.0	1.2	67.5	32.4	20.0	19.6	13.5	15.5	30.1	2.8	15.9	0.0	16.7	40.4	24.5	25.3	27.4	20.9	19.8	2.9	2.5	11.4	15.3	49.4	20.8	28.2	18.2	20.0	17.8	22.5	34.4	36.2	33.3	1.2	4.7	11.8	7.7	37.0	0.1	4.2	0.0	6.8	21.7	38.3	25.5	35.5	16.7	29.6	15.8	10.5	13.2	17.8	20.7	6.4	12.0	13.3	34.8	23.2	31.5	10.6	21.5	19.3	7.8	7.9	7.1	9.1	6.9	7.0	7.9	7.3	7.9	6.0	8.6	9.1	11.2	12.8	19.5	20.5	17.2	6.1	7.9	6.0	4.6	22.1	8.2	5.7	9.9	4.3	15.3	7.3	93.8	12.3	29.4	17.9	9.8	10.2	53.0	11.1	14.3	13.1	21.1	13.0	33.4	13.8	15.7	10.8	28.1	12.2	66.4	14.4	11.4	7.7	19.4	21.9	32.0	10.2	14.2	21.7	9.3	89.1	7.5	22.0	10.6	24.4	29.4	8.8	40.2	18.1	31.3	16.9	11.4	8.6	24.2	11.2	11.7	4.4	10.8	117.9	19.7	9.2	10.7	19.0	24.6	11.1	9.7	23.7	24.2	16.1	8.6	13.8
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
COP1	"CFAP78, FAP78, FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1 E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207286	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.1;Extravillous trophoblasts: 33.5;Syncytiotrophoblasts: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	14.2	9.5	5.9	12.0	7.1	16.8	12.7	11.4	9.1	12.1	8.4	18.1	13.8	11.8	9.8	14.2	9.4	9.5	9.8	8.5	5.9	12.4	16.6	12.5	15.7	4.6	5.0	8.7	13.2	10.5	8.0	11.2	5.0	10.1	16.7	8.6	13.1	8.5	13.6	17.5	13.9	11.0	5.7	16.7	13.7	15.6	6.1	14.9	10.6	7.4	16.8	14.7	11.9	8.8	35.3	17.5	22.1	13.8	23.0	22.6	56.1	21.7	22.0	17.7	18.6	30.0	28.1	59.4	25.8	20.9	18.9	32.3	16.9	27.0	17.7	23.7	17.0	22.6	19.4	28.0	18.9	49.2	33.0	16.8	28.9	17.6	19.8	17.9	26.6	21.7	43.9	24.9	24.8	42.5	27.0	28.2	47.4	55.8	2.0	26.1	20.4	40.2	26.8	93.7	22.6	41.6	27.8	44.9	35.9	37.4	32.1	69.1	40.4	19.4	16.1	28.3	23.4	35.3	62.7	49.8	19.1	26.7	26.9	8.5	3.0	12.0	1.9	3.7	1.4	1.7	2.0	1.4	2.1	1.5	2.7	2.0	14.1	0.6	3.4	1.1	1.7	1.0	5.9	7.1	11.4	9.1	8.5	5.9	4.6	5.0	5.0	5.7	6.1	8.8	15.8	22.4	14.5	0.0	4.4	0.0	0.0	0.0	0.0	0.0	15.4	10.9	0.0	0.0	3.1	9.2	0.0	28.1	12.2	0.0	21.5	14.8	0.0	17.9	14.6	7.2	0.0	0.0	0.0	22.7	33.5	7.4	0.0	20.1	7.6	18.1	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	21.8	0.0	0.0	3.1	0.0	0.0	22.1	4.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	31.3	6.7	13.8	0.0	0.0
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.4;pituitary gland: 22.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 41.0;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 10.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SH-SY5Y: 1.8"									CAB025251	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"			"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.2	0.0	4.1	0.0	1.7	0.0	0.4	10.4	4.8	2.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	1.9	0.4	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	22.6	0.0	0.2	0.6	0.0	3.5	0.2	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.2	2.8	0.0	0.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.7	10.4	4.8	1.9	0.4	0.0	1.5	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.8	1.1	1.3	1.2	10.2	0.7	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	53.4	0.6	0.3	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	0.4	3.2	1.6	0.1	0.1	0.4	0.5	0.0	0.5	1.6	5.1	1.5	9.9	3.3	0.0	2.5	0.0	0.1	1.7
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747562-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	119	"salivary gland: 28401.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Collecting duct cells: 79.1;Glandular and luminal cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 1142.2"									"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA		6300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"prognostic favorable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.3	0.1	1.1	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.0	3.7	0.4	0.1	0.2	238.8	8.0	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.7	7.1	37.3	0.0	0.1	4.1	1.4	13.0	0.2	0.0	28401.8	0.6	0.0	3.2	0.0	0.0	0.4	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.7	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	172.6	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.4	0.0	0.1	0.0	0.1	0.0	51.2	0.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	45.3	0.1	0.0	0.0	0.0	4.4	1142.2	0.7	0.0	0.1	0.0	0.3	5.6	0.0	0.0	223.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.7	1.4	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	14.3	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.7	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	31.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.5
CST2		ENSG00000170369	"Cystatin SA"	P09228	20	23823769-23826729	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	637	"salivary gland: 5987.1"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 5.2;Melanocytes: 16.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 24.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RT4: 67.7"									"CAB024963, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (1.57e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.82e-3)"	"unprognostic (6.43e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-11)"	"unprognostic (1.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.1	0.2	0.1	0.0	0.2	4.8	2.4	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	1.6	9.3	0.1	2.0	1.0	0.0	2.5	0.0	0.0	5987.1	1.3	0.0	0.4	0.2	3.8	0.0	0.1	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.8	67.7	0.0	0.0	0.0	0.0	5.4	0.9	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	16.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CST4		ENSG00000101441	"Cystatin S"	P01036	20	23685640-23689038	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	514	"salivary gland: 29036.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.7;Collecting duct cells: 9.2;Glandular and luminal cells: 3.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.5;RT4: 13.6"									"HPA043706, HPA044763"	Supported				"Secreted to digestive system"	NA	NA		2800000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA043706: AB_2678627, HPA044763: AB_2679080"	"unprognostic (2.80e-1)"		"unprognostic (7.88e-2)"	"unprognostic (2.48e-1)"		"unprognostic (1.09e-1)"		"unprognostic (2.59e-1)"		"prognostic unfavorable (4.98e-5)"	"unprognostic (1.00e-2)"	"unprognostic (9.52e-2)"		"unprognostic (2.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.95e-2)"	"prognostic favorable (2.88e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	56.4	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	29.9	0.0	0.0	3.8	0.0	2.4	0.0	0.0	29036.2	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	13.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3
CYFIP1	"KIAA0068, P140SRA-1, SHYC"	ENSG00000273749	"Cytoplasmic FMR1 interacting protein 1"	Q7L576	15	22867052-22981063	"Predicted intracellular proteins"	"Cell shape, Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 253.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 23.5;intermediate monocyte: 24.9;myeloid DC: 22.0;non-classical monocyte: 12.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.0;monocytes: 24.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA068106	Approved					NA	NA		1100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA068106: AB_2685955"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.93e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-3)"	41.2	26.0	16.6	19.8	16.9	4.7	36.4	15.8	20.0	33.2	16.7	37.7	31.5	33.8	23.8	46.2	24.7	24.0	21.8	15.5	17.9	25.9	26.1	40.5	19.2	20.7	19.5	28.9	41.7	37.3	13.3	39.5	23.1	29.3	28.1	4.4	39.3	24.6	21.2	39.7	29.3	24.9	23.5	26.5	33.8	15.9	21.7	10.2	27.5	14.4	16.2	29.9	36.6	28.6	67.6	74.8	35.5	72.2	42.7	49.3	49.7	47.5	35.7	32.1	31.7	70.0	32.9	0.2	34.1	50.0	32.9	64.2	31.9	58.8	29.7	36.2	45.5	41.3	40.9	51.9	37.3	14.4	29.5	39.3	43.1	25.4	29.7	33.6	48.3	37.0	20.0	23.4	37.8	58.1	1.5	25.7	25.1	87.1	61.8	18.3	45.7	16.6	81.4	114.3	43.1	44.3	40.9	67.2	46.3	35.0	53.1	30.3	49.5	58.7	47.2	24.3	69.6	3.4	7.7	0.7	56.6	32.5	33.7	0.0	23.5	0.4	0.5	24.9	2.4	2.0	2.1	1.0	22.0	0.3	0.4	0.1	0.7	4.3	12.5	3.3	1.6	8.2	16.6	16.9	15.8	20.0	15.5	17.9	20.7	19.5	23.1	23.5	21.7	28.6	56.7	35.3	37.9	18.6	5.7	20.0	27.3	33.8	23.9	2.3	28.9	29.8	7.4	17.2	37.9	18.4	2.1	38.6	4.1	78.7	11.7	33.5	4.5	33.8	35.8	50.7	17.4	9.2	41.8	35.0	40.0	32.2	42.8	50.6	8.8	99.1	35.3	31.5	108.7	5.0	46.1	34.0	28.5	104.5	29.5	5.3	36.4	73.8	28.4	253.9	43.3	17.9	0.0	19.6	16.0	43.2	43.2	32.4	6.3	33.2	41.9	21.8	39.6	2.0	26.3	29.5	40.8	9.0	17.9	40.4	26.3	31.7	4.8	38.5	33.0	34.8
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.7;intestine: 83.4;liver: 146.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 91.4;Cytotrophoblasts: 116.2;Hepatocytes: 58.3;Oligodendrocytes: 68.5;Proximal enterocytes: 134.6;Syncytiotrophoblasts: 240.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"OE19: 16.9;RT4: 62.3;SK-BR-3: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	1.2	0.4	18.3	1.2	22.1	0.1	9.3	23.6	19.1	2.3	8.4	19.0	34.1	1.0	0.8	13.1	0.9	2.0	89.7	14.7	19.4	3.0	146.2	1.4	0.2	20.7	20.7	0.0	2.2	0.0	0.9	22.3	18.9	3.3	21.3	3.5	14.5	0.7	25.3	8.9	83.4	1.8	20.2	0.1	4.7	0.6	28.0	0.5	0.1	6.4	0.7	5.8	3.6	21.8	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.7	0.1	1.2	0.3	2.8	0.0	0.8	0.0	3.5	0.9	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	3.2	0.0	0.0	1.5	16.9	2.6	0.0	6.3	0.0	3.4	62.3	0.9	3.8	0.1	16.4	0.6	0.1	4.1	0.0	0.0	2.2	2.5	0.0	0.9	1.9	0.1	0.0	0.5	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.3	0.2	0.0	0.4	2.9	2.6	0.0	0.4	0.0	0.6	0.0	0.4	18.3	22.1	23.6	19.1	14.7	19.4	20.7	20.7	18.9	20.2	28.0	21.8	0.0	3.2	4.1	35.6	0.7	0.4	1.7	5.5	7.4	0.0	5.1	3.0	91.4	11.5	28.9	0.0	0.0	116.2	0.1	26.4	0.0	9.5	22.7	3.1	1.7	1.3	9.0	0.0	0.1	0.9	9.3	2.3	4.1	7.7	0.0	1.5	0.0	58.3	7.0	0.0	0.4	18.7	6.1	0.8	0.3	23.3	0.0	0.2	0.0	1.9	0.6	12.5	0.0	29.7	68.5	2.0	18.1	0.0	0.3	1.5	134.6	2.5	20.1	0.9	0.0	0.7	1.0	0.3	0.2	7.3	2.3	240.9	0.2	0.4	24.1	2.1
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 242.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1227.5;Club cells: 405.1;Respiratory ciliated cells: 763.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"RT4: 286.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	81.8	4.9	0.3	0.0	0.3	0.0	62.0	0.2	0.6	13.4	1.2	14.6	1.3	9.5	1.7	44.0	48.0	0.5	40.2	0.2	0.3	2.4	0.1	242.2	0.5	0.3	0.3	1.7	3.4	0.7	9.3	1.2	0.3	22.7	0.7	0.0	16.6	15.8	24.0	42.7	15.2	0.1	0.3	0.4	11.5	0.5	0.4	3.1	22.3	24.6	15.2	81.7	30.5	0.3	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	286.7	0.1	0.0	0.0	11.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.3	60.8	1227.5	89.3	0.0	0.0	0.5	139.6	111.5	36.5	0.0	2.0	1.5	6.4	1.5	405.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	93.8	12.5	23.5	0.0	0.0	0.1	0.0	0.2	47.9	1.1	8.5	6.3	0.0	1.4	0.0	0.6	0.0	0.1	0.0	48.8	0.0	0.3	0.9	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	6.9	0.0	1.1	763.9	0.0	0.0	3.0	23.3	0.1	0.1	71.4	4.1	0.8	1.8	0.0	0.0	163.0
D2HGDH	"D2HGD, FLJ42195, MGC25181"	ENSG00000180902	"D-2-hydroxyglutarate dehydrogenase"	Q8N465	2	241734602-241768816	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;T-cells: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056216, HPA060548"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA056216: AB_2683070, HPA060548: AB_2732650"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.05e-2)"	11.5	17.7	6.9	11.2	8.0	18.6	7.6	6.2	7.3	10.5	14.9	16.6	11.4	11.8	13.0	15.0	16.1	14.1	11.4	6.6	6.1	15.9	19.1	10.6	12.0	8.4	6.9	14.8	16.6	15.2	10.5	8.9	6.6	14.6	14.6	3.2	18.7	14.9	33.8	39.4	14.9	9.3	6.1	15.1	14.7	4.9	7.3	7.4	18.0	23.7	11.5	8.9	9.6	8.6	10.2	10.5	6.2	9.6	14.7	7.9	21.5	9.7	12.2	9.6	7.7	11.8	21.9	8.3	4.4	9.7	11.0	23.2	5.9	7.8	4.0	8.8	5.7	15.9	11.3	20.5	8.2	19.0	12.1	14.1	13.7	7.6	7.3	18.5	9.5	13.1	20.7	5.3	8.6	16.8	16.0	19.7	3.0	13.8	20.8	19.5	6.9	16.2	17.6	36.7	20.4	7.2	9.4	23.8	6.6	4.1	14.7	6.7	4.1	14.9	5.6	7.9	5.8	9.9	1.9	13.4	10.3	20.8	10.0	0.0	0.2	0.0	0.2	0.2	0.4	2.5	0.1	1.0	0.4	0.1	0.6	0.2	0.0	0.0	0.3	0.1	0.8	0.1	6.9	8.0	6.2	7.3	6.6	6.1	8.4	6.9	6.6	6.1	7.3	8.6	10.4	9.6	14.3	33.3	10.4	19.8	23.5	13.7	25.6	14.3	22.8	22.7	10.6	25.8	16.3	18.4	14.6	44.0	13.0	40.9	23.5	10.5	3.6	12.5	13.2	9.7	31.8	6.9	7.1	8.7	15.9	15.7	23.0	19.2	5.7	28.0	13.2	46.0	18.2	11.8	9.9	56.4	14.2	10.8	7.5	4.8	16.8	12.6	3.6	15.9	5.3	37.4	8.2	28.6	12.8	6.7	32.0	18.0	15.0	19.3	26.4	31.4	13.9	12.0	6.6	14.0	11.7	2.1	7.0	25.7	14.8	22.6	14.0	27.0	49.9	22.2
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	26.5	50.4	24.1	5.3	49.5	0.4	54.6	47.9	20.2	55.2	4.8	57.7	12.3	23.4	4.5	150.1	46.2	11.4	42.1	17.5	40.7	96.8	6.3	33.7	1.2	68.7	47.3	41.5	99.7	19.7	67.9	4.2	57.9	70.2	10.7	4.5	131.7	13.8	40.5	121.1	47.3	1.1	38.8	11.5	71.1	16.5	46.3	7.0	85.9	4.3	3.0	45.0	88.4	58.9	58.2	18.5	26.0	5.4	1.7	2.4	16.2	1.4	0.4	0.8	0.1	25.2	29.8	0.5	30.9	5.1	26.8	90.9	5.7	70.1	0.3	32.0	9.9	0.2	18.7	6.7	5.0	0.0	1.2	3.3	35.4	0.4	0.5	16.1	2.0	1.4	17.3	0.7	4.0	36.5	2.0	0.1	4.5	31.8	3.8	3.9	19.5	2.2	13.1	93.5	4.7	2.5	5.4	41.4	19.4	8.6	103.0	0.6	4.3	12.8	11.7	1.2	13.6	0.8	0.1	2.6	8.4	0.0	11.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	24.1	49.5	47.9	20.2	17.5	40.7	68.7	47.3	57.9	38.8	46.3	58.9	1.9	35.3	24.6	54.5	3.8	53.0	68.3	125.5	67.2	7.4	77.0	57.9	18.0	37.1	79.8	90.1	0.0	63.6	1.5	109.7	5.9	125.5	15.1	58.5	6.5	4.1	46.2	2.7	1.2	76.2	26.0	7.4	63.7	58.4	1.3	29.5	2.2	0.6	6.1	6.7	7.5	69.8	109.9	0.8	5.4	30.1	8.4	2.5	16.0	9.4	13.1	139.9	1.0	60.3	73.8	71.5	78.2	5.3	0.8	68.1	77.3	5.4	104.2	8.0	6.6	10.5	11.9	1.5	6.8	81.8	51.9	46.5	1.9	4.1	67.1	88.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 137.8;Urothelial cells: 147.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 25.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	3.7	1.3	4.5	2.0	25.8	1.3	3.5	8.7	5.4	4.4	0.0	3.7	1.5	6.4	6.9	4.1	4.3	2.5	3.0	7.3	4.4	3.3	1.0	7.8	2.2	0.0	7.4	2.8	1.0	0.7	2.6	4.5	0.4	2.8	3.3	2.6	3.0	2.1	1.5	3.2	2.7	4.0	0.2	1.7	2.6	2.3	9.7	2.7	2.5	2.2	1.3	5.3	4.6	2.8	5.6	6.6	4.3	3.6	1.9	4.2	0.5	3.4	2.7	2.2	2.8	0.6	4.7	4.3	4.1	3.7	8.3	11.8	3.8	7.7	3.3	3.4	12.4	7.6	3.6	0.4	2.4	3.3	2.0	1.6	7.7	4.3	17.0	3.4	9.9	5.3	3.0	2.9	3.8	5.1	3.4	1.7	1.9	5.2	4.3	5.0	3.8	2.9	7.4	16.7	2.5	2.6	3.1	4.0	3.0	1.8	3.4	8.9	9.8	4.1	3.8	4.5	4.7	1.5	1.5	4.8	2.4	2.9	3.1	0.6	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.4	0.0	0.2	0.2	0.4	0.9	0.1	0.1	0.3	0.3	0.1	4.5	25.8	8.7	5.4	7.3	4.4	0.0	7.4	0.4	0.2	9.7	2.8	64.8	22.4	20.1	8.8	1.9	61.7	58.1	61.1	15.9	44.5	13.6	8.9	8.5	24.3	44.7	11.0	4.2	3.7	2.2	29.0	1.9	11.3	25.9	64.1	26.0	50.8	47.4	2.7	85.4	7.2	2.2	17.5	15.3	46.2	7.6	5.7	23.2	3.2	6.8	1.7	60.2	18.7	14.2	5.6	43.1	20.1	3.4	8.0	8.8	56.2	8.6	18.8	1.0	54.3	11.0	27.6	19.2	9.1	6.2	137.8	13.1	8.4	91.8	2.6	26.3	16.2	54.1	3.8	3.8	19.7	33.1	2.9	13.0	11.5	22.0	147.3
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 138.4;tongue: 144.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 673.9;Late spermatids: 1608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	16.5	20.0	60.6	14.0	67.7	63.7	12.6	62.6	138.4	14.1	45.6	18.0	13.8	8.3	20.2	15.8	38.9	11.2	123.3	68.6	93.1	26.7	3.3	19.7	11.3	65.7	73.3	12.1	6.6	7.4	30.9	9.5	89.8	26.7	18.5	33.0	15.6	15.6	123.2	28.6	16.3	19.6	59.8	13.5	24.2	78.3	73.5	9.4	9.6	144.6	12.4	29.6	13.6	71.3	33.6	0.2	0.0	0.0	0.0	0.0	0.1	4.1	0.0	1.1	0.5	0.0	43.3	0.0	0.3	3.2	0.0	31.3	0.0	0.0	0.1	0.1	0.0	19.9	47.3	0.0	9.4	0.0	20.6	3.6	4.1	2.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	33.6	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.1	85.2	53.3	0.0	42.7	8.6	3.6	2.3	32.4	39.8	0.5	0.0	8.7	4.0	0.4	0.6	2.4	0.0	0.1	4.2	0.0	0.0	0.3	1.1	0.6	0.3	1.0	0.7	0.9	0.9	0.4	0.1	1.7	1.4	0.0	0.1	0.4	0.2	0.5	0.6	60.6	67.7	62.6	138.4	68.6	93.1	65.7	73.3	89.8	59.8	73.5	71.3	41.9	6.4	4.8	12.7	10.0	28.8	209.9	14.0	2.2	19.6	44.6	29.2	43.6	2.8	33.5	7.3	81.3	1.9	6.7	55.5	1.9	1.3	673.9	124.0	11.4	18.9	100.3	92.8	16.6	2.4	3.8	18.3	21.4	41.8	36.9	7.5	6.8	0.2	16.5	6.7	24.0	34.9	10.2	9.5	81.7	1608.0	10.2	51.7	51.6	6.5	3.5	10.3	6.2	15.1	19.0	5.1	55.3	11.3	3.7	115.8	15.8	7.2	138.9	22.6	6.6	17.4	20.2	33.8	27.7	16.9	46.7	6.8	37.1	6.9	42.1	190.1
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440036-175444182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 21.3;retina: 8.4"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 40.1;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 26.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 164.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 86.7"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.4	0.6	4.7	0.0	21.3	0.0	0.2	0.0	8.5	0.4	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.0	3.1	0.4	0.7	1.1	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.1	1.1	0.0	1.1	0.3	8.4	0.0	0.4	0.0	0.0	0.3	0.1	0.7	0.1	0.2	0.0	1.8	0.3	0.1	0.6	0.1	0.7	0.4	2.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.4	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	21.3	0.0	8.5	3.1	0.4	0.3	0.9	0.0	0.7	1.8	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	40.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	33.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208588	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.6;Oligodendrocytes: 33.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 34.5;CAPAN-2: 37.7;OE19: 35.4;RT4: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA056760: AB_2683228, HPA059294: AB_2683969"	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.57e-3)"	10.4	1.9	13.9	5.5	21.2	9.3	9.5	21.4	20.0	8.0	8.2	17.5	16.4	3.8	1.9	4.7	5.8	4.9	3.2	13.2	21.2	8.5	32.5	18.1	5.3	30.2	22.4	15.0	7.9	1.0	4.1	14.8	27.0	7.5	17.2	10.4	21.7	3.1	1.4	3.9	14.4	2.5	33.5	6.7	11.6	1.7	25.6	1.5	10.2	1.7	6.5	15.0	3.9	50.5	4.8	5.7	30.5	0.6	8.5	0.5	62.8	0.4	2.7	0.3	0.4	34.5	37.7	11.6	2.1	0.7	1.2	16.5	9.5	11.8	0.1	0.8	0.5	0.1	6.6	11.2	2.4	0.9	2.3	1.4	19.3	0.1	0.5	2.1	0.0	2.1	0.1	1.1	1.4	2.7	0.5	0.1	16.1	35.4	1.5	4.1	27.1	1.3	2.6	95.2	0.0	0.1	24.3	6.4	0.8	7.7	4.9	0.5	0.3	0.1	4.9	0.1	0.0	0.4	0.1	1.1	0.2	2.8	2.6	0.7	0.4	0.4	0.0	0.4	0.0	1.0	0.0	0.0	0.6	1.3	0.0	0.0	1.5	0.0	0.2	2.8	0.0	0.1	13.9	21.2	21.4	20.0	13.2	21.2	30.2	22.4	27.0	33.5	25.6	50.5	8.9	19.2	16.8	9.4	3.1	1.7	3.2	7.9	2.2	2.0	2.9	3.9	1.4	28.6	21.8	7.3	0.0	15.0	6.9	33.6	0.0	10.2	0.4	1.5	8.1	3.6	4.9	0.0	12.0	4.9	19.2	7.2	12.2	3.0	1.3	4.9	5.7	23.1	3.7	0.0	8.4	10.5	2.0	2.5	2.5	0.4	4.1	2.7	5.4	3.7	0.9	30.3	0.0	7.5	33.9	10.8	16.3	3.4	0.0	3.1	19.8	9.1	14.9	2.0	0.0	22.1	3.6	0.4	1.7	1.8	1.3	5.5	1.2	5.9	18.5	22.5
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 8.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 26.7;granulocytes: 22.7;Syncytiotrophoblasts: 22.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 49.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.9;HDLM-2: 13.2;HMC-1: 52.7;RT4: 45.3;T-47d: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.4	0.1	0.2	0.4	0.1	0.4	4.8	0.1	0.1	0.7	0.0	0.3	0.4	0.4	5.2	3.3	1.2	0.8	0.9	0.1	0.1	1.1	0.3	0.7	1.2	0.2	0.2	0.4	3.8	0.1	0.1	4.9	0.1	3.6	0.3	0.0	1.4	6.1	0.0	5.8	0.3	0.1	0.1	1.2	6.3	3.4	0.2	2.3	6.4	0.0	2.6	8.7	1.0	0.1	0.0	3.8	0.3	0.0	0.0	0.0	15.9	0.0	0.0	1.3	0.8	1.0	0.0	0.0	0.0	0.2	4.3	8.8	6.5	9.6	1.2	13.2	7.6	0.1	0.1	1.4	0.0	0.4	52.7	0.0	2.7	0.9	0.8	0.0	0.0	1.8	0.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	3.4	0.1	0.0	0.0	45.3	0.4	0.3	0.0	1.2	0.2	0.3	12.6	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	49.5	0.3	0.1	3.1	0.4	4.1	0.1	4.7	6.1	0.5	0.2	0.4	3.2	0.3	5.3	0.2	0.1	5.1	2.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.0	1.3	0.0	0.4	6.9	7.3	16.3	13.1	0.0	7.1	7.4	4.1	5.7	8.4	0.0	0.0	26.7	3.0	0.1	3.9	1.7	10.6	0.2	1.2	1.2	0.0	2.5	0.5	0.9	14.2	1.1	5.1	0.4	22.7	2.8	5.0	0.5	3.4	0.0	0.6	0.1	8.2	1.5	8.9	9.3	0.3	0.6	12.4	1.0	3.7	0.6	0.0	1.0	0.4	0.6	0.0	0.4	1.8	4.2	0.1	0.4	3.2	0.1	0.0	1.4	6.1	13.4	3.7	6.5	5.3	22.6	6.2	0.3	0.0	5.3
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924227-34462774	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.3;skin 1: 118.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064895			Supported	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA064895: AB_2685384"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	14.6	0.8	32.9	9.4	40.9	0.3	10.0	38.2	37.5	12.3	15.4	25.9	35.7	10.0	4.4	27.0	9.4	13.8	110.3	29.7	38.9	16.3	4.9	8.3	5.7	34.3	37.5	2.1	4.3	0.3	3.4	25.4	32.2	9.1	20.0	15.2	11.2	12.0	20.8	118.2	40.9	11.7	31.9	4.9	37.7	1.1	42.9	4.9	2.8	6.4	9.8	51.3	20.8	36.1	31.1	8.0	0.9	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	8.2	0.0	10.0	0.1	0.9	0.9	15.0	29.4	0.0	3.1	8.0	8.3	20.5	1.0	0.0	0.0	0.4	4.0	14.5	0.0	0.1	0.0	0.0	2.3	16.9	0.0	0.4	2.7	0.7	0.1	24.3	26.7	2.8	0.0	44.6	11.1	38.2	122.9	6.2	7.0	2.0	11.8	3.2	18.2	12.0	0.1	0.0	0.2	3.2	0.0	1.8	0.4	6.7	0.1	7.2	0.0	0.5	0.0	0.0	1.8	0.1	0.0	0.0	0.0	1.2	0.9	2.6	0.0	0.1	0.1	0.1	1.1	0.0	25.5	0.0	0.9	32.9	40.9	38.2	37.5	29.7	38.9	34.3	37.5	32.2	31.9	42.9	36.1	6.0	0.0	0.6	36.2	1.6	213.7	49.0	56.6	3.4	11.6	16.0	17.0	105.8	4.3	24.8	9.2	2.1	11.4	16.0	135.5	9.8	15.6	1.8	42.3	8.5	25.1	16.2	0.4	1.0	6.9	115.9	16.8	74.9	17.2	1.3	0.1	12.5	0.3	3.1	1.7	4.3	31.6	12.2	1.9	62.8	4.9	2.5	10.8	40.9	0.0	0.9	11.6	0.0	6.6	54.2	46.6	41.9	0.7	0.4	17.4	59.7	20.5	37.2	2.4	0.0	17.7	9.4	1.7	0.3	4.1	231.6	103.0	4.5	1.2	14.1	25.7
ELF4	"ELFR, MEF"	ENSG00000102034	"E74 like ETS transcription factor 4"	Q99607	X	130063955-130110716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 34.3;Granulosa cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058595, HPA060277"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Nucleoplasm	"HPA058595: AB_2683768, HPA060277: AB_2684239"	"unprognostic (1.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.43e-3)"	"unprognostic (7.86e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (1.43e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.42e-4)"	12.2	3.7	1.8	14.6	1.6	53.1	9.6	2.8	2.0	9.4	2.6	18.1	14.2	10.6	2.0	11.7	12.1	9.3	5.6	1.8	2.4	6.0	2.8	15.9	18.3	2.8	2.4	17.5	2.6	4.8	4.2	23.7	2.4	6.1	17.7	0.6	5.5	4.1	2.0	10.9	17.0	10.6	1.5	18.1	20.3	2.6	2.9	19.6	3.9	3.6	18.0	18.8	9.1	3.1	56.0	20.7	3.7	0.4	9.1	19.3	52.6	25.3	32.1	30.4	33.4	28.7	38.9	28.6	49.5	34.8	42.3	35.2	20.5	30.0	29.9	31.0	16.8	56.7	27.3	13.6	20.2	49.7	69.3	20.4	32.6	49.1	48.0	19.0	30.0	6.5	22.0	7.7	16.5	32.8	8.2	28.2	2.4	28.4	19.4	17.6	6.5	12.2	18.3	63.9	13.6	6.0	22.8	21.9	6.9	19.1	11.0	46.9	27.6	21.2	16.6	39.5	47.7	4.2	1.8	22.6	24.6	44.8	5.0	1.6	4.0	5.8	7.1	7.6	5.6	2.6	4.2	6.1	4.5	2.7	4.2	4.8	6.9	6.5	5.5	2.7	4.8	4.2	1.8	1.6	2.8	2.0	1.8	2.4	2.8	2.4	2.4	1.5	2.9	3.1	10.7	9.6	4.4	0.0	8.0	13.6	8.2	2.9	9.1	0.0	2.1	1.5	0.8	0.0	4.4	0.0	0.0	10.6	12.2	24.1	0.0	2.3	0.1	8.9	3.8	8.4	9.0	7.4	0.2	4.0	34.3	6.4	17.9	17.1	1.3	27.5	6.4	1.0	9.7	0.0	0.3	8.3	2.0	12.2	9.2	0.6	1.8	14.8	3.6	5.6	13.1	0.0	16.5	0.0	1.2	9.1	17.4	1.2	2.0	7.5	11.6	0.3	5.4	0.0	6.6	2.6	2.5	0.0	4.0	6.5	10.4	11.2	9.5	5.2	7.1	18.9
ENOSF1	"FUCD, HSRTSBETA, rTS, TYMSAS"	ENSG00000132199	"Enolase superfamily member 1"	Q7L5Y1	18	670318-712662	"Enzymes, Predicted intracellular proteins"		"Isomerase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 216.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA047829	Enhanced					NA	NA		7300	"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA047829: AB_2680170"	"prognostic favorable (2.27e-4)"	"unprognostic (8.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.44e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-2)"	8.4	25.0	3.1	3.2	4.4	7.7	9.3	3.3	7.2	10.0	5.5	12.0	5.5	6.6	2.1	12.0	10.6	3.2	11.0	2.9	4.2	28.0	29.3	8.1	2.8	3.8	3.4	8.6	15.8	5.0	11.3	4.0	3.7	13.3	3.9	5.9	14.9	2.5	5.0	7.5	11.0	2.3	3.2	9.5	14.6	5.3	4.0	3.2	18.6	1.6	1.9	9.0	8.1	5.3	3.5	9.6	6.0	5.8	1.6	2.1	5.2	4.9	5.4	1.0	3.6	10.6	10.5	3.8	1.8	0.8	4.1	4.1	8.0	3.7	2.2	2.6	4.4	7.2	12.0	5.4	6.9	11.8	3.2	3.2	8.5	1.7	5.7	1.7	5.7	10.5	6.2	9.6	2.0	8.8	13.8	7.3	2.6	13.1	5.0	4.7	2.2	12.7	5.3	14.0	7.6	3.1	7.7	8.4	2.7	2.2	3.2	14.2	2.9	2.8	5.4	5.5	2.6	14.0	15.2	8.1	12.8	8.3	2.6	0.0	0.5	1.4	3.5	1.6	2.7	0.8	2.3	1.9	0.8	0.5	3.3	3.4	0.1	1.2	0.6	2.4	1.7	0.9	3.1	4.4	3.3	7.2	2.9	4.2	3.8	3.4	3.7	3.2	4.0	5.3	17.9	35.3	99.5	36.9	10.1	11.9	29.5	29.6	24.5	35.2	38.4	36.4	19.6	28.6	44.7	47.8	116.7	44.6	25.6	36.7	115.4	32.4	7.0	61.6	32.2	19.6	24.7	73.2	4.2	14.4	27.7	26.5	61.2	40.1	22.2	26.2	23.9	56.6	39.1	0.0	7.6	36.0	38.7	12.6	8.8	6.8	23.6	20.9	19.6	30.0	12.1	30.9	24.7	38.2	143.6	21.9	36.2	28.2	25.2	25.9	50.9	216.9	78.3	98.8	13.1	38.7	15.8	14.7	29.3	39.8	12.1	37.8	22.0	67.8	49.4	20.8
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387184-40428744	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;cervix: 21.3;salivary gland: 22.4"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.2	1.3	3.4	1.1	20.8	0.1	2.4	2.0	6.5	21.3	0.8	3.5	1.3	3.1	2.4	6.5	0.9	2.0	0.6	4.5	4.5	2.6	0.1	3.9	0.4	6.2	4.0	1.7	15.8	0.5	2.9	0.5	6.1	3.4	2.8	2.6	22.4	4.0	1.2	2.9	1.4	1.9	2.2	4.2	6.8	0.5	5.3	0.9	5.5	2.5	1.7	13.0	3.6	4.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.6	0.0	13.0	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.0	1.5	18.4	1.8	0.2	0.4	1.1	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.0	3.5	0.2	0.0	3.4	20.8	2.0	6.5	4.5	4.5	6.2	4.0	6.1	2.2	5.3	4.7	5.5	3.2	4.2	4.9	0.2	2.3	1.3	2.3	8.0	0.7	6.1	0.3	0.5	0.0	5.1	0.0	0.0	0.0	1.3	1.0	0.0	2.7	0.4	7.6	2.5	0.7	2.4	0.0	22.6	22.5	0.0	0.4	2.6	14.9	0.0	0.0	0.0	0.0	0.1	0.0	92.6	0.1	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.9	0.0	3.7	0.0	7.1	5.9	6.9	0.0	0.7	0.1	1.4	0.0	0.0	1.9	0.8	19.7	0.6	19.9	0.2	0.1	14.5	2.3	0.0	0.2	0.1	0.2	4.7
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 66.0;skin 1: 65.8"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 226.6;Sertoli cells: 105.2;Suprabasal keratinocytes: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"MOLT-4: 39.6;RT4: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	9.2	0.7	26.9	1.8	42.0	2.2	3.6	9.7	66.0	18.6	9.2	2.6	0.0	8.9	2.3	10.6	13.5	1.5	3.2	27.7	14.4	4.0	1.5	4.0	2.3	12.9	14.1	7.9	12.4	0.9	2.4	0.4	12.9	14.3	0.1	2.8	5.7	7.3	1.4	65.8	5.0	1.6	12.6	4.3	3.3	5.0	16.7	14.5	9.4	0.7	2.3	7.8	18.5	48.7	0.2	0.0	0.0	0.8	7.5	3.0	0.0	0.9	0.8	0.2	0.1	1.0	2.3	0.0	0.0	0.1	0.0	8.8	0.4	0.0	0.0	2.0	0.3	0.6	0.0	0.3	1.2	9.7	0.4	1.7	0.8	3.0	0.0	0.1	0.5	5.2	2.1	0.0	0.1	0.2	39.6	5.8	6.8	1.4	3.6	0.8	0.0	0.0	0.0	71.7	0.0	0.0	3.3	2.0	0.0	1.5	6.1	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.8	0.4	0.0	0.3	0.3	1.6	1.1	0.6	0.5	0.3	1.4	0.7	0.5	0.0	0.1	0.0	1.0	0.7	26.9	42.0	9.7	66.0	27.7	14.4	12.9	14.1	12.9	12.6	16.7	48.7	1.9	3.2	1.7	6.2	12.5	54.4	30.7	13.3	42.1	12.1	1.8	6.7	3.0	45.8	10.0	7.3	2.1	0.2	1.9	0.1	5.9	28.2	0.9	5.7	20.0	2.8	1.8	8.6	65.1	6.8	0.0	15.6	6.1	7.2	0.0	3.2	1.8	3.5	4.2	0.0	43.4	0.1	0.0	13.2	10.4	8.3	30.1	8.9	12.4	8.4	7.1	226.6	5.2	5.5	4.6	32.4	0.1	9.8	1.6	11.0	0.0	0.6	4.9	6.6	105.2	31.5	20.5	0.5	7.2	40.0	118.5	0.3	14.0	0.7	0.1	22.2
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.1	1.5	0.3	2.4	0.0	1.0	0.9	1.4	2.5	1.2	1.9	5.3	1.3	0.6	0.7	11.1	12.3	5.3	1.0	2.4	5.6	10.2	0.9	1.0	1.8	2.1	0.9	34.2	2.2	1.3	0.2	1.9	2.7	3.3	2.3	1.3	2.3	0.0	0.7	1.5	0.5	1.1	0.2	12.6	2.4	4.7	0.7	0.6	0.0	0.7	1.9	0.5	1.3	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.4	0.9	1.4	1.0	2.4	1.8	2.1	1.9	1.1	4.7	1.3	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.8;RT4: 154.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	3.9	7.9	4.2	3.7	10.4	2.0	6.3	10.9	3.7	10.8	14.4	11.3	4.4	5.6	2.6	14.9	6.4	11.3	10.0	2.9	6.1	24.9	4.6	6.3	3.5	10.1	10.3	4.5	3.9	50.1	1.5	7.8	8.8	6.0	11.4	2.2	19.1	4.1	7.6	9.3	6.5	3.8	6.5	3.1	13.3	4.7	8.9	4.6	26.6	9.9	6.4	17.1	4.8	13.1	45.1	43.1	1.8	5.2	22.6	20.7	22.6	5.1	11.1	2.3	1.9	10.4	27.2	10.7	19.2	8.4	25.9	32.2	9.6	29.4	3.3	55.6	7.6	56.2	20.0	20.4	4.8	16.0	21.3	10.5	12.9	2.1	13.3	28.6	30.1	4.6	6.9	9.9	2.8	20.7	0.6	6.2	6.6	28.0	8.4	1.7	5.3	14.1	76.8	154.6	9.9	3.3	7.1	52.2	8.1	24.5	33.7	20.5	18.0	1.5	5.0	3.4	16.1	8.9	13.6	5.5	6.7	13.0	4.1	0.2	0.1	0.3	0.4	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.1	0.1	4.2	10.4	10.9	3.7	2.9	6.1	10.1	10.3	8.8	6.5	8.9	13.1	3.4	6.4	1.1	24.8	2.2	2.9	18.3	13.3	2.8	4.0	11.1	5.8	13.7	12.8	22.8	73.5	10.4	6.8	5.2	32.1	0.0	4.6	22.3	11.4	10.9	6.3	11.4	6.3	21.0	3.0	7.1	4.6	13.7	13.8	8.9	53.4	2.9	6.1	5.7	3.3	32.8	8.9	10.2	1.6	2.2	41.8	3.1	4.5	1.8	24.4	2.1	3.0	8.2	22.1	88.8	3.5	22.5	4.9	4.1	7.0	9.2	3.3	16.6	2.9	6.6	5.8	4.3	8.8	4.6	17.5	4.5	4.1	5.9	39.8	15.7	66.9
ERP27	"C12orf46, FLJ32115, PDIA8"	ENSG00000139055	"Endoplasmic reticulum protein 27"	Q96DN0	12	14914039-14938537	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"pancreas: 1802.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Collecting duct cells: 40.5;Distal tubular cells: 164.4;Endometrial ciliated cells: 40.7;Exocrine glandular cells: 39.7;Theca cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RT4: 102.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA039636, HPA052851"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039636: AB_10795403, HPA052851: AB_2681972"	"unprognostic (9.02e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.45e-2)"	0.9	0.8	1.2	3.7	0.3	5.3	6.7	0.0	1.4	6.7	0.2	0.8	1.1	1.1	2.1	1.4	77.4	1.0	1.0	0.9	0.0	27.0	0.6	11.9	5.0	0.1	0.0	1.6	1802.9	1.4	1.0	2.5	0.1	2.0	1.3	0.7	5.7	2.8	0.3	2.0	2.5	0.8	0.1	4.2	3.7	0.4	0.0	2.5	8.3	0.4	3.8	18.0	0.9	0.0	3.4	0.0	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.0	0.0	1.1	19.5	1.6	2.0	0.0	0.0	4.0	0.0	0.2	0.0	0.1	0.0	4.5	0.1	19.3	0.0	1.5	2.2	0.1	0.0	0.0	0.0	0.1	0.5	4.9	0.0	0.9	0.0	7.0	3.2	5.9	0.0	0.2	0.0	1.8	0.0	0.4	0.6	102.3	0.1	0.0	0.0	15.8	0.0	1.8	0.7	4.8	2.4	0.3	0.1	0.0	0.0	0.1	0.1	3.1	0.0	1.4	0.0	3.0	3.4	4.1	4.8	3.8	6.3	1.5	4.3	3.4	2.5	1.5	5.4	5.8	1.5	1.3	4.6	0.2	5.9	2.6	1.2	0.3	0.0	1.4	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	41.7	20.8	0.0	1.6	0.4	2.7	0.2	0.0	0.2	8.7	2.2	0.2	0.0	17.9	40.5	0.0	5.9	2.4	0.2	164.4	25.0	0.0	40.7	1.1	0.8	1.8	0.0	0.0	39.7	14.1	1.1	0.0	8.7	1.3	0.2	0.4	0.0	1.5	0.0	0.0	0.0	0.0	1.9	1.2	0.0	1.8	1.1	0.0	3.7	2.5	3.1	4.1	0.0	0.0	18.9	3.5	0.0	1.3	1.8	0.0	8.6	18.0	0.2	0.0	0.0	1.0	0.0	0.0	0.4	0.4	0.8	3.9	104.3	0.3	14.3
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027306	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 281.2;skin 1: 147.4;vagina: 101.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Cytosol	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	1.3	0.3	0.6	1.0	0.6	2.5	2.6	1.1	1.0	47.5	0.8	8.9	11.0	1.5	1.7	281.2	2.1	1.7	0.2	0.6	0.3	17.0	0.3	9.4	0.6	2.8	1.3	0.3	4.0	3.4	1.5	0.3	2.8	8.0	1.5	0.6	42.3	1.8	1.4	147.4	9.1	1.0	0.5	0.3	5.2	0.8	0.6	0.4	10.7	0.1	7.9	12.7	101.9	1.5	28.1	23.4	0.0	0.3	0.2	0.0	9.6	0.2	0.0	0.0	0.0	2.6	16.7	0.0	0.1	0.0	0.0	59.8	0.1	7.8	0.1	0.1	0.2	0.7	19.4	17.4	0.0	0.2	4.2	0.2	12.3	0.2	0.0	0.0	0.0	3.7	0.1	1.1	0.0	40.4	1.0	3.6	0.1	11.9	10.5	11.5	0.1	0.4	16.7	87.8	1.1	0.0	11.4	43.2	0.0	0.2	54.1	0.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.6	0.6	1.1	1.0	0.6	0.3	2.8	1.3	2.8	0.5	0.6	1.5	0.2	19.2	19.5	0.0	0.0	11.7	4.7	10.5	26.7	0.3	5.1	2.9	3.7	4.3	16.5	5.5	0.0	0.2	0.2	10.8	1.9	4.4	0.0	4.3	0.6	0.3	20.4	1.3	0.3	0.5	0.2	0.5	12.8	8.9	12.6	0.2	0.0	0.0	0.0	0.0	0.1	5.7	2.0	0.6	2.1	0.1	0.9	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.1	8.4	7.4	1.9	1.2	4.6	19.3	3.4	13.1	0.1	0.0	0.7	0.7	0.1	1.2	94.1	25.9	0.0	0.4	0.4	15.5	12.9
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	11.3	13.4	22.3	4.2	32.7	1.2	8.6	18.8	23.9	12.6	3.2	8.6	7.3	10.1	6.0	15.1	7.8	6.5	50.7	20.7	25.7	7.2	3.8	7.2	3.1	23.9	25.7	15.0	5.0	13.2	6.1	13.0	23.3	8.0	5.7	14.1	7.7	8.9	11.1	26.5	9.1	10.0	16.4	5.2	6.9	6.9	22.2	4.4	10.2	11.5	6.4	9.7	13.0	40.9	21.7	16.3	14.7	17.8	41.2	16.9	25.3	15.6	21.9	13.2	8.6	22.3	3.3	5.6	9.5	26.2	19.6	35.4	12.4	25.7	18.9	4.2	10.1	16.7	11.0	12.8	22.2	2.4	5.5	14.6	36.6	14.9	23.1	20.6	21.8	8.7	1.8	0.0	17.6	7.5	6.4	2.9	15.3	14.9	9.0	3.4	26.4	2.3	12.7	50.1	7.3	6.3	26.7	8.2	10.9	16.1	5.7	2.3	24.3	15.2	12.8	13.1	9.6	5.5	5.9	0.0	17.7	1.2	12.4	1.3	0.5	0.0	0.7	0.4	0.5	0.7	0.5	0.4	0.4	0.7	0.6	0.9	0.0	0.5	0.6	0.1	0.8	0.4	22.3	32.7	18.8	23.9	20.7	25.7	23.9	25.7	23.3	16.4	22.2	40.9	17.8	0.0	4.1	210.3	4.1	26.1	10.2	9.8	14.8	17.4	5.2	5.2	87.1	12.8	5.1	9.2	25.0	15.1	5.0	10.2	5.9	9.3	62.9	5.6	14.5	14.1	3.0	2.1	351.1	11.5	13.2	12.4	30.5	9.2	8.2	11.6	11.4	5.6	4.6	16.8	393.6	6.0	4.1	12.0	7.1	8.2	8.4	5.0	5.4	286.7	2.0	9.9	1.0	288.5	863.3	11.0	8.6	7.5	3.7	8.1	28.2	5.5	8.4	11.1	0.0	13.5	14.7	12.0	4.9	13.1	37.4	24.6	4.7	5.5	4.5	10.7
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505435-108593768	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skin 1: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebellum: 67.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 20.9;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	8	"cerebellum: 30.9"							NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favorable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.4	0.1	1.3	0.5	2.5	0.2	2.9	67.7	2.3	2.2	12.8	3.9	0.7	0.7	2.7	7.4	1.7	0.3	0.2	2.1	1.9	2.4	7.7	3.9	0.1	1.5	3.6	0.3	1.0	4.7	0.5	2.8	4.6	1.5	4.4	0.3	4.4	0.3	0.1	25.8	0.8	0.4	1.1	0.2	3.2	0.7	1.7	0.8	1.0	0.2	1.4	0.7	3.8	3.4	3.9	0.4	0.2	0.1	0.0	0.1	3.2	0.2	0.1	0.0	0.6	1.0	5.9	0.0	0.2	0.2	0.9	7.9	5.7	2.1	0.2	0.1	1.7	1.6	0.8	0.0	0.5	0.8	0.1	0.1	3.3	0.0	11.2	0.5	0.0	1.3	3.0	0.0	3.1	0.6	1.0	0.0	0.2	6.4	2.4	0.0	0.1	0.0	0.6	20.5	1.4	0.8	1.0	9.7	0.2	1.1	6.4	0.1	0.1	0.0	2.3	0.0	1.1	0.1	0.0	0.0	0.1	0.4	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.5	0.8	0.9	0.1	0.2	0.0	0.1	1.3	2.5	67.7	2.3	2.1	1.9	1.5	3.6	4.6	1.1	1.7	3.4	0.6	147.4	60.0	18.6	0.9	107.7	12.9	16.6	58.6	0.6	14.1	8.6	5.7	4.3	65.3	20.2	14.6	44.5	2.4	47.9	3.9	5.4	10.3	74.8	7.8	2.5	4.9	3.2	9.0	4.9	4.9	5.6	20.9	89.5	1.3	0.9	0.7	24.2	3.8	0.0	4.9	38.6	14.2	0.6	15.2	2.3	0.6	1.8	5.4	16.9	1.3	0.5	1.0	3.0	0.6	3.6	17.5	0.0	1.5	30.4	1.9	3.7	98.5	1.4	0.0	0.3	2.1	1.1	0.5	46.9	72.2	54.6	2.8	0.4	29.1	19.3
FAM110C		ENSG00000184731	"Family with sequence similarity 110 member C"	Q1W6H9	2	38814-46870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 248.8;Basal squamous epithelial cells: 90.0;Endometrial ciliated cells: 85.6;Glandular and luminal cells: 158.2;Urothelial cells: 236.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.3;HBEC3-KT: 10.3;hTCEpi: 10.1;RPTEC TERT1: 17.3;RT4: 24.5;SK-BR-3: 10.9"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.9"	"Low region specificity"	"Detected in some"			"HPA036144, HPA036145"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA036144: AB_10670710, HPA036145: AB_2674968"	"unprognostic (4.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.47e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.68e-1)"	11.1	3.4	2.0	1.8	3.2	0.1	5.3	0.0	2.5	8.7	3.3	8.4	10.9	3.9	20.7	32.8	8.7	8.4	3.2	2.5	0.5	16.5	17.5	3.3	0.2	1.1	0.5	6.5	14.3	5.3	4.0	0.2	0.7	4.2	10.1	1.1	5.8	19.8	0.1	9.9	9.6	1.8	0.6	0.3	7.5	3.6	1.2	1.9	5.8	0.3	2.2	11.1	15.4	1.7	5.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	8.3	0.0	6.3	0.0	0.3	13.3	0.0	10.3	0.0	0.8	0.4	0.0	1.8	1.1	0.0	0.0	0.0	0.0	10.1	0.0	1.7	0.0	0.0	9.1	0.0	0.0	0.0	9.0	6.0	0.1	1.2	6.1	3.2	0.0	0.0	0.0	17.3	24.5	0.6	0.0	0.0	10.9	0.0	1.0	3.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	2.0	3.2	0.0	2.5	2.5	0.5	1.1	0.5	0.7	0.6	1.2	1.7	0.1	0.0	5.8	2.3	0.2	22.9	248.8	12.1	90.0	0.1	9.5	4.7	5.8	27.1	17.4	35.0	0.0	0.0	0.7	40.1	19.6	13.5	0.2	85.6	14.2	1.6	29.8	0.0	2.7	5.3	0.0	4.4	10.2	158.2	0.0	57.3	0.7	13.4	0.1	3.3	0.7	35.8	6.1	0.3	0.7	0.9	2.1	1.6	0.0	0.0	0.0	2.2	1.0	0.0	0.3	9.0	38.6	1.9	1.4	23.1	14.6	13.3	4.3	0.1	0.0	0.1	3.4	0.5	0.2	71.8	30.1	0.0	2.6	0.1	11.1	236.0
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617448-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"		"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	5.6	5.6	13.8	5.9	13.2	1.1	27.2	9.7	14.6	16.9	9.1	10.7	6.3	8.2	7.2	8.4	24.0	6.1	10.5	13.9	14.5	5.3	6.9	21.0	8.5	14.0	16.0	16.2	76.6	2.9	26.5	6.7	14.6	32.2	15.2	6.4	52.5	16.2	16.2	8.4	8.5	4.9	7.8	4.0	35.0	17.9	14.9	8.0	37.2	15.9	7.4	26.3	6.6	19.5	0.3	12.2	8.0	2.4	0.0	0.2	1.0	4.6	21.8	0.2	0.0	74.3	8.6	1.2	20.6	0.6	5.8	0.4	13.9	0.5	0.0	0.5	6.5	0.7	1.4	1.0	1.3	1.1	3.2	1.0	0.3	0.2	0.2	0.5	10.5	6.8	1.2	54.7	12.2	91.8	2.7	0.1	39.2	76.3	0.0	8.9	22.5	109.6	5.4	221.3	4.9	3.9	6.4	42.7	14.3	22.7	33.8	7.9	0.0	0.0	1.6	0.3	10.3	1.7	17.2	2.6	0.2	0.8	5.3	0.9	0.6	0.8	0.1	0.7	0.2	0.3	1.8	0.0	0.5	0.3	2.0	2.6	2.9	0.7	0.0	3.5	8.9	0.6	13.8	13.2	9.7	14.6	13.9	14.5	14.0	16.0	14.6	7.8	14.9	19.5	8.5	105.8	22.2	13.7	1.7	2.3	14.7	1.7	5.7	7.0	26.3	11.3	5.2	5.7	12.6	7.3	8.4	1.4	2.3	3.7	7.9	5.5	22.6	17.8	4.2	10.3	42.1	0.8	24.0	14.6	21.2	4.9	19.4	23.4	18.4	1.3	22.1	7.0	5.4	11.8	24.4	60.9	24.4	3.8	4.8	57.8	5.9	4.9	12.4	22.5	0.4	3.9	0.0	17.1	44.8	19.1	1.6	1.9	6.6	24.2	3.0	1.5	14.5	3.7	0.0	7.7	3.7	1.0	5.0	3.9	3.0	0.7	3.4	1.8	5.5	24.3
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729940-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	0.5	0.6	18.0	0.2	20.3	0.1	0.4	19.8	14.3	1.3	5.9	1.4	0.2	0.7	0.1	0.3	1.0	0.0	1.7	14.5	14.7	0.7	0.0	0.0	0.0	26.9	20.8	0.8	0.5	0.1	1.2	0.0	16.3	0.6	0.0	0.6	0.8	0.5	0.2	0.3	0.4	0.1	23.9	0.0	0.4	0.2	19.9	0.0	0.8	0.1	0.2	1.1	0.7	23.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	20.3	19.8	14.3	14.5	14.7	26.9	20.8	16.3	23.9	19.9	23.6	0.7	0.0	0.0	56.2	0.0	0.3	0.2	0.1	0.0	0.8	1.0	3.6	2.9	0.0	0.1	5.5	0.0	0.0	0.0	0.0	3.9	0.1	0.0	24.1	1.8	1.3	0.0	0.0	0.4	0.0	0.0	1.2	0.0	2.4	0.0	0.6	0.0	0.0	0.1	0.0	0.6	1.5	0.0	0.0	0.3	0.4	0.6	0.2	1.8	1.9	0.0	18.4	0.0	22.1	19.0	0.0	0.0	0.4	0.0	0.2	0.1	0.4	0.1	1.1	0.0	1.6	7.0	0.1	1.6	0.3	0.0	0.0	0.1	2.2	0.2	0.1
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 26.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 611.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.5	2.0	2.2	0.3	2.0	1.1	1.3	1.5	2.3	1.4	1.3	1.0	0.3	0.9	0.9	0.9	0.9	0.5	2.3	1.9	1.2	2.0	1.0	0.7	0.4	1.4	0.8	1.2	1.3	0.2	2.9	0.3	1.4	1.3	0.4	2.7	1.7	0.4	1.3	1.0	0.9	0.5	0.4	1.7	1.1	26.1	1.7	0.2	1.4	0.1	0.3	1.0	0.8	2.9	0.2	0.3	0.4	0.6	0.4	0.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.5	0.1	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.9	0.0	0.2	0.2	0.6	0.5	0.2	0.4	0.1	0.6	0.1	0.2	0.1	0.4	0.2	0.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.3	1.1	0.3	0.2	0.2	0.2	0.4	0.5	0.2	0.1	1.3	0.5	0.1	0.8	0.3	0.9	0.4	0.3	0.3	0.2	0.3	1.6	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.4	0.1	0.4	0.1	0.0	2.2	2.0	1.5	2.3	1.9	1.2	1.4	0.8	1.4	0.4	1.7	2.9	0.5	3.2	2.2	17.0	0.4	0.0	1.8	0.3	0.6	12.2	1.3	0.8	1.4	2.8	0.2	3.7	52.1	0.6	0.1	0.5	0.0	1.5	138.7	2.1	2.0	1.5	1.2	0.0	11.9	0.7	0.7	1.4	3.1	5.6	2.5	2.0	2.2	0.8	0.9	0.0	10.2	1.1	0.0	1.3	0.4	611.8	4.1	1.4	0.0	2.8	1.1	2.7	1.0	6.6	10.6	1.6	1.8	3.0	2.0	2.5	0.5	0.3	0.2	19.0	0.0	6.5	1.4	13.1	4.0	0.4	0.1	2.5	1.1	4.0	1.4	1.1
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668668-13732346	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 437.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	21.1	16.2	19.3	23.0	36.0	74.9	20.6	34.3	31.5	23.8	24.5	32.9	38.7	24.7	24.9	50.9	17.7	13.7	20.0	22.6	29.7	14.0	5.0	20.2	20.5	48.4	29.9	19.9	21.3	29.1	15.6	24.6	44.1	20.5	37.6	32.6	18.2	15.4	15.2	12.2	21.1	30.7	37.3	20.5	62.0	20.8	32.1	16.5	19.8	18.6	23.9	28.4	30.0	94.8	79.5	50.6	49.1	38.4	45.9	52.6	26.7	69.2	27.6	50.0	52.7	53.5	66.4	100.9	30.2	55.5	74.3	84.3	73.2	69.9	76.1	30.0	59.4	43.4	44.8	0.2	44.1	87.9	33.7	40.2	70.3	36.2	107.7	36.9	49.6	50.2	68.9	29.3	41.5	39.9	65.5	26.3	25.8	100.1	72.6	56.9	62.6	28.4	48.4	126.4	37.7	27.3	65.5	61.6	34.4	56.2	37.8	54.1	62.1	68.5	58.2	63.7	58.4	16.4	59.6	84.7	43.4	26.4	42.4	10.4	24.9	28.0	7.7	21.3	5.4	3.5	3.7	6.6	28.5	5.5	3.3	5.5	38.9	9.1	18.2	4.4	5.3	7.7	19.3	36.0	34.3	31.5	22.6	29.7	48.4	29.9	44.1	37.3	32.1	94.8	38.6	35.3	21.1	80.0	24.2	32.2	24.2	21.5	41.5	46.0	27.6	20.3	24.1	5.7	26.2	22.0	41.7	25.7	40.2	59.8	5.9	12.8	100.8	21.1	36.5	31.4	36.0	38.5	146.0	25.9	18.5	26.8	114.7	26.2	38.7	23.3	29.6	2.5	33.9	47.1	113.5	28.8	26.4	53.5	57.0	181.3	26.8	48.8	35.6	71.2	54.8	20.6	20.6	93.5	437.2	29.3	43.4	25.6	36.1	30.8	23.3	8.7	18.7	50.4	26.3	29.3	29.3	41.6	32.3	116.9	19.9	9.9	25.8	17.0	47.7	42.0
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 37.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 35.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	13.3	3.7	17.5	2.1	15.9	2.7	6.2	23.8	18.7	6.3	6.4	6.8	2.2	4.7	2.4	15.4	5.3	5.5	19.6	15.4	8.9	6.4	7.5	3.2	3.7	10.7	6.7	10.2	4.8	2.5	4.1	3.8	9.1	8.9	8.7	4.9	7.4	7.8	1.6	37.5	4.9	7.4	4.9	3.1	3.8	4.7	11.1	4.0	4.6	2.4	4.0	7.7	9.7	13.1	9.1	11.4	0.3	7.2	15.3	0.8	3.3	1.2	6.7	5.2	4.9	3.8	3.4	0.9	17.5	10.3	9.0	15.5	0.6	6.6	3.4	0.8	0.4	0.3	3.0	0.6	2.7	0.9	2.5	5.5	10.2	5.4	0.4	8.2	3.3	0.4	5.4	1.2	7.2	8.1	0.6	1.4	8.1	3.0	20.4	0.2	0.1	1.1	3.4	35.3	0.4	10.8	17.7	2.2	0.1	4.8	9.2	1.7	4.0	0.5	0.4	0.3	0.9	3.5	8.9	1.9	9.0	0.2	0.3	1.1	0.3	0.2	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.4	0.3	1.7	1.7	0.2	0.5	0.3	0.2	17.5	15.9	23.8	18.7	15.4	8.9	10.7	6.7	9.1	4.9	11.1	13.1	0.2	3.2	15.0	2.3	0.1	5.9	4.1	1.4	9.1	7.5	3.8	4.2	9.5	7.2	6.4	1.8	0.0	36.1	0.5	0.2	1.9	1.5	3.7	1.9	3.6	3.2	0.0	0.0	4.8	0.8	4.8	2.7	6.1	1.6	7.6	2.3	1.4	3.2	4.9	8.4	4.6	0.2	8.2	0.3	4.9	2.5	2.8	2.1	0.0	1.0	1.1	5.6	0.0	3.0	4.1	0.3	0.0	4.1	1.9	2.3	6.9	7.3	4.7	3.0	0.0	1.8	1.5	6.4	2.0	13.5	17.8	27.0	1.3	0.4	0.2	5.3
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FRY	"13CDNA73, bA37E23.1, C13orf14, CG003"	ENSG00000073910	"FRY microtubule binding protein"	Q5TBA9	13	31846713-32299125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 26.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 185.6;Excitatory neurons: 259.2;Inhibitory neurons: 272.7;Oligodendrocyte precursor cells: 229.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 7.6;eosinophil: 11.8;neutrophil: 8.3"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 12.3;RT4: 25.1;THP-1: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041635	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041635: AB_2677588"	"unprognostic (4.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (2.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.25e-2)"	7.3	1.9	8.2	2.1	8.4	7.4	4.8	18.0	9.7	3.7	0.0	6.0	1.4	3.5	2.7	1.9	5.1	6.1	26.1	8.9	6.6	5.6	4.3	6.7	2.3	4.0	3.2	2.4	7.7	2.8	5.5	2.7	6.5	4.5	2.1	11.2	2.0	5.9	13.6	5.4	2.4	5.8	2.7	3.1	4.6	2.8	5.7	3.1	3.3	19.7	1.1	7.1	2.8	3.4	0.0	0.0	0.7	0.5	1.4	1.4	0.0	2.1	7.6	0.7	0.8	7.0	0.0	1.3	0.2	2.3	2.3	0.6	1.0	0.0	0.7	3.2	0.4	0.9	1.6	2.3	6.7	1.8	0.7	0.3	0.3	1.0	0.7	0.0	12.3	1.3	0.0	4.0	1.1	0.1	0.1	4.3	1.7	0.8	0.6	0.0	1.0	3.0	0.5	25.1	1.8	1.4	3.6	2.2	0.2	0.8	0.3	15.8	2.9	0.7	0.3	0.5	0.3	2.3	2.6	0.1	1.1	2.3	1.1	7.6	1.1	11.8	0.3	0.5	0.3	0.0	0.4	0.2	0.8	0.0	0.2	0.1	8.3	0.3	1.2	0.0	0.1	0.2	8.2	8.4	18.0	9.7	8.9	6.6	4.0	3.2	6.5	2.7	5.7	3.4	53.9	16.0	29.5	17.3	3.0	4.2	9.6	2.1	6.8	47.1	12.7	7.2	73.4	27.1	14.3	14.7	185.6	0.3	7.1	0.7	1.9	6.0	1.9	7.7	3.1	54.3	2.4	6.1	259.2	5.1	0.2	9.6	21.4	3.7	6.3	3.5	36.0	19.9	1.2	37.0	272.7	8.1	10.2	8.1	8.3	4.4	5.9	14.0	17.8	66.5	16.9	8.1	5.2	229.2	20.6	4.2	2.7	25.6	3.1	4.0	0.8	0.7	11.0	6.8	19.7	17.3	49.3	3.7	5.7	0.6	4.3	0.1	3.0	4.5	0.8	8.4
FSIP2	FLJ34780	ENSG00000188738	"Fibrous sheath interacting protein 2"	Q5CZC0	2	185738804-185833290	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 18.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 137.8;Alveolar cells type 2: 93.8;Early spermatids: 289.6;Gastric mucus-secreting cells: 68.3;Spermatocytes: 124.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036139			Approved	Microtubules,Mitochondria		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Microtubules	Mitochondria	"HPA036139: AB_10602134"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.64e-5)"	0.1	0.2	0.3	0.2	0.5	0.0	0.2	0.3	0.3	0.2	0.0	1.5	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.2	0.4	0.1	0.6	0.2	0.9	0.6	0.2	0.0	0.0	0.2	0.2	0.0	0.6	0.0	2.6	18.3	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.2	0.3	0.5	0.4	0.6	0.6	0.3	0.9	1.7	137.8	93.8	5.2	2.6	0.5	0.1	1.4	1.8	16.3	3.0	1.7	3.9	0.0	31.5	0.0	10.4	0.3	1.0	26.0	0.0	0.7	289.6	3.3	3.3	5.6	7.7	0.0	4.5	0.2	0.1	7.3	68.3	2.1	40.4	2.7	1.8	0.1	0.4	18.5	5.4	19.7	0.0	0.8	1.0	50.8	2.1	5.9	1.8	3.7	0.7	3.9	2.1	23.6	14.0	5.4	5.5	3.8	1.3	0.2	0.5	0.2	46.0	7.2	0.0	4.0	0.8	124.4	5.4	0.2	0.3	0.3	6.0	2.6	5.2	0.2
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain autophagy adaptor 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 263.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	16.7	13.0	10.5	9.7	12.0	6.5	13.4	9.6	9.4	23.1	11.3	42.0	8.0	25.6	10.3	21.3	15.4	18.7	66.8	8.6	10.3	10.7	10.8	14.7	8.6	15.5	10.8	23.1	12.7	20.3	7.6	8.2	14.8	19.3	10.7	33.0	14.9	22.9	263.3	19.3	14.4	28.2	15.1	10.2	20.4	3.3	11.9	10.5	16.5	104.6	8.2	39.6	16.9	15.1	10.8	10.3	3.0	13.0	27.9	21.8	4.9	10.2	23.7	13.1	14.6	5.6	9.3	7.9	5.6	14.2	12.7	7.9	8.5	17.0	15.7	3.3	9.0	11.4	8.7	6.3	19.0	8.8	7.9	24.3	16.7	21.1	20.5	20.3	26.7	13.4	7.4	11.3	9.5	6.7	9.0	5.5	4.5	8.8	9.8	3.1	8.3	4.4	15.9	37.2	2.2	3.4	6.4	20.0	17.6	4.4	9.7	5.7	20.8	5.0	5.9	17.0	5.7	6.4	4.4	2.7	17.2	11.1	9.6	0.7	0.5	0.3	2.0	0.5	2.7	0.2	1.2	2.1	0.2	0.2	0.5	0.7	0.4	1.5	0.3	1.3	1.2	0.7	10.5	12.0	9.6	9.4	8.6	10.3	15.5	10.8	14.8	15.1	11.9	15.1	9.5	28.9	13.7	12.4	4.8	4.1	4.8	5.6	3.4	11.2	8.5	4.8	89.3	8.6	13.0	16.5	35.5	4.3	8.7	6.8	3.9	8.8	0.1	6.4	8.9	9.3	9.6	6.9	0.8	8.3	2.2	14.0	12.8	11.2	2.5	14.9	11.4	9.2	4.1	0.0	0.8	7.6	2.0	5.8	4.6	1.6	12.8	5.1	10.6	10.3	4.0	20.0	6.2	8.0	21.2	11.0	2.5	17.7	3.0	17.3	8.7	6.2	18.6	37.1	6.6	20.8	12.8	2.3	0.8	8.4	4.1	2.9	12.7	6.1	6.2	7.9
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	66.6	89.2	3.1	31.8	3.2	8.0	64.6	2.8	4.7	80.4	2.5	100.4	15.0	63.4	11.7	41.2	64.4	22.7	21.4	2.5	4.6	27.3	27.7	89.7	26.2	8.8	5.1	60.5	7.5	27.9	13.8	8.1	5.7	54.6	18.4	0.5	34.6	20.6	53.8	55.4	62.0	31.8	3.7	51.1	46.0	9.0	6.4	9.3	21.1	16.5	15.9	83.8	65.4	4.0	5.4	0.1	0.0	0.0	19.1	12.5	1.9	2.1	17.0	2.1	6.8	0.0	5.0	0.0	20.3	14.0	14.8	0.7	0.0	0.1	1.3	25.9	0.0	0.1	3.1	1.3	2.6	0.5	0.9	14.1	0.0	5.1	0.0	9.3	18.1	0.0	0.3	0.4	7.4	0.0	0.0	4.3	0.0	4.6	0.1	0.0	7.5	0.0	3.7	21.6	0.0	0.2	7.4	1.5	0.1	0.5	0.1	1.0	13.9	2.7	0.1	3.1	1.5	14.0	0.0	0.0	6.9	0.1	0.1	19.1	31.4	10.9	34.4	42.8	43.3	4.7	32.4	32.9	11.6	3.4	24.3	25.4	139.4	26.7	77.8	0.6	79.1	32.5	3.1	3.2	2.8	4.7	2.5	4.6	8.8	5.1	5.7	3.7	6.4	4.0	35.4	25.6	34.3	0.7	21.5	46.5	123.5	24.9	18.2	0.2	56.1	30.4	4.1	27.1	27.1	18.4	0.0	40.2	47.7	41.9	0.0	113.9	35.7	59.6	39.7	60.5	10.2	8.2	0.6	73.2	51.2	41.2	18.3	152.4	47.4	2.5	28.2	30.5	33.2	0.0	1.1	15.7	8.2	84.5	29.4	33.3	4.7	81.1	8.8	14.0	60.6	0.5	110.2	1.5	0.1	73.2	25.9	8.6	17.3	80.3	128.3	12.2	27.5	0.2	19.7	81.9	45.2	1.8	4.6	24.9	61.8	57.7	81.8	33.3	15.3	87.0
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1 activator of EIF2AK4"	Q92616	12	120127202-120194715	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	17.2	16.5	9.5	16.0	11.6	19.1	16.9	10.3	10.1	17.1	12.7	18.7	12.1	20.0	9.5	22.3	17.3	9.5	16.1	8.9	9.4	16.2	17.8	16.0	18.3	11.6	10.6	20.2	22.9	18.0	21.1	16.5	10.0	15.8	12.4	8.8	18.2	12.7	44.4	22.0	18.1	14.7	9.2	20.5	20.5	17.9	11.8	18.3	19.7	22.9	16.3	18.6	16.4	13.4	51.4	99.3	35.1	39.7	54.4	32.7	122.4	44.9	38.9	45.8	37.2	85.6	34.5	67.8	49.6	64.8	29.0	49.5	82.1	63.5	28.4	45.5	66.9	84.0	65.5	59.8	35.2	78.2	51.5	40.3	36.3	54.3	50.9	40.2	42.5	30.3	100.3	17.0	38.8	51.6	49.7	59.1	62.3	48.8	59.9	59.7	36.0	67.3	31.2	172.8	57.4	57.4	73.8	31.7	26.5	33.1	67.5	43.8	58.6	37.3	41.0	24.7	47.0	66.2	65.4	67.1	35.7	40.5	38.2	0.7	1.8	1.3	3.3	1.7	4.1	2.0	2.6	2.7	2.3	2.1	1.9	2.1	0.0	1.8	4.1	2.7	2.6	1.9	9.5	11.6	10.3	10.1	8.9	9.4	11.6	10.6	10.0	9.2	11.8	13.4	12.0	9.6	17.9	0.0	11.2	0.0	6.8	0.0	9.6	14.1	11.9	13.6	0.0	12.8	9.3	22.0	10.4	14.2	12.0	8.1	1.9	15.6	1.9	9.0	14.1	10.5	3.6	16.2	0.0	15.9	38.2	10.5	25.5	14.9	5.1	25.7	10.4	24.6	11.2	16.8	0.0	11.4	0.0	9.1	0.0	3.5	14.3	8.9	0.0	0.0	11.1	9.0	7.2	0.0	0.0	18.6	8.6	12.8	17.7	15.7	11.1	9.1	2.9	12.1	6.6	16.4	8.9	8.8	20.8	14.1	0.0	14.6	10.1	14.3	11.7	15.8
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20667144-20679243	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 9.8;seminal vesicle: 22.4"	"Group enriched"	"Detected in some"	12	"Endometrial stromal cells: 137.0;Granulosa cells: 83.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 4.4;RT4: 8.3;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069106			Approved	Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA069106: "	"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.4	0.4	0.2	1.0	0.5	0.2	0.1	0.0	2.5	9.8	0.0	0.5	0.2	7.2	3.3	0.9	0.7	0.6	0.8	0.4	0.1	3.6	5.0	0.4	2.3	0.3	0.1	0.3	0.6	0.1	0.3	0.8	0.0	3.8	0.2	0.1	0.1	22.4	0.0	1.3	1.6	1.1	0.0	1.3	0.7	0.2	0.3	0.2	0.2	0.6	1.8	1.1	6.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	1.2	8.3	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.5	0.4	0.1	0.3	0.1	0.0	0.0	0.3	0.6	0.1	6.4	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.5	0.0	0.0	8.8	2.8	3.1	5.5	0.0	0.0	0.1	0.1	1.9	0.1	0.1	3.5	137.0	1.8	0.0	2.7	0.2	0.0	0.1	1.3	0.0	2.9	0.0	83.7	0.0	8.2	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	4.1	0.7	0.0	0.0	0.3	7.1	0.5	1.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232365	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.6;esophagus: 195.4;vagina: 139.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Cell line enriched"	"Detected in some"	10	"RT4: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	0.5	0.2	55.8	0.3	59.4	95.6	3.8	73.0	80.9	65.9	36.0	0.0	0.0	0.9	0.2	195.4	0.4	1.3	0.1	50.2	63.5	0.0	0.1	0.3	0.8	60.0	71.8	0.0	0.1	0.0	4.4	0.0	57.5	0.2	0.1	0.0	34.5	0.0	0.1	56.8	0.2	0.0	47.7	0.2	0.3	1.4	76.3	37.6	5.3	0.0	15.4	10.3	139.3	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	4.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	186.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	1.1	0.6	0.5	0.0	0.0	0.0	2.6	0.2	55.8	59.4	73.0	80.9	50.2	63.5	60.0	71.8	57.5	47.7	76.3	42.7	0.0	0.0	0.0	58.8	0.0	12.2	1.7	15.6	4.0	0.0	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.9	5.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	12.2	0.0	0.4	4.6	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.1	0.3	31.0	3.8	0.0	0.3	0.0	0.0	2.4
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850945-109880541	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 334.1;skin 1: 276.6"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 266.5;Suprabasal keratinocytes: 479.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056461, HPA065503"	Approved		Supported	Cytosol		NA	NA		25000	"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA056461: AB_2683138, HPA065503: "	"unprognostic (1.18e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (4.17e-6)"	"unprognostic (3.28e-2)"	19.0	21.7	59.1	17.5	98.8	19.3	27.1	93.6	75.1	94.4	43.1	38.4	14.6	15.9	34.8	334.1	13.6	14.2	21.0	62.3	69.9	53.2	15.1	24.4	19.3	110.3	89.5	18.2	23.8	31.4	12.5	17.8	102.5	29.4	31.8	7.0	84.7	19.1	18.6	276.6	32.1	18.8	84.0	21.5	21.6	16.3	87.3	18.0	23.5	18.1	108.2	33.6	178.0	138.5	39.3	27.9	15.5	16.7	36.2	41.4	11.0	47.4	58.2	36.0	29.7	11.3	14.9	34.5	25.3	57.8	17.5	47.3	24.2	54.9	50.7	35.0	21.5	22.6	15.9	16.5	31.6	24.6	25.5	30.1	68.8	64.6	45.3	53.9	61.3	34.8	10.1	22.5	53.2	52.9	33.6	19.8	28.1	32.0	36.8	29.3	36.4	36.3	20.5	116.1	20.0	19.8	30.1	77.1	26.0	14.1	36.1	8.6	83.2	41.4	21.9	61.5	36.5	30.1	27.7	23.8	83.0	25.1	25.9	42.6	65.7	37.3	51.5	66.0	32.4	23.9	31.0	46.5	48.8	21.5	20.1	35.8	32.9	42.4	57.0	8.0	37.6	40.6	59.1	98.8	93.6	75.1	62.3	69.9	110.3	89.5	102.5	84.0	87.3	138.5	48.1	25.6	60.9	10.4	37.5	145.4	109.1	72.1	88.2	11.4	55.6	44.4	14.6	18.6	62.7	44.1	14.6	86.5	48.3	95.6	199.6	39.0	20.5	30.1	33.3	47.9	32.4	10.1	9.9	56.5	20.0	35.0	28.5	59.1	20.8	19.0	34.2	15.3	34.5	13.5	11.4	39.2	50.8	61.6	84.6	11.7	23.0	55.3	60.5	13.1	61.8	23.4	64.9	21.6	140.1	53.5	40.0	18.0	26.2	80.6	102.3	38.2	25.2	12.3	39.5	23.5	37.3	22.9	20.8	266.5	479.2	210.6	46.3	31.4	59.1	129.0
GPATCH2L	"C14orf118, FLJ10033, FLJ20689"	ENSG00000089916	"G-patch domain containing 2 like"	Q9NWQ4	14	76151916-76254342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018856	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA018856: AB_1845553"	"unprognostic (5.98e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.81e-1)"	9.9	8.9	7.5	12.1	10.1	37.5	9.7	10.7	9.7	8.9	11.4	9.9	8.5	10.5	9.5	11.3	8.0	12.2	13.3	7.8	10.2	8.9	6.8	10.7	12.1	9.9	8.9	10.4	8.7	9.2	6.9	11.3	9.4	9.8	10.8	15.5	8.2	9.8	12.1	9.0	9.2	11.9	9.9	10.8	9.3	13.8	8.8	11.6	9.7	14.0	12.1	10.5	9.3	12.8	18.7	24.0	19.2	15.3	11.0	17.0	15.7	21.7	15.0	20.7	20.1	16.0	30.8	22.2	12.6	16.8	16.8	22.0	23.4	14.2	36.6	24.7	12.9	19.5	26.1	10.1	14.2	13.7	27.6	17.6	12.6	17.8	23.0	16.2	21.9	18.1	20.6	30.6	18.6	30.6	18.3	17.7	24.2	11.1	17.5	20.3	23.2	11.5	14.7	37.0	15.5	19.2	24.5	21.6	12.0	19.7	25.2	21.2	24.0	26.7	15.3	14.9	16.5	30.7	31.3	29.2	21.4	18.4	28.0	5.3	7.3	7.9	3.5	6.6	3.0	6.3	1.9	5.2	7.2	5.3	4.2	3.0	5.6	5.6	4.8	5.6	4.5	3.7	7.5	10.1	10.7	9.7	7.8	10.2	9.9	8.9	9.4	9.9	8.8	12.8	35.3	16.0	18.2	48.0	30.2	23.3	37.4	26.0	22.2	100.0	19.9	21.2	46.3	18.6	25.2	18.4	104.3	16.2	36.8	18.8	3.9	20.0	151.4	28.9	46.2	38.2	47.8	17.1	76.0	13.3	12.7	36.6	21.9	54.5	43.7	48.2	29.3	11.6	25.2	158.2	67.0	19.3	24.4	43.0	48.9	138.9	24.8	43.5	23.2	59.0	47.7	42.3	43.3	82.0	75.0	30.4	29.4	37.6	24.6	56.9	40.2	13.5	24.4	122.7	26.3	55.0	41.7	56.6	27.2	18.7	27.3	17.4	31.2	34.9	20.6	42.6
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoli	"HPA043054: AB_2678293, HPA046782: AB_2679803"	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	11.4	13.1	13.6	17.5	16.7	16.2	13.2	14.7	16.7	10.4	10.9	60.4	48.3	10.6	11.3	41.0	10.9	14.2	11.0	15.7	14.8	16.4	23.3	9.7	19.6	12.9	12.0	6.7	9.9	9.5	8.1	13.8	13.3	13.9	54.6	67.8	12.1	9.9	12.7	14.5	56.6	15.9	13.9	11.8	23.3	48.7	13.7	11.1	10.3	10.6	22.4	21.1	16.2	14.9	21.9	30.5	33.6	23.1	25.2	29.1	56.6	39.7	30.7	26.2	28.8	22.7	36.6	20.9	23.6	30.4	15.9	23.8	22.1	24.2	37.9	49.9	21.1	8.8	16.1	17.5	23.4	23.1	14.5	23.2	37.7	33.1	32.7	20.1	34.6	23.5	19.2	18.7	33.6	53.5	17.0	18.6	37.3	33.9	38.3	16.7	31.4	19.3	61.5	79.9	11.8	38.4	44.8	41.6	34.9	33.7	31.9	14.3	37.8	12.0	15.1	25.6	12.8	21.7	67.0	17.8	30.6	16.4	19.6	64.4	20.9	47.0	27.7	24.3	42.8	38.3	37.6	32.4	21.2	33.1	37.0	34.5	40.9	37.5	33.6	17.9	66.6	28.6	13.6	16.7	14.7	16.7	15.7	14.8	12.9	12.0	13.3	13.9	13.7	14.9	12.6	12.8	7.4	5.9	24.8	45.2	24.2	27.6	19.9	26.8	18.4	14.5	18.9	14.3	21.7	20.2	41.7	42.7	17.9	166.1	72.4	34.1	384.9	32.3	11.1	17.4	28.1	24.0	14.3	39.4	43.3	12.1	41.8	32.2	19.7	6.6	17.9	17.3	23.6	23.5	10.8	73.0	52.9	19.8	19.6	321.7	8.1	16.8	19.6	5.6	25.2	22.3	16.5	10.6	17.9	39.9	102.9	7.9	22.6	37.4	81.8	47.4	28.6	104.0	19.7	6.5	16.5	40.0	34.1	35.7	65.9	119.6	24.4	7.9	69.1	43.7
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763035-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	11.0	10.9	18.1	9.6	20.4	36.8	19.5	25.1	23.1	10.9	23.8	10.8	10.2	12.2	15.1	11.4	11.9	19.6	10.0	19.8	19.9	9.5	12.9	10.5	18.8	21.7	19.0	13.8	13.1	13.6	9.0	12.5	25.9	10.2	13.1	18.6	9.7	10.0	13.6	20.9	10.8	14.3	17.9	13.8	12.1	13.9	19.5	13.4	15.1	7.3	10.9	11.6	9.4	31.8	14.4	19.2	28.4	22.2	13.1	19.4	28.0	26.2	16.3	24.7	25.0	41.4	23.0	29.8	15.9	15.7	24.1	19.2	24.4	23.3	28.7	35.0	26.6	37.2	59.9	38.6	21.8	32.8	28.9	25.8	21.4	17.8	25.0	21.9	22.6	25.7	45.6	54.6	14.9	34.0	28.6	29.2	16.9	16.9	29.3	24.4	20.7	19.8	17.6	43.2	22.6	20.5	16.7	14.6	17.8	35.9	15.4	21.1	15.0	21.2	15.1	16.7	19.3	26.0	34.4	22.2	21.8	24.4	16.9	8.4	4.7	4.4	3.9	3.1	3.5	4.8	3.5	4.0	2.8	6.8	4.2	4.0	4.4	4.8	5.8	4.3	4.8	2.3	18.1	20.4	25.1	23.1	19.8	19.9	21.7	19.0	25.9	17.9	19.5	31.8	17.4	22.4	16.0	19.2	11.6	4.0	12.2	16.6	10.2	18.1	8.8	8.8	35.8	7.2	21.4	14.7	18.8	15.3	18.1	7.7	13.7	12.4	4.4	18.2	17.4	17.0	12.5	19.1	24.7	12.3	12.6	12.9	11.2	13.3	14.0	24.7	12.8	8.2	13.5	0.0	29.8	10.1	16.2	12.7	5.0	4.6	13.4	11.8	7.2	27.2	22.0	12.5	9.2	23.1	38.5	14.7	6.4	10.9	16.3	8.4	12.9	10.9	37.2	15.6	6.6	10.1	13.6	44.7	24.8	11.6	5.5	15.7	12.2	18.2	11.9	9.4
H4C4	"H4/b, H4FB, HIST1H4D"	ENSG00000277157	"H4 clustered histone 4"	P62805	6	26188710-26189112	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 33.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.2;HeLa: 5.0;RT4: 8.9"									HPA042201	Supported					NA	NA		25000000	"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	0.1	0.5	10.8	0.0	19.0	0.8	0.8	33.9	11.4	0.3	5.0	0.2	0.0	0.2	0.3	0.6	0.7	0.1	0.2	7.9	3.4	0.2	0.4	0.4	0.2	4.0	3.3	0.1	0.1	0.1	0.3	0.2	6.7	1.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.1	15.4	0.6	0.2	0.4	9.7	2.0	0.5	0.0	0.1	0.0	0.3	5.6	1.0	1.1	0.8	0.0	1.3	0.0	0.5	0.7	0.4	1.9	0.9	1.8	0.4	4.0	0.3	0.0	1.5	0.5	2.3	0.4	0.6	0.3	5.2	0.6	5.0	1.7	0.0	0.4	0.1	0.4	0.0	0.2	0.7	0.0	1.6	0.5	1.3	1.1	0.0	1.9	1.5	2.7	1.4	0.9	0.3	0.4	0.0	0.5	0.5	8.9	0.5	0.3	0.8	0.5	0.5	0.6	0.9	0.3	0.0	0.4	2.9	0.3	1.1	1.2	1.2	0.0	0.8	1.1	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.2	0.2	3.4	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.3	10.8	19.0	33.9	11.4	7.9	3.4	4.0	3.3	6.7	15.4	9.7	5.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730844	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.5;parathyroid gland: 40.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"				"prognostic unfavorable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	5.5	0.3	0.4	0.2	0.4	1.0	11.5	1.7	0.7	0.7	0.4	0.1	0.3	0.4	1.2	0.2	1.7	0.2	0.2	0.6	0.1	0.8	0.1	0.4	0.4	0.3	0.1	0.4	0.1	40.4	0.3	1.0	0.3	1.0	0.1	0.6	5.0	5.1	1.2	0.7	0.3	0.2	0.1	2.3	2.0	0.8	0.2	0.3	1.3	0.1	0.1	1.2	0.3	1.2	0.1	0.3	0.2	0.3	0.0	0.0	1.9	0.1	0.0	0.0	0.1	2.5	12.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.6	1.8	0.2	0.3	0.2	0.6	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.6	0.1	8.1	0.2	0.4	0.3	3.0	0.6	0.3	0.2	0.3	0.1	35.3	2.6	0.2	0.1	4.2	0.0	0.3	3.4	0.1	0.3	0.4	0.2	0.2	0.2	0.4	0.1	0.4	0.2	0.2	0.3	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.1	0.1	0.4	0.4	1.7	0.7	0.6	0.1	0.3	0.1	0.3	0.1	0.2	1.2	1.3	0.0	0.5	0.0	0.0	0.1	1.4	0.2	0.0	0.3	8.7	5.2	0.4	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	9.6	0.2	0.2	0.3	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.3	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	1.0
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;esophagus: 16.8;lymphoid tissue: 19.6;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.7"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Cell line enriched"	"Detected in some"	4	"RT4: 37.1"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	5.6	0.1	0.0	9.2	0.1	27.4	2.3	0.0	4.7	2.5	0.2	0.5	0.2	0.0	0.5	16.8	0.7	0.6	0.7	0.1	0.0	0.9	1.8	8.2	0.4	0.0	0.0	0.1	0.0	3.4	0.2	1.9	0.9	1.5	0.1	0.1	3.4	2.7	0.1	17.4	0.2	0.2	0.0	19.6	0.4	0.1	0.1	4.0	0.4	1.1	7.8	7.1	4.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	58.6	2.2	0.8	0.0	16.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	177.2	0.0	84.4	0.0	0.0	2.9	0.0	0.1	0.0	4.7	0.1	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	3.2	6.7	0.0	0.7	94.4	81.1	57.3	159.4	0.2	0.7	0.3	0.0	0.0	24.6	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.5	1.4	0.0	0.1	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	12.2	10.6	57.4	0.2	0.0	20.1	8.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.7	0.0	0.1	2.2	0.2	0.0	0.0	1.4	0.1	0.0	66.9	106.3	13.8	1.0	0.0	0.0	66.1
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA041062: AB_2677281, HPA045473: AB_2679338"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.7	6.5	6.3	3.1	6.1	14.2	6.8	15.6	6.9	10.0	3.4	11.3	2.0	9.5	4.0	11.0	8.4	3.1	6.8	5.9	2.0	7.5	7.6	7.8	3.8	1.0	0.8	8.5	8.8	6.1	11.7	4.1	1.3	10.5	3.6	10.8	7.9	4.0	8.0	10.7	7.6	4.2	0.4	7.6	10.0	6.8	1.2	6.5	13.5	5.6	4.1	8.8	9.7	6.7	5.1	9.2	7.7	6.1	8.7	7.4	3.2	3.2	3.6	4.8	4.0	8.6	1.3	5.2	3.2	6.7	5.4	4.6	10.8	4.3	3.9	7.0	9.4	8.6	10.7	3.8	2.6	6.1	6.3	4.7	4.8	7.3	5.1	8.7	7.7	9.6	10.2	3.9	4.5	4.4	6.7	7.7	3.3	5.7	7.1	8.3	4.2	3.3	2.4	8.8	12.8	8.0	9.2	7.5	2.8	7.2	5.3	6.7	11.0	5.2	4.0	5.7	4.6	11.8	5.7	6.5	4.1	3.3	2.9	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.0	6.3	6.1	15.6	6.9	5.9	2.0	1.0	0.8	1.3	0.4	1.2	6.7	14.7	19.2	20.8	96.9	15.7	11.5	8.4	8.3	18.8	54.3	15.1	11.7	20.1	12.8	9.4	12.9	141.8	10.9	15.2	14.6	0.0	8.0	7.0	23.9	25.9	14.2	27.6	47.4	190.4	8.7	5.2	11.2	23.9	32.2	8.2	17.9	15.7	15.2	6.6	80.8	180.0	14.2	8.2	11.1	6.7	6.3	11.5	12.6	7.2	66.5	11.1	17.7	14.4	109.1	138.8	10.3	9.0	15.8	15.8	12.8	9.2	5.6	16.0	53.8	0.0	19.3	14.6	25.0	7.8	22.1	14.9	8.9	12.9	12.4	14.0	9.0
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 291.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.7;RT4: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Vesicles, Cytosol"		"HPA043519: AB_2678525, HPA050351: AB_2681102"	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (7.59e-5)"	"prognostic favorable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	40.0	20.6	15.8	10.3	15.1	4.1	45.8	15.5	21.0	31.4	14.3	35.8	52.0	15.1	46.8	55.5	27.0	20.9	63.3	14.8	15.2	54.9	46.8	24.0	7.1	15.3	14.3	24.9	98.1	38.4	113.8	14.2	15.5	53.1	25.0	13.4	59.3	26.8	70.7	56.2	43.1	10.7	12.7	18.0	41.8	24.7	14.8	7.5	96.2	34.0	13.3	25.1	39.3	15.5	38.5	9.7	11.3	8.0	12.5	11.5	40.5	11.9	5.6	6.5	8.3	33.3	44.2	7.5	20.8	11.5	5.7	48.6	12.0	34.3	6.8	19.7	8.8	7.5	21.1	11.0	5.9	4.2	10.2	14.0	32.4	8.3	13.4	15.0	3.9	14.6	12.6	5.7	13.6	83.7	4.3	7.8	4.8	24.9	10.2	12.1	7.1	18.6	13.4	100.5	28.1	14.5	8.7	25.7	7.3	11.5	35.3	9.1	7.2	12.6	8.5	19.7	4.2	20.6	23.9	4.5	13.4	14.2	9.3	0.2	0.8	0.0	1.4	1.3	0.9	1.7	1.8	0.6	1.3	1.2	3.0	1.9	1.0	1.3	0.8	0.6	0.4	1.1	15.8	15.1	15.5	21.0	14.8	15.2	15.3	14.3	15.5	12.7	14.8	15.5	14.8	19.2	38.0	25.1	34.4	50.5	99.8	135.0	158.8	117.7	84.4	62.9	29.6	75.8	84.5	82.8	100.1	85.0	11.9	137.2	43.0	77.5	9.2	26.2	21.0	18.6	63.0	11.1	28.9	45.4	40.2	24.2	140.2	39.3	12.6	30.7	22.1	24.4	16.6	63.9	43.3	93.9	118.0	11.1	21.6	9.1	27.1	20.4	28.4	6.5	19.7	26.6	10.3	17.1	10.6	46.7	98.0	26.7	30.1	131.6	291.7	45.4	49.3	84.5	13.1	24.5	25.4	73.9	26.1	82.1	65.5	128.1	27.9	42.1	95.6	87.1
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
HYAL4		ENSG00000106302	"Hyaluronidase 4"	Q2M3T9	7	123828983-123877481	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 4.0;skeletal muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.8;Cytotrophoblasts: 4.3;Extravillous trophoblasts: 8.1;Spermatogonia: 4.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CAPAN-2: 5.9;RT4: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.1	0.6	0.0	0.7	0.5	0.1	1.0	1.0	0.1	0.5	0.2	0.0	0.1	0.4	0.4	0.0	0.1	0.2	0.7	0.4	0.4	0.1	0.4	0.2	0.5	0.3	0.2	0.5	0.0	0.0	4.0	0.7	0.2	0.1	1.0	0.5	0.2	3.9	0.9	0.2	0.0	0.1	0.8	0.2	2.1	0.5	0.0	0.4	0.0	1.0	0.2	0.0	1.3	0.2	0.4	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.0	13.9	0.2	0.0	0.0	0.8	0.0	1.1	0.2	0.0	2.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.0	0.6	0.7	1.0	1.0	0.7	0.4	0.5	0.3	0.7	0.1	0.5	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	8.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	4.4	0.0	0.0	2.2	0.0	0.0	0.0	0.2
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229742-46231243	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"esophagus: 113.0;salivary gland: 34.5;vagina: 31.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.7;Basal respiratory cells: 12.5;Prostatic glandular cells: 4.4;Squamous epithelial cells: 2.1;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 6.9;RT4: 25.6;SK-BR-3: 8.6"									HPA014001	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	34.5	0.0	0.0	3.5	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.8	0.0	0.0	4.8	0.4	31.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	6.9	0.0	1.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	12.5	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.3	2.1	3.4	0.0	0.0	0.0	0.0	0.2
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 1969.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2"	"Group enriched"	"Detected in many"	694	"dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000	45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	13.0	2.1	0.2	46.7	0.4	233.3	9.0	0.4	1.3	278.1	1.1	4.4	10.7	2.5	2.9	1969.7	2.1	17.0	2.5	0.3	0.3	1.6	248.5	20.1	1.4	0.4	0.5	0.9	1.8	2.0	2.3	21.1	0.8	2.4	4.0	0.0	287.1	7.5	0.8	128.6	8.8	3.9	0.8	14.7	45.5	6.4	1.3	5.2	6.4	3.0	311.7	185.7	465.0	0.6	59.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.2	0.0	0.6	0.2	0.2	0.0	1.1	112.3	0.0	3.3	0.0	0.1	0.0	0.3	0.0	17.3	0.0	0.3	20.3	0.0	14.3	0.7	0.0	2.0	0.0	0.0	0.3	0.3	0.0	0.5	0.1	14.7	0.0	13.2	0.0	0.0	0.1	0.1	0.0	106.6	0.0	0.0	0.1	0.8	0.1	0.0	0.0	27.3	0.3	1.4	0.0	0.7	0.1	0.6	0.1	0.2	10.3	10.5	0.3	0.0	63.8	1.9	0.0	27.7	0.0	0.1	0.0	0.0	61.7	0.1	0.1	0.1	240.2	0.0	13.7	0.8	0.1	19.8	0.2	0.4	0.4	1.3	0.3	0.3	0.4	0.5	0.8	0.8	1.3	0.6	1.7	6.4	7.7	0.0	4.1	184.4	81.3	151.8	56.9	0.0	4.9	3.4	0.4	11.5	60.6	3.7	0.0	1.8	0.2	6.5	0.0	27.5	34.8	7.8	1.4	4.8	0.0	3.2	0.3	28.0	2.9	11.0	44.4	23.6	10.1	0.0	3.3	53.0	306.0	0.0	0.2	1.1	6.1	39.8	292.6	93.3	0.6	111.1	24.9	0.0	22.6	0.0	2.1	0.5	0.2	149.9	0.1	0.4	2.8	58.4	9.3	0.2	20.2	0.0	0.0	0.3	3.8	0.8	0.2	469.7	336.6	4.5	3.3	0.0	3.2	464.9
INO80	"hINO80, INO80A, INOC1, KIAA1259"	ENSG00000128908	"INO80 complex ATPase subunit"	Q9ULG1	15	40978880-41116280	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"	"Actin-binding, DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041484, HPA048601"			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA041484: AB_2677506, HPA048601: "	"unprognostic (5.39e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.69e-2)"	"prognostic favorable (6.30e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.47e-2)"	9.3	6.5	5.4	7.3	5.7	15.7	8.8	10.1	5.9	8.3	5.3	9.3	7.3	8.9	4.7	9.6	7.7	5.7	6.9	5.3	5.2	7.9	7.8	9.4	9.7	5.9	5.2	9.1	6.9	10.0	5.5	6.8	5.6	7.9	8.6	5.7	7.3	6.6	15.7	10.9	8.7	8.2	5.0	8.9	7.9	7.0	5.8	10.8	8.5	9.6	10.4	9.1	8.5	7.5	13.1	12.9	10.6	10.7	16.5	13.8	11.4	12.2	18.8	17.3	15.0	14.8	10.4	14.0	8.8	17.6	21.6	24.3	19.5	20.7	19.0	17.5	10.0	18.9	17.7	11.8	15.2	17.9	16.2	13.5	18.4	13.8	36.9	11.1	16.8	14.5	20.5	11.6	12.3	10.6	13.2	11.2	11.3	20.6	13.5	19.1	11.2	11.0	12.7	26.1	14.5	9.6	9.6	18.5	7.3	10.4	10.5	19.9	19.2	14.3	11.1	17.3	19.0	12.4	9.6	22.2	16.1	24.7	11.7	0.3	1.0	0.2	0.8	0.5	0.9	1.3	0.8	0.8	0.7	1.1	1.0	1.1	0.3	2.1	0.2	0.6	0.7	0.4	5.4	5.7	10.1	5.9	5.3	5.2	5.9	5.2	5.6	5.0	5.8	7.5	23.7	9.6	25.7	27.4	27.6	8.5	16.2	7.5	23.3	30.4	18.1	15.9	25.1	14.3	16.4	16.5	22.9	13.5	25.4	17.3	7.9	17.6	2.2	17.2	21.5	17.6	13.1	23.8	54.1	13.3	12.0	16.0	32.6	28.9	15.8	18.4	13.2	10.0	9.8	26.9	47.5	11.8	2.0	14.4	6.8	3.3	14.6	18.6	7.2	25.3	20.8	12.9	19.6	43.2	53.3	15.2	16.1	15.8	19.8	21.7	9.5	11.3	16.3	33.0	6.6	28.1	21.3	19.2	24.7	28.2	12.8	19.2	25.8	25.1	13.9	15.1
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343570-190371665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 96.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 96.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		31000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	24.0	35.0	35.6	11.4	41.2	14.8	20.7	36.5	47.5	27.4	24.5	22.3	36.7	18.1	12.5	71.9	18.9	23.5	30.9	36.2	42.0	19.6	33.1	27.9	9.3	37.5	37.0	11.8	26.6	41.6	29.6	13.4	37.6	18.2	21.0	17.0	17.0	13.4	21.2	37.4	25.3	19.6	34.7	25.8	18.2	52.9	38.1	23.7	19.0	35.7	20.9	42.1	35.8	54.0	26.7	7.4	13.9	0.0	15.0	31.8	0.3	30.9	41.5	28.8	37.5	28.8	16.5	0.2	36.3	30.5	9.3	35.8	5.4	19.9	35.0	32.8	11.7	19.5	22.1	17.5	31.5	15.2	6.0	21.6	30.6	32.9	18.6	20.7	54.7	0.3	48.6	16.3	51.3	0.1	1.1	14.3	4.2	42.3	40.4	0.7	11.2	0.3	22.6	62.2	20.6	7.8	21.7	1.4	31.7	14.4	0.1	21.0	51.0	18.4	13.2	33.3	18.5	3.1	3.5	0.3	5.7	6.0	14.9	26.2	8.3	96.0	6.9	8.1	6.3	3.3	4.3	4.7	8.7	4.4	2.4	3.6	3.9	16.2	4.7	0.2	20.3	5.1	35.6	41.2	36.5	47.5	36.2	42.0	37.5	37.0	37.6	34.7	38.1	54.0	63.0	3.2	5.5	44.1	8.0	86.4	155.4	33.2	50.7	15.0	9.9	14.6	20.9	38.6	27.5	11.0	6.2	6.9	9.7	50.4	7.9	33.4	727.4	18.8	16.0	59.6	31.1	1.7	30.3	85.4	2.6	30.7	29.6	26.9	8.8	3.8	88.5	21.9	8.8	16.8	36.7	23.7	20.3	10.7	27.3	836.0	26.8	14.0	26.6	17.8	12.2	73.2	14.4	29.7	125.6	53.1	40.8	23.7	12.9	90.7	50.6	20.8	13.0	11.9	26.3	26.0	19.4	18.1	11.4	170.2	97.3	4.0	10.4	37.8	35.4	229.0
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590056-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RT4: 369.7;SuSa: 297.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	39.9	38.7	20.1	36.5	30.8	6.4	27.7	39.7	23.5	39.7	40.3	20.1	15.9	36.8	10.5	24.5	26.3	47.3	80.0	18.2	32.7	52.1	18.0	25.7	15.8	42.5	33.0	64.7	25.7	82.7	11.9	47.4	46.4	29.8	21.6	80.4	32.1	28.1	16.3	41.4	16.3	56.7	45.3	21.4	34.2	14.7	30.2	18.0	62.6	30.5	21.6	43.1	16.0	54.6	49.1	57.5	37.4	119.9	134.1	90.0	141.7	93.8	75.5	32.5	32.5	50.7	164.0	0.4	179.7	106.3	113.4	60.2	19.3	88.5	46.7	9.7	17.2	11.7	69.1	69.6	52.8	8.3	7.0	65.8	41.3	72.7	61.1	194.1	78.7	5.9	11.6	23.9	87.4	19.4	5.0	6.8	28.3	29.1	28.5	0.1	76.2	6.8	83.5	369.7	7.7	23.0	108.6	33.2	40.1	297.0	26.2	22.4	240.5	199.4	61.9	41.4	80.3	5.9	10.4	5.5	80.3	3.3	100.6	6.2	0.6	0.9	0.4	1.1	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	20.1	30.8	39.7	23.5	18.2	32.7	42.5	33.0	46.4	45.3	30.2	54.6	39.8	28.9	22.9	134.8	4.9	128.4	64.0	127.7	42.7	118.4	50.4	23.4	145.5	80.1	35.3	77.3	77.2	55.1	9.4	32.4	1.9	78.7	0.6	61.7	61.1	47.2	7.3	2.1	36.3	101.8	26.9	65.4	57.6	100.2	49.5	21.2	27.8	18.2	27.6	15.2	35.9	19.9	14.2	44.3	56.7	3.1	19.3	29.3	46.2	75.9	17.4	70.9	2.1	184.5	156.1	165.9	23.8	25.9	9.2	103.4	11.2	32.4	27.0	60.2	32.9	29.0	63.3	1.7	2.4	27.7	103.7	39.7	10.9	18.1	15.5	77.7
JMJD7		ENSG00000243789	"Jumonji domain containing 7"	P0C870	15	41828092-41837581	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 31.2;RT4: 43.5"	"Low region specificity"	"Detected in all"							HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (2.92e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	6.7	8.4	6.3	4.2	6.2	8.2	9.0	19.9	9.5	13.6	8.0	7.3	4.8	6.5	3.1	35.4	8.6	6.5	11.2	5.8	6.3	10.1	10.3	10.8	7.3	5.8	5.2	11.6	15.9	9.0	9.8	3.0	7.0	14.5	3.0	1.9	21.9	6.8	7.7	33.3	8.0	2.9	5.1	7.9	11.5	6.7	5.9	5.6	15.6	6.6	6.6	11.4	21.0	7.0	7.9	7.5	9.3	2.6	2.5	1.7	5.8	3.1	6.6	5.1	4.1	10.5	5.9	1.0	6.4	2.0	5.3	19.6	4.3	15.6	1.6	7.7	4.6	10.5	10.4	6.5	4.1	5.1	11.0	1.1	13.6	3.4	7.2	4.7	5.8	9.9	7.0	6.2	3.7	10.8	6.6	4.9	4.0	31.2	4.8	2.9	6.3	7.6	11.5	43.5	9.9	3.5	2.6	13.5	4.3	2.7	26.2	5.4	5.4	3.7	8.3	8.0	6.1	10.2	3.7	3.2	4.9	12.4	5.7	6.1	14.8	10.8	14.1	15.8	14.8	7.2	15.7	18.6	10.6	11.1	19.7	15.6	3.9	13.0	15.8	6.7	16.7	12.6	6.3	6.2	19.9	9.5	5.8	6.3	5.8	5.2	7.0	5.1	5.9	7.0	0.1	3.2	5.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	2.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	3.4	0.1	0.0	0.6	0.0	0.0	0.0
JMJD7-PLA2G4B		ENSG00000168970	"JMJD7-PLA2G4B readthrough"		15	41828095-41848155	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Club cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RT4: 2.6"									HPA005726	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA005726: AB_1852017"	"unprognostic (9.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.75e-3)"	1.1	0.3	0.1	0.8	0.0	1.0	0.9	0.3	0.4	1.4	0.5	0.9	0.2	1.1	0.4	1.9	1.1	0.4	0.6	0.1	0.1	0.4	0.3	0.9	0.2	0.1	0.1	1.2	0.5	0.9	0.4	0.1	0.3	0.7	0.2	0.2	1.5	0.4	0.8	2.8	0.8	0.6	0.1	0.6	0.8	0.3	0.3	0.4	0.8	0.5	0.3	1.0	1.4	0.2	0.2	0.0	0.6	2.0	0.5	1.3	0.7	0.4	1.1	0.5	0.8	0.8	0.0	0.2	0.8	0.5	0.0	1.8	0.2	1.2	0.1	0.0	0.2	0.3	0.4	0.2	1.9	0.0	0.9	0.7	0.9	0.2	0.4	0.0	0.2	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.8	0.5	2.6	0.6	0.8	1.8	0.0	0.2	0.0	0.4	2.1	0.3	0.3	0.2	2.0	0.7	0.5	0.2	0.0	1.0	0.2	0.2	0.0	0.3	0.0	1.1	0.4	0.5	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.1	0.3	0.2	0.2	9.6	4.8	0.0	0.9	0.1	0.2	0.1	2.2	0.6	0.4	0.1	0.6	1.5	2.7	0.0	0.0	0.2	0.1	1.1	0.0	0.6	0.0	0.1	0.3	0.4	2.4	0.0	0.0	0.5	0.1	0.2	1.5	0.4	1.3	0.1	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	1.0	0.0	0.1	1.1	0.5	0.0	2.3	0.1	1.2	0.0	0.9	0.6	0.0	0.1	0.2	0.0	0.1	2.0	1.0	0.1	1.0	0.1	1.2	0.1
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.6;parathyroid gland: 6.0;testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 41.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;RT4: 1.9;SuSa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.3	0.8	1.7	1.7	1.5	0.0	0.2	0.9	1.9	0.1	5.6	0.4	0.5	0.2	1.0	0.2	0.3	0.4	1.6	1.6	1.4	3.9	0.5	0.4	0.6	1.6	2.3	0.1	0.3	6.0	0.3	0.2	1.8	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.5	0.3	1.8	0.6	0.4	9.2	2.2	1.1	1.9	0.0	0.5	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.9	0.7	0.2	0.0	0.7	0.5	2.9	0.0	0.7	0.0	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.5	0.9	1.9	1.6	1.4	1.6	2.3	1.8	1.8	2.2	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	6.3	0.0	0.4	0.0	0.0	6.0	0.0	4.4	0.0	0.0	4.0	8.1	0.6	0.0	3.2	0.0	41.2	9.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.3	0.1	0.1	0.4	0.0	0.1
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 905.8;thyroid gland: 593.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315, CAB079970"	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA		1300000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	27.1	0.7	0.0	1.4	0.0	0.3	272.9	0.0	0.2	48.4	0.0	1.6	0.4	12.9	15.2	91.7	75.9	82.4	5.6	0.0	0.0	147.5	14.2	325.2	1.7	0.2	0.0	2.4	57.4	5.6	12.0	265.1	0.2	58.1	0.7	0.3	905.8	213.2	1.7	78.3	1.3	0.4	0.1	0.8	17.8	0.8	0.1	3.3	593.0	2.0	6.7	389.8	20.1	0.4	4.9	2418.2	0.6	1.7	2.8	0.0	2737.9	509.6	0.6	261.3	23.6	7.6	1683.1	0.3	1.4	176.3	0.8	1871.6	0.2	6225.3	13.3	3.0	0.0	2.2	1179.8	8.0	57.4	1.5	1.5	1.3	380.7	1.3	2433.8	1.0	267.4	0.0	0.7	2.2	0.1	13.7	1.8	3.7	7.6	1.1	2.6	2.0	4.8	38.6	1520.5	7463.2	3.5	2.4	5833.6	3363.4	0.0	27.5	130.3	0.0	2028.2	1.9	3.7	2.4	1.1	1.8	0.4	2.0	2.0	1.6	1.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	8.1	653.9	109.4	0.0	2.5	3.6	1172.6	173.6	8.0	0.0	451.3	426.3	0.8	724.9	684.8	360.5	0.0	1756.7	8.9	2.2	135.0	2931.3	16.1	106.2	20.4	30.6	6.6	0.0	0.1	2143.5	4196.1	29.9	14.3	253.2	3.8	0.1	4.2	2.9	189.9	0.0	0.0	3.5	954.2	3.4	4.6	140.0	3.7	11.0	131.6	0.0	35.6	0.0	0.0	0.0	0.0	6163.7	0.3	0.4	1.4	2386.6	0.2	8.5	249.2	0.0	0.0	7.6	72.1	0.6	1.3	35.3	2.3	1442.5	9.2	0.0	4.4	1900.8
KRTAP5-10	KRTAP5.10	ENSG00000204572	"Keratin associated protein 5-10"	Q6L8G5	11	71565563-71566735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"epididymis: 1.4;skin 1: 4.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.7;Late spermatids: 1.0;Respiratory ciliated cells: 1.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"RT4: 3.5"															NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (4.05e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-4)"	0.2	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.2	0.1	0.0	0.2	0.2	0.4	0.2	0.1	0.0	0.2	0.2	0.0	0.5	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.1	0.3	0.2	4.9	0.1	0.0	0.2	0.2	0.1	0.6	0.2	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.6
KRTAP5-7	"KRTAP5-3, KRTAP5.7"	ENSG00000244411	"Keratin associated protein 5-7"	Q6L8G8	11	71527267-71528669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.3;testis: 1.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1.6;Late spermatids: 3.5;Spermatocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RT4: 1.7"															NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (3.69e-1)"			"unprognostic (2.49e-4)"	"unprognostic (1.64e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.40e-2)"		"unprognostic (7.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.35e-3)"		"unprognostic (2.35e-1)"	"unprognostic (5.68e-3)"	0.0	0.0	0.6	0.0	0.6	0.0	0.1	0.3	1.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.5	0.7	0.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	5.3	0.0	0.0	0.4	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.3	1.0	0.5	0.5	0.8	0.5	0.7	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KRTAP5-9	"KRN1, KRTAP5-1, KRTAP5.9"	ENSG00000254997	"Keratin associated protein 5-9"	P26371	11	71548420-71549608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.1"	"Group enriched"	"Detected in some"	7	"Early spermatids: 2.3;Late spermatids: 5.6"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"RT4: 8.6"															NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.82e-4)"	"prognostic favorable (9.25e-4)"	0.4	0.3	0.7	0.0	0.7	0.2	0.3	0.3	1.2	0.3	0.3	0.5	0.1	0.2	1.7	0.5	0.4	0.3	0.1	0.7	0.6	0.5	0.8	0.4	0.1	0.5	0.8	0.1	0.2	0.2	0.8	0.1	0.5	0.6	0.2	0.3	0.3	0.3	0.4	0.9	0.5	0.0	0.3	0.6	0.2	3.1	0.5	0.0	0.3	0.0	0.1	1.3	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.3	1.2	0.7	0.6	0.5	0.8	0.5	0.3	0.5	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832254-96995956	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824"	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.16e-4)"	3.7	3.1	7.1	6.2	6.4	25.5	5.0	21.8	6.6	4.3	3.3	8.7	11.2	4.2	4.6	7.0	3.9	3.9	3.7	4.8	15.6	5.3	5.9	4.8	6.3	6.9	5.6	6.4	8.2	4.3	5.3	4.9	6.7	4.7	8.5	15.8	5.6	3.5	9.2	4.1	10.7	3.4	4.8	5.5	8.3	4.6	7.5	6.0	5.4	5.1	6.0	6.8	4.7	15.8	14.7	9.3	16.5	8.9	4.4	6.2	7.9	6.2	6.0	7.5	8.5	12.0	10.0	15.4	7.3	6.4	7.0	12.2	16.5	8.6	13.3	7.4	8.0	17.7	6.0	15.2	8.4	22.1	8.8	4.9	7.5	11.5	20.4	7.7	8.1	7.8	12.7	7.2	11.9	6.7	9.2	8.4	6.3	7.9	4.0	11.2	12.7	4.3	8.6	30.7	7.5	6.6	7.0	4.4	8.8	7.1	8.3	6.9	12.5	5.8	13.0	5.2	11.6	9.4	6.7	17.9	6.1	13.9	3.1	1.7	5.0	8.0	5.8	4.1	4.7	4.6	4.4	5.3	3.7	8.6	4.7	3.7	16.7	5.0	2.0	5.4	3.6	2.5	7.1	6.4	21.8	6.6	4.8	15.6	6.9	5.6	6.7	4.8	7.5	15.8	26.4	19.2	26.8	72.1	36.1	15.4	16.7	31.3	25.6	45.2	37.0	20.3	17.8	37.1	38.2	31.3	77.2	18.8	46.5	85.3	11.7	27.0	0.8	34.6	26.8	23.1	46.9	17.7	138.3	33.9	8.2	17.1	28.1	35.9	26.6	67.1	20.3	22.2	14.1	40.4	151.6	31.2	52.9	30.5	29.7	2.3	10.2	40.0	21.4	103.0	28.1	11.7	24.7	143.2	264.9	41.5	62.0	13.9	36.8	26.9	67.1	25.4	54.1	58.9	19.7	21.6	26.8	21.7	26.3	29.2	12.9	38.6	34.0	22.0	33.6	34.4
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	2.0	0.0	1.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.8	6.3	0.5	76.7	0.1	0.0	1.8	1.9	0.2	0.6	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.2	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	1.1	0.8	6.3	1.8	1.9	1.3	0.2	4.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LRATD1	"FAM84A, FLJ35392, NSE1"	ENSG00000162981	"LRAT domain containing 1"	Q96KN4	2	14632700-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.2;intestine: 41.0"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 35.0"	"Group enriched"	"Detected in many"	7	"amygdala: 19.7;basal ganglia: 10.8;cerebral cortex: 18.1;hippocampal formation: 13.0;white matter: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.5	1.4	19.7	4.9	10.8	0.0	2.4	0.0	18.1	10.6	0.0	41.0	26.3	2.7	32.2	28.6	2.9	3.4	2.1	13.0	2.0	4.0	1.4	3.0	0.2	0.0	0.2	8.2	3.2	5.2	3.3	5.3	0.0	13.6	36.2	0.9	13.9	2.0	0.9	18.5	25.3	2.8	0.0	0.2	3.0	12.3	1.4	1.3	2.2	0.1	1.4	14.8	16.6	6.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	2.5	0.6	0.5	0.0	0.3	0.0	0.0	0.3	0.0	9.4	1.0	4.2	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	18.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	1.3	7.8	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	6.9	49.3	4.3	2.0	0.0	1.8	0.0	0.3	0.0	0.0	2.9	8.2	0.7	0.0	3.2	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	10.8	0.0	18.1	13.0	2.0	0.0	0.2	0.0	0.0	1.4	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	162.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	207.8	0.0	0.0	0.0	0.0
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 115.1;Late spermatids: 117.0;Oligodendrocytes: 138.8;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	14.0	2.2	8.7	5.1	13.8	2.9	13.3	10.1	11.2	13.2	13.7	25.5	17.3	5.1	7.5	18.2	8.5	7.8	4.2	9.2	10.4	7.7	0.8	7.6	2.7	13.9	10.8	4.8	8.8	22.6	7.9	11.1	14.2	8.7	25.4	7.1	16.7	6.7	1.5	22.5	18.1	5.1	10.9	1.5	14.8	14.5	11.1	13.9	15.3	1.4	10.7	14.5	18.0	24.1	45.2	5.7	6.1	10.9	1.6	0.8	42.8	6.1	12.3	5.2	7.1	49.4	21.7	6.4	4.9	3.9	9.7	21.7	47.9	19.4	6.6	7.9	13.8	3.9	4.5	33.5	15.2	4.9	2.9	1.6	15.8	0.4	11.5	8.1	9.4	23.1	0.9	5.8	2.9	19.7	33.6	0.6	4.8	33.5	4.2	6.8	10.2	3.3	14.1	57.4	15.7	1.5	7.3	31.7	9.9	15.2	20.6	5.0	4.3	3.9	12.6	0.2	5.6	5.8	4.9	4.6	4.4	6.7	4.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	8.7	13.8	10.1	11.2	9.2	10.4	13.9	10.8	14.2	10.9	11.1	24.1	19.8	41.7	3.9	53.2	2.9	52.6	25.5	16.3	12.0	43.0	16.0	8.1	3.5	11.5	20.6	16.5	4.2	54.5	2.3	115.1	7.9	20.5	88.5	38.8	9.4	18.8	18.0	1.7	11.9	15.6	62.0	5.9	26.0	74.3	5.7	10.5	8.6	0.3	5.1	8.4	21.9	23.6	12.2	0.6	7.1	117.0	9.3	1.3	10.6	26.2	2.5	32.7	6.2	35.2	138.8	29.5	62.5	10.1	4.2	18.5	32.5	12.3	14.1	3.0	6.6	3.5	3.7	27.3	7.3	19.9	52.7	107.4	3.1	1.6	24.5	32.5
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;esophagus: 7.0;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;EFO-21: 13.4;RT4: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 6.2"	HPA039551			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.1	0.0	0.8	0.1	1.4	0.6	0.3	2.0	5.2	1.7	0.0	1.5	0.2	0.2	0.1	7.0	0.0	0.0	0.0	1.0	0.8	1.3	1.7	0.2	0.1	1.5	2.1	0.1	0.0	0.0	0.0	0.7	3.5	0.8	1.3	1.3	0.8	0.6	0.3	6.2	0.3	0.0	0.5	0.2	0.2	0.4	3.3	0.2	0.1	0.1	0.6	0.6	2.9	5.3	2.6	0.0	0.4	0.2	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.3	0.7	1.8	13.4	0.0	0.1	2.5	0.1	0.1	0.0	0.4	0.0	0.4	0.2	2.7	0.0	0.5	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.2	0.2	1.1	0.4	0.9	0.4	0.5	0.2	0.5	14.4	0.3	0.3	2.0	1.4	0.3	1.4	1.6	0.3	0.2	0.6	1.1	0.3	0.2	1.2	2.2	0.7	0.3	0.2	0.7	0.9	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.6	0.1	0.1	1.5	1.2	0.1	0.3	0.0	0.0	0.8	1.4	2.0	5.2	1.0	0.8	1.5	2.1	3.5	0.5	3.3	5.3	0.1	44.8	48.3	2.0	0.0	0.6	2.5	0.4	0.6	0.1	0.1	0.0	0.4	0.0	18.5	3.7	0.0	6.3	0.0	5.3	1.9	0.1	0.6	3.1	0.3	2.9	0.0	0.0	13.2	0.2	0.6	4.4	0.0	4.8	17.7	0.0	0.0	0.5	0.3	0.0	10.1	1.2	6.1	0.3	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.2	0.0	6.0	31.6	0.0	1.1	0.0	0.0	0.8	1.2	0.9	13.2	0.3	0.0	0.1	0.2	0.0	0.2	3.7	1.7	13.7	2.6	0.1	1.4	0.5
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 133.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 33.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 33.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	15.1	24.6	32.4	17.7	32.2	28.4	14.8	46.7	44.5	16.1	0.3	17.9	12.4	15.1	12.0	11.1	14.0	12.2	24.6	40.5	21.2	17.1	13.0	19.0	20.9	18.2	18.8	18.8	17.5	18.4	65.7	16.0	22.1	20.7	16.6	133.2	16.6	17.1	30.1	22.8	19.0	14.6	7.0	22.0	18.8	28.5	16.7	23.6	14.4	23.4	17.9	18.7	15.0	32.1	14.0	28.7	30.8	27.6	20.6	14.3	6.9	19.3	25.8	24.2	25.9	21.0	12.9	29.6	6.0	21.3	31.1	27.2	25.2	13.6	20.8	33.1	25.6	52.7	55.0	18.3	14.8	36.1	69.4	13.9	14.3	12.7	15.9	16.4	22.4	18.7	34.5	21.1	21.5	19.7	17.2	38.6	18.4	32.8	19.6	23.2	49.5	19.7	12.4	66.0	48.4	31.5	24.9	29.0	17.6	18.1	22.8	27.0	19.2	22.4	14.1	32.3	13.2	24.9	27.9	16.6	20.9	25.1	21.5	33.3	3.4	6.5	5.6	5.6	5.0	4.0	3.9	4.6	5.2	4.2	4.5	3.6	0.9	5.7	7.9	2.7	7.5	6.2	32.4	32.2	46.7	44.5	40.5	21.2	18.2	18.8	22.1	7.0	16.7	32.1	10.6	12.8	9.2	21.5	11.7	10.7	4.1	6.1	6.8	80.9	11.3	10.2	23.4	7.2	5.8	7.3	125.1	4.6	29.0	21.2	0.0	7.5	14.6	5.3	7.0	11.5	16.3	8.6	37.4	4.9	2.3	7.8	23.4	8.3	26.6	13.9	14.6	7.0	11.5	132.9	33.7	17.7	4.1	19.4	14.9	4.9	7.2	14.9	10.6	21.5	11.1	14.4	23.7	14.1	22.4	12.0	12.2	12.8	17.7	8.0	12.2	5.1	6.2	106.8	6.6	8.7	7.7	14.9	23.2	6.7	8.2	4.4	15.4	16.2	13.7	5.9
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368612	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	49.3	66.1	20.2	23.9	21.1	37.6	49.3	17.7	28.8	52.1	18.6	41.8	25.5	49.3	12.1	29.9	50.5	16.4	55.6	20.0	17.8	52.8	50.0	50.3	20.3	22.8	18.1	58.5	49.1	26.3	56.6	21.1	20.9	49.4	14.9	14.8	37.3	19.5	58.5	36.8	41.6	18.6	17.5	54.7	46.0	34.8	19.8	17.1	64.8	24.5	12.7	45.7	41.5	22.0	11.0	25.5	21.3	15.7	23.8	20.4	27.1	25.3	23.5	12.9	10.9	20.3	38.3	5.7	14.6	18.6	11.8	33.0	11.7	17.1	8.4	30.8	26.1	34.0	58.5	18.1	35.3	23.1	5.7	25.3	17.0	12.3	15.3	27.3	30.9	16.9	20.5	27.4	10.7	22.1	11.9	25.2	9.0	13.2	11.8	16.0	11.0	34.6	16.8	49.8	13.2	22.7	16.4	23.9	11.5	15.6	26.1	26.1	61.5	27.1	18.7	19.0	25.5	27.9	7.1	9.3	17.6	25.9	27.6	4.0	19.8	3.5	9.2	23.0	9.1	3.2	6.9	6.8	22.6	2.6	9.5	6.9	2.2	6.0	18.9	9.2	10.2	14.3	20.2	21.1	17.7	28.8	20.0	17.8	22.8	18.1	20.9	17.5	19.8	22.0	34.1	22.4	51.7	29.0	12.5	13.5	15.2	13.0	11.4	30.7	18.2	16.3	2.8	5.7	19.2	9.2	54.2	17.2	17.2	22.4	3.9	11.4	10.4	10.1	18.3	23.2	34.2	7.6	28.9	8.7	10.9	20.4	39.3	12.7	31.7	46.8	32.5	22.4	20.4	28.6	23.8	19.5	12.2	29.8	20.2	14.0	23.3	26.3	16.0	15.0	31.4	17.3	19.6	18.1	19.5	11.2	20.0	12.4	12.9	16.0	27.9	15.9	19.3	52.4	26.3	25.6	16.3	21.1	10.4	14.9	8.5	21.2	16.2	17.0	24.0	15.3
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528136-220664461	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 73.8;Excitatory neurons: 171.3;Inhibitory neurons: 170.1;Oligodendrocyte precursor cells: 167.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 11.3;RT4: 33.7;SuSa: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	6.3	1.8	6.9	1.4	7.1	0.0	4.9	6.4	10.0	4.6	8.4	5.4	0.4	4.2	9.7	4.8	3.3	1.7	8.0	7.4	6.7	2.3	0.3	3.1	0.5	6.4	6.8	1.7	0.9	2.4	6.9	1.1	7.4	3.0	1.2	9.3	3.7	4.0	2.2	2.5	2.5	3.9	5.7	1.3	2.8	6.9	6.5	1.4	4.3	3.5	1.9	5.3	5.1	6.4	0.4	0.0	5.4	1.1	0.0	0.0	1.8	1.6	2.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	2.5	2.5	11.3	6.0	1.0	0.0	8.4	0.0	2.3	0.0	0.0	0.7	0.8	0.9	4.7	0.0	3.0	0.8	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.1	5.5	1.8	0.0	7.4	0.0	0.0	33.7	6.4	6.2	0.3	0.3	0.5	12.2	0.5	0.0	0.0	0.0	2.4	4.0	7.1	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.1	6.4	10.0	7.4	6.7	6.4	6.8	7.4	5.7	6.5	6.4	3.2	0.0	0.5	73.8	0.5	3.4	2.6	10.0	13.1	28.6	1.6	3.8	21.9	0.0	4.7	3.7	31.3	2.1	0.0	0.7	0.0	1.6	7.3	19.3	6.4	3.4	9.0	0.0	171.3	0.0	2.3	6.3	2.6	35.5	0.0	13.6	3.3	0.0	0.3	10.1	170.1	0.4	4.1	0.3	1.5	3.6	2.1	0.2	0.0	15.0	0.0	12.3	0.0	167.9	45.9	0.1	0.0	6.4	0.6	4.8	1.5	0.2	4.1	11.9	0.0	6.9	17.5	17.4	5.1	13.1	3.3	1.0	0.4	1.1	0.9	4.8
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663775	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	16.0	0.9	7.3	7.3	7.2	1.4	12.3	8.5	7.3	21.3	2.4	24.9	19.8	17.3	4.4	13.5	23.4	8.3	13.0	4.9	6.3	41.3	1.4	25.5	1.5	9.1	7.2	2.3	23.3	1.7	4.2	17.4	8.9	6.9	30.0	1.8	8.8	8.0	4.3	2.6	10.2	8.0	4.1	6.2	73.3	3.0	8.1	2.0	5.7	12.0	5.3	30.4	7.5	6.3	25.8	0.7	0.9	0.2	3.7	2.7	1.1	3.7	4.2	1.1	2.2	10.7	26.1	0.9	39.1	0.6	5.5	13.4	10.2	15.7	3.1	1.4	16.6	16.7	7.6	1.1	0.4	0.3	5.1	5.7	2.2	1.0	12.1	12.0	55.5	1.4	13.0	1.8	10.3	9.8	0.9	0.4	1.7	13.5	6.6	9.8	13.1	0.3	71.2	119.6	1.0	3.1	1.3	6.7	0.3	1.5	7.1	1.1	53.4	9.7	6.6	2.5	16.9	1.4	0.7	0.9	4.8	1.0	1.6	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.4	0.5	1.6	0.1	0.0	7.3	7.2	8.5	7.3	4.9	6.3	9.1	7.2	8.9	4.1	8.1	6.3	80.2	60.9	184.8	16.0	0.6	2.2	33.3	29.4	10.2	0.0	1.2	0.9	11.4	2.8	69.6	125.0	0.0	1.1	0.1	25.5	52.8	1.6	10.4	71.9	5.8	70.5	19.9	7.4	10.3	75.4	0.2	4.8	111.1	107.7	9.5	0.8	69.3	0.2	0.0	0.0	9.1	29.0	20.3	0.6	1.9	3.2	0.3	2.6	1.8	346.6	1.0	0.0	0.0	6.0	13.8	49.8	19.3	0.0	0.3	13.9	6.2	0.7	53.2	0.1	0.0	1.4	5.7	3.0	1.2	39.4	1.4	0.4	1.3	0.5	53.9	45.4
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102714630-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	2.8	2.2	1.4	2.9	1.4	4.1	2.6	4.3	2.0	3.6	1.8	6.4	8.7	1.8	2.8	4.5	1.8	2.3	1.4	1.9	1.7	4.6	10.5	2.2	3.2	1.4	1.6	2.4	9.2	4.1	3.4	2.4	1.5	2.6	5.8	2.4	4.9	3.1	1.3	2.9	7.2	1.9	1.3	2.7	4.7	1.2	1.7	4.5	2.9	1.2	3.6	3.3	2.2	1.2	3.1	2.4	3.0	5.2	3.6	1.6	6.1	1.9	1.9	2.8	2.8	8.6	4.1	2.7	3.1	1.2	4.3	4.7	4.8	1.8	1.8	11.5	4.4	4.5	3.1	10.9	3.0	3.6	6.2	1.6	6.1	1.7	0.9	2.9	1.8	8.8	2.7	1.3	1.4	2.9	3.7	7.2	2.3	7.4	3.1	2.8	4.9	2.8	5.9	9.4	5.8	4.1	1.7	6.1	6.9	3.2	2.3	5.7	1.3	1.9	4.0	3.2	2.7	3.6	2.9	1.8	2.1	8.4	2.6	1.3	0.3	1.5	1.2	0.6	0.9	0.8	0.9	0.8	0.6	0.6	0.9	1.1	1.0	1.0	0.5	1.2	0.7	0.7	1.4	1.4	4.3	2.0	1.9	1.7	1.4	1.6	1.5	1.3	1.7	1.2	1.6	0.0	1.5	1.0	4.1	3.3	3.2	3.7	2.8	1.5	4.1	1.3	3.1	1.5	5.4	7.3	4.2	8.2	4.3	15.9	0.0	5.8	12.8	3.3	2.0	1.6	3.0	1.7	5.4	8.6	9.1	3.3	7.1	5.3	3.8	3.0	1.4	11.5	4.8	0.0	12.2	8.7	10.2	2.9	1.4	4.5	0.9	2.6	0.0	1.9	4.3	1.4	7.2	4.0	1.3	11.4	8.0	1.2	8.9	4.2	10.4	3.6	3.9	2.8	6.6	2.1	2.4	1.0	5.3	4.3	4.4	11.5	5.1	3.1	7.2	8.2
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.8"	"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	9.2	17.0	7.3	6.3	6.9	18.0	11.0	5.4	15.5	10.5	6.4	16.2	13.3	9.1	5.3	17.0	11.0	3.6	14.0	7.5	2.7	17.2	11.7	17.0	7.0	11.8	4.2	7.7	26.7	5.6	22.3	5.5	10.9	17.2	3.4	0.9	17.3	5.7	5.2	17.8	17.6	2.1	1.1	21.7	18.9	13.0	4.9	4.2	58.8	2.1	3.7	12.9	12.6	3.8	17.0	6.9	0.9	6.5	3.1	3.3	29.3	7.3	5.1	4.0	5.5	11.6	29.7	8.9	10.5	4.2	9.8	15.9	1.0	11.2	1.8	5.1	9.5	10.8	22.1	10.7	7.8	4.8	11.0	6.1	11.4	6.4	9.2	4.7	5.8	7.2	4.5	3.9	4.5	36.3	8.4	10.2	2.5	11.6	32.0	10.8	2.2	9.3	5.9	33.0	7.4	6.4	18.3	17.5	5.4	2.5	12.8	6.7	14.6	8.1	15.2	16.6	6.1	6.8	3.6	9.5	16.0	14.3	4.9	4.8	5.7	1.5	1.8	7.5	1.3	0.9	1.5	1.8	4.3	1.5	1.4	1.0	1.1	0.8	6.8	1.3	4.6	2.2	7.3	6.9	5.4	15.5	7.5	2.7	11.8	4.2	10.9	1.1	4.9	3.8	5.2	9.6	26.3	33.0	6.5	6.2	8.5	9.2	6.8	36.4	12.6	9.5	12.4	5.7	16.6	5.5	12.5	31.3	7.0	39.8	3.9	12.2	5.1	17.8	6.7	7.8	23.4	1.7	56.7	16.6	19.2	6.4	63.7	25.2	14.5	14.3	3.9	7.0	19.7	37.0	61.2	24.8	18.3	11.9	11.4	12.2	3.1	14.5	1.8	13.1	11.4	5.7	7.2	14.6	7.9	18.6	17.5	2.6	9.7	17.6	30.7	5.8	18.8	3.5	6.6	7.2	6.7	19.1	26.2	9.7	5.8	50.1	9.1	7.8	22.3	14.8
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	3.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.3
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95821766-95925315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 120.1;Oligodendrocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	14.7	9.3	11.0	11.2	16.8	4.4	11.8	16.3	18.3	12.2	12.2	12.9	7.1	12.3	6.2	14.7	12.4	14.3	13.5	10.8	14.3	16.4	4.3	12.3	9.5	15.1	14.4	11.5	7.8	12.7	6.4	24.5	15.8	16.1	13.9	18.6	20.5	11.4	6.2	8.2	8.3	18.0	13.5	8.6	13.0	31.0	14.1	15.1	9.9	8.9	12.1	15.2	10.4	22.4	24.1	25.3	54.1	39.2	19.2	29.0	47.5	43.3	37.9	42.4	37.8	57.3	47.1	16.2	50.3	45.5	35.9	30.9	47.7	48.2	38.9	30.8	21.3	31.5	55.0	33.0	42.8	59.3	26.7	24.0	31.2	56.6	54.5	41.8	64.4	35.4	44.7	14.2	39.6	17.9	29.0	27.2	46.6	59.0	34.9	23.2	32.2	16.8	43.9	125.0	35.6	40.6	43.6	36.4	19.2	35.1	27.6	26.5	64.4	47.7	45.1	34.4	41.1	13.1	42.4	14.3	20.4	15.6	50.6	9.8	3.9	1.7	12.4	4.7	13.4	5.8	7.9	15.7	7.6	4.9	4.0	11.3	0.9	14.1	7.2	3.7	8.1	7.8	11.0	16.8	16.3	18.3	10.8	14.3	15.1	14.4	15.8	13.5	14.1	22.4	19.6	3.2	8.6	28.7	9.6	10.3	15.0	9.0	8.6	0.0	8.0	6.7	17.3	0.0	11.6	9.2	0.0	9.0	8.8	9.1	9.8	17.8	74.8	18.1	14.1	20.2	16.2	12.8	69.8	16.9	34.3	17.0	9.7	8.7	19.0	49.1	11.0	1.0	12.5	0.0	37.5	9.8	24.4	10.3	8.2	120.1	11.1	8.3	3.6	40.3	6.8	0.0	14.4	63.8	226.6	17.7	4.7	12.0	7.0	15.1	6.0	29.3	17.0	0.0	32.9	7.9	29.0	46.8	19.2	15.4	6.0	9.0	8.8	12.9	10.6	15.6
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA049189: AB_2680669, HPA049447: AB_2680771"	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	3.0	2.1	1.5	1.7	3.3	1.1	3.3	4.1	1.9	2.7	8.5	6.9	4.6	2.6	2.1	2.1	3.4	3.1	2.6	1.2	2.2	6.5	5.7	4.4	1.1	2.7	2.2	3.7	2.9	2.9	0.9	2.8	2.7	2.2	6.7	3.9	1.7	1.8	1.5	2.2	5.5	2.7	1.6	1.7	7.1	3.6	2.6	1.3	4.6	3.9	1.3	2.9	1.7	3.6	4.2	3.9	1.6	1.4	9.7	7.5	2.3	4.0	2.9	2.1	3.2	4.4	2.1	0.9	3.2	6.8	4.1	3.4	3.2	4.7	4.8	1.9	1.4	1.6	6.0	2.5	2.3	1.5	1.8	2.9	3.0	3.4	4.2	5.0	3.3	1.7	2.9	1.4	4.8	2.9	0.6	0.8	0.8	1.8	3.6	0.7	2.6	1.0	5.8	7.8	1.0	0.8	3.4	2.5	2.5	3.9	2.9	1.5	5.7	5.5	4.6	2.6	1.8	2.4	1.9	1.2	3.3	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	1.5	3.3	4.1	1.9	1.2	2.2	2.7	2.2	2.7	1.6	2.6	3.6	53.0	38.5	72.2	103.5	145.5	1030.4	399.8	231.1	117.8	18.4	81.2	89.2	21.4	223.1	94.4	38.6	27.1	205.9	58.8	173.8	84.1	57.4	30.9	57.8	73.5	155.1	293.5	49.0	88.0	99.2	276.5	154.4	103.9	69.3	107.2	43.3	287.0	203.7	154.5	82.4	79.7	515.3	91.6	531.4	1016.1	49.5	274.3	78.0	629.7	81.5	186.0	19.5	171.9	105.1	130.9	78.5	335.8	129.4	52.4	304.8	343.9	103.1	59.2	26.9	118.3	388.6	265.6	45.1	41.2	118.4	1304.2	229.3	182.3	31.4	528.3	305.2
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401513-35404749	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1114.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 391.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favorable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	281.0	171.3	75.6	150.7	78.0	1114.7	171.4	75.4	92.5	123.8	78.3	121.0	61.2	95.5	29.6	151.8	141.2	130.4	145.5	71.4	75.9	104.5	208.1	366.0	122.6	90.1	76.2	255.7	101.9	68.8	92.4	92.7	81.6	112.6	80.9	18.7	118.3	110.0	139.7	260.5	148.5	92.7	77.0	226.2	130.7	31.7	84.9	123.2	111.9	138.3	181.4	366.2	166.8	79.8	62.5	54.1	20.1	18.2	114.7	75.9	71.1	25.2	240.7	53.3	47.3	16.9	36.5	37.5	66.1	40.2	125.2	79.5	38.3	104.9	76.1	229.2	14.9	18.6	39.9	101.4	68.6	29.9	15.0	83.1	103.5	36.4	92.2	35.5	48.6	18.4	15.9	58.4	38.6	73.0	39.2	71.0	18.6	60.0	33.1	87.8	23.1	31.6	92.8	391.7	17.9	31.2	67.2	115.9	29.7	41.0	66.1	62.2	91.7	72.8	26.5	21.3	41.0	70.9	77.7	64.5	60.8	22.0	15.3	322.0	444.9	301.4	175.3	267.2	264.0	258.4	207.1	182.5	428.9	329.7	178.1	153.0	942.9	285.9	183.7	233.0	154.9	506.4	75.6	78.0	75.4	92.5	71.4	75.9	90.1	76.2	81.6	77.0	84.9	79.8	802.9	535.2	914.0	14.4	505.6	4056.6	1862.8	2061.4	1729.6	27.0	430.7	414.0	188.6	367.4	719.2	62.5	12.5	196.4	762.2	447.8	195.6	875.0	4.3	703.8	935.6	1079.8	203.5	87.8	7.1	394.8	174.9	1145.1	333.8	1440.1	906.1	68.2	313.4	147.2	791.2	48.8	5.1	453.0	634.7	491.4	4828.7	14.7	153.1	1609.0	1085.1	39.4	428.1	95.2	97.9	6.6	8.6	383.5	511.5	116.2	1039.4	1412.0	1051.6	115.9	298.2	37.4	203.8	956.9	847.2	3.3	26.4	1544.6	3420.6	660.0	838.4	91.8	346.0	1004.6
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460213-157474722	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7;skin 1: 61.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0;urothelial cancer: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 1.6;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"B-cells: 4.8"	"Group enriched"	"Detected in some"	8	"hTCEpi: 31.7;RT4: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038259	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.82e-4)"	0.4	0.0	3.5	2.0	9.7	3.4	2.2	8.5	7.1	5.9	1.1	3.7	0.3	1.2	0.1	15.1	0.1	0.5	1.5	3.9	6.2	0.0	0.0	0.7	0.4	12.4	8.7	0.0	0.0	0.0	0.5	0.6	10.5	1.5	0.6	0.1	1.9	1.4	0.2	61.2	0.9	1.1	7.6	0.2	2.5	0.1	8.0	0.4	0.3	0.0	5.8	11.5	15.1	18.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.1	1.1	0.0	0.0	0.7	0.4	0.0	6.3	0.3	2.7	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	31.7	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	108.1	0.0	0.4	0.0	0.0	0.0	8.5	1.6	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	9.7	8.5	7.1	3.9	6.2	12.4	8.7	10.5	7.6	8.0	18.7	0.0	0.0	0.5	0.0	2.4	29.7	9.8	0.6	2.2	0.6	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	0.3	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.3	3.8	0.0	0.0	0.1	1.1	0.0	5.2	0.3	0.0	0.1	9.8	42.1	0.0	0.2	0.0	0.0	4.4
NRXN3	"C14orf60, KIAA0743"	ENSG00000021645	"Neurexin 3"	"Q9HDB5, Q9Y4C0"	14	78170373-79868291	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.8;retina: 42.9"	"Group enriched"	"Detected in many"	10	"Excitatory neurons: 3526.5;Inhibitory neurons: 5083.8;Oligodendrocytes: 2145.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 106.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 9.7;RT4: 24.7;SK-BR-3: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002727	Approved					NA	NA		710000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002727: AB_1079468"	"unprognostic (7.96e-2)"	"unprognostic (5.70e-4)"	"unprognostic (8.18e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.31e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.83e-7)"	"unprognostic (4.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	0.8	5.9	13.4	2.8	17.0	0.1	1.6	106.8	48.3	3.9	0.0	23.0	2.3	5.4	1.7	4.7	5.0	2.5	3.0	23.6	21.3	1.7	0.4	2.6	0.4	8.6	24.2	0.7	3.1	8.8	4.9	1.3	7.2	6.7	4.1	42.9	2.8	11.3	0.3	1.8	8.4	21.1	0.0	5.8	9.3	7.5	4.2	1.0	0.5	0.5	0.4	4.4	2.7	21.5	0.0	0.0	7.6	0.0	0.2	0.3	0.0	3.0	2.2	9.7	7.3	2.6	0.0	0.1	0.0	0.3	0.0	2.8	0.1	0.3	6.8	3.0	6.0	0.0	0.2	0.0	0.7	0.0	0.0	1.8	0.3	4.3	1.4	4.6	2.5	0.0	0.0	0.2	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.2	0.0	0.0	5.2	24.7	1.3	0.0	0.0	9.3	0.5	3.1	0.0	0.0	0.0	0.1	6.2	0.0	3.2	0.0	0.0	0.0	1.8	0.3	5.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.4	17.0	106.8	48.3	23.6	21.3	8.6	24.2	7.2	0.0	4.2	21.5	0.2	12.8	5.5	100.2	0.0	4.6	7.0	0.4	0.6	180.7	3.2	3.0	3.9	1.5	3.4	3.7	12.5	9.2	0.0	1.1	0.0	2.2	15.9	36.3	2.2	0.8	6.0	0.0	3526.5	3.1	0.5	1.8	0.0	31.5	0.0	0.8	1.4	0.1	0.7	116.1	5083.8	0.6	4.1	0.0	0.3	18.9	7.5	0.3	17.8	88.1	0.0	54.3	0.0	328.2	2145.0	0.7	0.2	6.4	1.2	7.5	0.0	0.1	9.3	10.7	0.0	0.4	2.2	2.1	0.8	0.1	0.9	37.9	0.6	0.0	1.0	3.0
OPA3	"FLJ22187, MGA3"	ENSG00000125741	"Outer mitochondrial membrane lipid metabolism regulator OPA3"	Q9H6K4	19	45527427-45602212	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044881	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA044881: AB_10964052"	"unprognostic (3.37e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (3.14e-3)"	"unprognostic (4.53e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.72e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.30e-12)"	"unprognostic (5.85e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	4.8	7.2	3.3	4.7	3.4	4.0	3.5	4.4	5.2	3.0	3.7	4.6	4.0	4.9	3.0	5.8	3.4	3.3	10.5	3.2	3.1	7.4	7.8	4.4	4.7	4.9	4.0	3.4	4.4	12.0	6.0	4.4	5.0	3.8	3.9	6.4	4.0	4.1	11.1	5.8	5.0	4.7	2.5	5.8	4.9	8.9	5.5	4.6	4.6	12.9	4.7	4.1	3.5	3.2	15.2	18.9	7.4	7.3	4.8	5.9	11.3	9.7	8.9	10.1	10.7	8.8	10.5	13.0	6.9	9.8	11.5	12.0	12.5	13.3	8.9	24.0	12.6	20.1	10.8	9.1	8.8	14.1	25.0	8.9	10.1	11.2	12.2	5.8	7.3	7.6	17.5	14.2	6.9	9.3	11.3	5.8	6.5	12.6	12.9	10.9	6.7	7.1	8.0	26.9	5.5	6.6	12.4	11.3	5.2	6.6	6.3	8.0	15.9	8.5	9.7	7.1	16.7	9.5	19.1	10.6	8.2	10.1	13.1	5.6	5.3	2.9	3.6	7.8	3.6	4.4	3.2	3.1	5.6	3.9	3.9	4.0	4.7	7.8	10.5	5.1	4.8	3.6	3.3	3.4	4.4	5.2	3.2	3.1	4.9	4.0	5.0	2.5	5.5	3.2	11.0	12.8	11.7	8.5	23.0	18.7	22.4	14.6	13.1	22.8	9.2	7.9	25.4	17.2	11.6	11.0	52.1	25.6	15.7	18.8	25.4	18.4	18.5	12.8	13.8	15.2	13.8	5.7	9.5	21.1	29.8	10.6	14.3	20.1	15.9	8.9	11.4	21.9	16.3	20.2	10.2	14.5	16.2	11.4	28.3	20.2	6.2	17.4	14.2	4.7	19.0	15.1	11.3	3.0	8.1	18.2	19.2	6.4	11.9	15.8	21.2	16.8	10.7	36.0	0.0	23.3	23.6	23.9	13.1	11.2	19.6	36.3	14.4	19.5	16.6	16.7
OR10H1		ENSG00000186723	"Olfactory receptor family 10 subfamily H member 1"	Q9Y4A9	19	15804549-15815664	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 57.7;Alveolar cells type 2: 53.1;Club cells: 29.7;granulocytes: 39.1;Respiratory ciliated cells: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"RT4: 3.1"															NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"					"unprognostic (3.29e-1)"				"unprognostic (1.97e-3)"				"unprognostic (4.18e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.38e-1)"					"unprognostic (9.30e-2)"	0.3	0.2	2.0	0.2	2.7	0.8	0.2	4.1	3.6	0.0	1.4	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.1	1.7	1.0	0.2	0.2	0.1	0.2	2.0	0.8	0.2	0.1	0.1	0.0	0.1	2.1	0.2	0.2	1.5	0.2	0.1	0.7	0.7	0.3	0.2	0.4	0.2	0.2	0.5	2.8	0.2	0.1	0.1	0.1	0.6	0.0	3.4	0.4	0.2	0.3	0.3	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.7	0.4	0.4	0.1	0.4	0.3	0.1	0.2	0.1	0.3	0.1	0.5	0.6	0.2	0.0	0.4	0.7	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.2	0.8	0.1	0.1	0.2	0.4	0.3	0.3	0.1	0.2	0.3	0.2	0.1	3.1	0.2	0.2	1.0	0.3	0.3	0.4	0.1	0.2	0.5	0.8	0.6	0.3	0.6	0.4	0.3	0.3	0.3	0.2	0.2	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.2	0.1	0.2	0.1	0.0	2.0	2.7	4.1	3.6	1.7	1.0	2.0	0.8	2.1	0.4	2.8	3.4	0.1	57.7	53.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	29.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	1.9	0.2	3.4	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.8	39.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0
OR1L8		ENSG00000171496	"Olfactory receptor family 1 subfamily L member 8"	Q8NGR8	9	122567117-122583384	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Excitatory neurons: 8.6;Inhibitory neurons: 5.1;Microglial cells: 1.9;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RT4: 4.9"					"Not detected"	"Not detected"									NA	NA					"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (9.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.68e-1)"		"unprognostic (4.94e-3)"		"unprognostic (1.36e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-4)"	"unprognostic (9.82e-3)"	"unprognostic (3.33e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.7	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51Q1		ENSG00000167360	"Olfactory receptor family 51 subfamily Q member 1"	Q8NH59	11	5422111-5423206	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"RT4: 2.8"	"Not detected"	"Not detected"							HPA044998	Uncertain					NA	NA					"Cluster 15: RT4 - Unknown function"				"HPA044998: AB_10794780"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52K1		ENSG00000196778	"Olfactory receptor family 52 subfamily K member 1"	Q8NGK4	11	4482646-4493497	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"bone marrow: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;RT4: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"																					0.1	0.0	0.4	0.2	0.2	1.0	0.1	0.7	0.6	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.1	0.6	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.7	0.2	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.4	0.3	0.3	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.3	1.1	0.5	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.6	0.3	0.1	0.0	0.3	0.2	0.0	0.2	0.4	0.2	0.2	0.1	1.3	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.5	0.3	0.2	0.2	0.1	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.7	0.6	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORMDL2	"adoplin-2, HSPC160, MST095, MSTP095"	ENSG00000123353	"ORMDL sphingolipid biosynthesis regulator 2"	Q53FV1	12	55818041-55821879	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.68e-2)"	37.5	38.1	14.6	24.2	17.0	20.4	31.3	18.3	20.5	30.0	24.7	44.5	27.2	28.4	51.3	75.9	26.3	20.6	30.1	14.8	18.4	40.7	47.5	35.5	23.0	19.0	18.0	16.8	32.9	44.5	29.7	22.3	18.5	30.8	48.4	14.8	40.2	23.2	19.7	36.4	30.2	26.4	17.2	33.2	32.9	42.7	18.3	27.6	27.4	11.1	38.5	41.7	36.8	20.2	55.9	103.5	43.1	22.4	81.2	40.4	47.7	66.5	66.0	57.0	49.9	116.6	133.8	34.5	69.3	80.7	58.5	100.3	34.6	138.7	56.6	35.9	51.4	46.7	89.7	65.9	85.8	56.7	47.4	50.9	125.2	99.9	103.3	73.3	81.0	38.2	25.0	91.1	73.7	89.3	34.8	25.3	20.9	87.8	82.0	22.8	34.5	88.4	149.8	159.1	37.4	23.8	84.9	99.9	38.4	64.8	120.0	40.1	59.4	30.5	42.6	36.4	42.7	43.6	39.1	28.1	48.9	22.4	43.1	50.4	73.0	107.1	86.5	92.8	76.8	93.2	82.1	92.1	73.4	76.1	67.8	81.5	91.8	74.1	108.7	119.9	107.8	72.1	14.6	17.0	18.3	20.5	14.8	18.4	19.0	18.0	18.5	17.2	18.3	20.2	43.1	73.7	38.3	1.3	39.8	23.3	71.9	132.9	15.4	9.9	43.1	30.0	3.9	45.8	99.4	53.3	12.5	74.7	49.6	125.7	29.4	133.7	171.0	77.9	25.7	42.0	46.1	26.5	0.7	168.1	117.5	22.0	28.1	86.0	51.9	14.0	35.3	82.2	125.3	8.4	0.8	66.7	69.2	42.5	49.1	68.0	25.4	57.4	56.9	2.8	111.4	24.8	77.2	1.0	4.0	197.4	133.5	23.3	50.8	95.7	89.7	76.0	149.2	18.4	19.7	13.5	32.9	107.0	61.7	50.6	33.4	151.6	44.6	30.5	56.2	91.3
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"Extravillous trophoblasts: 49.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"myeloid DC: 1.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6"	"Not detected"	"Not detected"							HPA067673			Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	1.3	0.0	1.0	1.3	0.8	0.1	4.2	0.5	1.5	1.0	0.5	2.0	0.2	0.5	2.5	2.1	1.6	0.1	0.2	0.8	2.1	4.0	0.0	0.4	0.1	1.2	1.3	0.1	0.5	0.3	0.3	0.9	1.0	0.5	1.6	0.0	3.0	0.4	0.2	2.6	0.4	0.5	0.7	0.4	0.2	0.1	2.6	0.3	0.5	0.3	0.8	1.7	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.1	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.0	0.8	0.5	1.5	0.8	2.1	1.2	1.3	1.0	0.7	2.6	1.3	0.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.2	1.9	0.0	0.2	0.7	0.1	0.8	1.2	0.0	0.6	0.0	49.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.5	0.0	0.0	0.4	0.1	0.0	0.3	3.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	3.7	0.0	0.0	1.2	0.0
P3R3URF-PIK3R3		ENSG00000278139	"P3R3URF-PIK3R3 readthrough"		1	46043661-46176488	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	8	"testis: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 3.1;RT4: 10.7"									HPA005751	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 15: RT4 - Unknown function"				"HPA005751: AB_1855350"																		0.4	0.0	0.0	0.4	0.1	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	21.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.0	0.0	1.2	0.4	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	1.4	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.8	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 17.0;urinary bladder: 25.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 14.0;RT4: 17.4;T-47d: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	17.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	3.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	3.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.0	0.0	1.4	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.5	0.1	0.1	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	7.9
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258745-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.7;pituitary gland: 84.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 35.8;Bipolar cells: 82.8;Inhibitory neurons: 34.0;Sertoli cells: 19.7;Squamous epithelial cells: 23.5;Urothelial cells: 39.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RT4: 13.8;T-47d: 8.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 206.6"	HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	2.7	0.4	14.1	0.8	71.7	0.1	1.8	19.6	33.2	4.0	0.9	5.6	1.7	1.8	2.6	18.8	2.1	2.0	0.8	6.8	14.7	0.9	4.0	4.6	0.2	39.7	23.3	2.2	0.5	0.4	84.3	0.3	39.8	11.0	2.5	39.2	1.9	16.4	0.4	5.6	2.8	6.6	28.1	0.3	2.0	1.8	15.2	2.0	0.7	1.5	2.6	35.6	17.1	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	13.8	1.9	0.0	0.0	0.2	0.0	0.2	8.9	0.3	0.2	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	14.1	71.7	19.6	33.2	6.8	14.7	39.7	23.3	39.8	28.1	15.2	13.9	0.0	3.2	6.4	2.0	0.0	0.0	35.8	8.3	12.5	82.8	3.2	1.0	0.2	0.0	7.6	0.0	6.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.1	1.3	1.9	0.2	4.6	0.3	1.3	0.0	0.0	0.9	0.1	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	3.5	0.0	5.0	1.4	0.2	0.0	1.9	0.0	2.5	0.0	0.6	0.9	5.9	19.7	0.0	10.0	1.3	1.5	23.5	0.3	1.8	0.0	0.0	0.0	39.9
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	16.7	16.6	20.9	8.5	32.3	3.3	10.5	21.9	22.4	11.6	15.2	24.0	15.3	9.1	7.3	6.4	9.0	15.8	8.0	17.3	20.1	24.3	30.0	10.8	5.6	23.8	28.5	12.7	14.5	16.9	6.7	11.4	23.6	6.9	21.9	14.5	6.4	9.6	5.8	6.3	13.6	10.6	19.5	6.3	11.0	11.0	26.9	4.6	12.3	6.5	5.1	17.7	7.0	45.2	29.0	48.4	7.9	5.4	32.7	17.2	9.6	19.4	21.1	16.6	18.9	10.9	16.9	5.8	14.6	25.9	19.7	20.2	33.8	14.9	22.0	10.8	20.2	7.7	30.3	15.6	23.5	4.5	11.3	17.4	9.1	19.6	18.6	14.3	21.6	6.4	15.6	18.3	15.2	24.5	2.6	4.5	3.8	9.5	8.6	3.6	6.5	8.1	13.2	89.0	18.3	14.1	18.9	20.3	55.5	8.7	6.7	8.7	17.1	38.4	13.6	13.9	31.6	8.9	16.7	6.2	26.1	18.1	11.0	0.0	0.9	0.6	0.3	0.7	0.6	0.2	0.5	0.6	0.5	0.3	0.7	0.3	0.0	0.2	1.6	0.0	1.1	0.2	20.9	32.3	21.9	22.4	17.3	20.1	23.8	28.5	23.6	19.5	26.9	45.2	30.7	6.4	26.5	83.9	14.8	11.3	11.1	13.9	18.2	13.0	6.6	5.2	6.8	41.5	15.4	7.3	12.5	8.0	5.5	58.7	7.9	11.3	6.4	12.5	21.6	24.3	14.5	0.8	60.8	9.6	7.1	16.2	26.5	20.6	22.1	17.9	14.3	23.3	10.8	10.1	126.2	19.0	4.1	12.3	18.9	5.6	10.8	19.2	10.6	85.3	9.0	2.6	10.3	119.1	968.6	11.5	31.8	11.3	7.2	25.4	22.1	21.1	10.5	31.2	39.5	17.8	24.5	25.6	17.3	7.5	10.4	4.5	10.8	25.3	28.5	26.4
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.8;Urothelial cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	9.5	8.0	6.6	6.7	7.1	7.4	11.1	9.7	9.2	10.2	10.2	10.2	10.2	9.2	7.5	10.2	6.6	8.8	11.9	6.8	7.4	13.6	25.0	9.3	6.8	6.7	7.1	11.0	11.8	9.6	7.4	9.3	6.8	14.6	10.7	8.8	8.7	5.8	14.6	7.9	9.8	8.1	6.6	6.7	10.1	14.9	7.1	7.3	13.7	13.6	6.7	13.8	9.1	7.7	15.5	11.3	15.7	20.3	14.8	11.5	24.2	15.9	12.3	10.6	10.8	16.9	22.9	10.0	16.7	15.6	19.9	22.8	14.1	19.2	20.0	9.9	9.7	9.2	15.1	28.0	17.5	13.9	10.8	14.2	28.9	14.5	22.3	16.2	19.4	11.3	22.8	8.7	16.3	14.1	10.4	16.6	17.2	28.6	11.2	11.1	17.4	12.7	20.3	38.2	17.7	12.2	17.7	23.7	14.9	18.5	15.8	7.1	15.3	20.2	27.0	11.8	13.6	14.2	11.6	25.0	12.7	14.0	14.5	12.4	3.9	5.9	5.0	3.9	4.7	5.4	5.8	5.5	5.1	4.1	6.1	4.6	3.7	5.5	5.0	4.5	5.4	3.9	6.6	7.1	9.7	9.2	6.8	7.4	6.7	7.1	6.8	6.6	7.1	7.7	12.9	19.2	19.1	14.0	13.8	51.2	35.1	61.9	25.6	11.9	23.0	13.2	21.9	28.6	53.0	22.0	8.4	36.9	13.4	27.6	25.4	28.8	125.8	24.5	16.1	15.1	2.4	9.9	18.8	28.5	43.1	14.5	12.8	28.8	8.2	15.6	13.6	49.3	20.9	16.8	16.8	14.5	36.7	14.6	25.9	28.7	9.6	14.8	16.0	25.3	19.3	12.6	18.6	14.1	19.4	23.2	13.2	11.7	9.9	43.9	28.8	33.2	38.7	15.0	6.6	11.6	18.8	66.8	26.4	21.8	50.3	68.7	15.0	11.4	18.1	112.0
PGAP1	"Bst1, FLJ12377, SPG67"	ENSG00000197121	"Post-GPI attachment to proteins inositol deacylase 1"	Q75T13	2	196833004-196927796	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 89.6;Inhibitory neurons: 104.5;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.21e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.95e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.88e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.91e-2)"	3.9	8.4	10.2	1.1	11.7	2.0	3.8	8.9	12.1	3.5	4.6	3.0	3.7	3.0	3.1	3.5	2.8	1.5	3.2	7.9	19.2	1.7	1.2	4.5	1.1	6.8	15.1	9.3	4.4	2.8	9.2	3.3	7.3	3.2	2.8	13.0	2.2	2.2	1.4	12.3	4.3	2.2	4.4	1.4	2.0	1.5	17.8	1.7	2.1	1.4	1.1	3.0	3.9	5.8	1.5	0.6	15.2	8.3	6.8	4.1	2.5	1.9	1.4	1.1	1.3	0.8	1.6	1.8	2.4	2.8	2.4	2.8	4.0	4.3	1.7	9.0	5.2	1.2	4.0	4.1	1.8	2.6	2.0	3.0	3.0	1.9	2.2	7.9	6.6	5.9	0.3	3.0	4.2	0.6	2.4	3.3	7.1	2.4	3.5	3.7	3.8	0.5	2.4	13.8	12.6	10.0	1.3	1.9	2.4	9.0	1.9	1.0	7.6	5.1	2.2	2.5	2.6	2.7	1.5	2.4	3.9	1.2	5.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.7	0.7	0.1	0.2	0.6	0.5	0.2	0.1	0.0	0.0	0.9	0.0	10.2	11.7	8.9	12.1	7.9	19.2	6.8	15.1	7.3	4.4	17.8	5.8	9.3	3.2	2.6	37.9	12.7	34.4	13.5	21.4	30.1	43.3	5.4	5.6	6.8	2.8	6.9	25.8	25.0	37.4	4.6	5.8	0.0	1.4	8.3	11.9	14.5	9.7	38.9	3.2	89.6	3.7	9.1	15.8	14.3	4.3	4.5	8.8	4.2	4.4	6.2	13.5	104.5	13.6	8.2	1.9	14.9	4.8	14.3	3.0	7.2	23.4	1.3	17.5	3.1	130.2	58.7	0.9	8.2	15.8	8.2	11.4	12.4	1.6	16.7	41.1	6.6	12.0	33.8	11.0	8.2	23.4	30.0	15.9	18.5	8.1	24.0	11.9
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 199.0;Endothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"RT4: 76.1"					"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	31.2	12.2	13.0	7.2	11.2	0.7	28.0	35.9	14.8	15.3	14.0	7.5	3.2	15.9	10.3	7.1	10.1	10.7	35.2	11.4	14.9	16.2	4.0	18.5	6.2	16.7	17.3	4.1	4.7	12.1	8.5	13.3	16.8	12.0	4.9	17.9	12.5	6.1	12.0	6.4	8.6	11.5	15.5	11.2	9.9	25.4	15.9	10.8	14.2	18.5	5.3	14.8	7.4	11.4	10.9	3.6	47.4	24.4	4.6	2.0	15.2	6.3	4.6	8.2	10.1	2.1	3.2	14.3	18.9	2.5	9.9	6.4	16.9	5.8	5.3	11.1	15.0	9.3	41.8	1.6	1.5	8.3	11.8	5.8	3.3	8.7	3.2	7.8	17.3	32.8	3.5	10.0	11.8	16.7	33.4	5.1	16.9	3.1	9.6	42.0	12.7	17.0	20.4	76.1	34.4	24.9	20.5	53.5	5.7	28.5	14.9	7.3	32.4	8.7	8.0	1.5	6.2	14.1	15.8	8.5	6.9	10.9	4.5	0.0	0.2	5.8	2.0	0.3	1.9	0.3	0.4	1.8	0.0	0.0	0.1	1.1	0.0	0.0	2.4	0.3	2.3	0.6	13.0	11.2	35.9	14.8	11.4	14.9	16.7	17.3	16.8	15.5	15.9	11.4	199.0	0.0	8.4	15.7	3.1	2.5	5.4	42.1	14.8	48.3	32.0	30.1	21.1	0.0	28.8	18.4	45.9	4.4	13.9	21.7	0.0	0.6	11.8	13.9	21.0	83.3	7.8	5.9	26.2	1.2	1.1	16.2	55.5	26.2	9.5	6.1	0.0	0.0	1.7	3.3	55.9	8.6	38.7	0.0	4.4	19.9	1.2	8.4	5.4	60.9	0.9	33.5	3.1	22.1	7.1	1.4	1.5	7.9	10.1	7.2	4.5	4.2	26.7	42.8	0.0	13.3	18.0	35.9	31.7	8.0	1.8	1.4	15.7	19.2	6.6	5.0
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139323-20150381	"Enzymes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"lymphoid tissue: 8.0;skin 1: 14.9;urinary bladder: 11.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.7"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	69	"RT4: 139.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.0"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	8.0	11.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.9
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.1;Club cells: 1.3;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 7.8"															NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	8.8	7.6	6.9	0.5	6.9	3.7	10.7	6.9	10.1	26.0	6.9	9.1	1.6	8.3	1.9	36.6	13.9	1.7	11.4	6.9	6.9	16.9	16.7	11.4	3.4	6.9	6.9	20.0	19.3	0.3	16.3	0.5	6.9	24.8	0.8	0.4	16.7	2.4	5.3	48.8	12.5	0.6	6.9	16.9	12.5	9.6	7.0	1.3	22.9	0.1	5.7	12.3	30.2	7.0	1.1	0.8	0.0	0.0	0.2	0.1	2.9	0.3	0.8	1.0	0.2	0.4	0.5	0.2	0.1	0.6	0.1	3.6	1.0	0.9	0.2	0.1	1.7	0.9	1.3	2.5	1.5	0.2	1.4	0.6	3.6	0.3	1.0	0.2	0.4	1.6	1.2	0.1	0.2	1.6	1.1	3.1	0.8	4.0	0.9	0.0	0.9	0.5	0.8	7.8	0.4	0.7	0.0	1.4	0.8	0.6	4.2	1.4	0.0	0.0	0.8	1.0	0.1	2.5	0.1	0.7	0.2	3.8	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.1	0.2	0.1	1.5	0.2	0.2	0.0	1.1	0.0	0.1	0.4	0.0	6.9	6.9	6.9	10.1	6.9	6.9	6.9	6.9	6.9	6.9	7.0	7.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		10000000		"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	11.2	7.6	13.9	7.0	13.0	1.0	9.6	0.6	16.4	11.6	0.5	9.1	3.4	10.9	2.3	11.3	10.2	4.8	15.8	14.0	7.9	8.6	3.2	14.7	6.3	5.5	5.6	13.8	9.3	24.0	5.5	8.2	5.6	9.3	1.9	1.7	12.9	6.3	10.9	15.1	7.9	5.2	1.3	13.2	7.9	9.0	14.8	6.3	9.6	6.1	4.2	9.8	10.0	5.5	45.3	21.1	22.8	18.1	29.3	32.7	36.3	26.3	22.2	14.8	14.7	70.2	20.6	5.0	38.6	28.4	20.0	68.2	11.7	51.6	6.1	7.2	18.6	0.7	13.4	18.3	19.2	5.4	3.6	32.8	35.4	27.4	21.2	14.9	7.5	14.7	26.3	9.1	16.1	26.3	10.6	9.9	22.0	14.2	18.5	14.0	58.0	14.1	12.9	89.4	20.2	22.1	19.1	17.9	24.7	14.7	28.8	33.9	28.0	23.6	30.0	43.4	28.1	5.5	3.9	9.8	33.9	10.2	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.9	13.0	0.6	16.4	14.0	7.9	5.5	5.6	5.6	1.3	14.8	5.5	1.9	48.1	4.1	8.8	1.8	15.8	5.6	23.4	6.2	6.7	6.6	7.4	13.0	1.5	18.6	12.9	4.2	21.8	0.8	3.6	0.0	8.9	4.4	5.0	10.0	3.8	9.6	0.4	22.1	6.9	2.5	13.8	7.1	5.6	0.0	20.8	2.2	0.9	13.1	20.2	11.3	4.0	0.0	7.4	12.8	1.0	7.8	7.4	8.8	5.6	1.0	2.5	1.0	13.6	3.6	17.0	2.3	6.4	3.1	21.3	7.4	1.5	11.2	3.3	6.6	6.4	9.9	5.3	9.5	6.7	16.1	7.3	2.2	4.7	5.1	9.5
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.8;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	2.2	0.9	2.1	2.4	2.2	2.0	1.4	9.7	3.1	1.4	0.0	7.0	7.0	2.1	1.1	4.1	2.2	1.2	6.3	1.6	0.4	0.8	1.6	3.6	1.4	1.9	0.2	1.3	1.0	4.4	0.6	1.5	2.0	1.8	6.0	12.4	1.4	3.3	6.2	3.3	6.4	2.8	0.4	2.1	3.8	0.8	0.3	0.9	0.4	2.5	1.8	3.7	2.6	0.5	0.5	1.9	0.7	4.5	1.8	0.6	7.3	0.3	0.0	0.5	0.7	8.5	1.8	9.2	1.3	0.0	2.1	5.5	6.9	3.5	0.6	0.5	5.9	8.6	3.6	1.8	0.5	12.0	3.2	0.9	4.6	1.8	3.0	0.2	1.0	4.0	6.0	2.9	0.4	2.3	4.4	5.4	2.9	2.6	4.8	8.3	5.0	5.1	1.4	11.2	2.4	0.5	1.2	9.8	1.5	1.3	2.5	3.9	1.3	1.0	1.6	3.6	1.8	3.6	2.8	5.3	2.2	7.4	0.9	0.5	0.9	0.1	0.1	1.7	0.3	0.8	0.1	0.1	1.1	0.3	0.2	0.2	0.6	0.3	3.1	0.1	0.1	0.3	2.1	2.2	9.7	3.1	1.6	0.4	1.9	0.2	2.0	0.4	0.3	0.5	6.1	0.0	1.1	1.6	3.0	5.1	3.9	17.9	12.0	111.8	2.5	3.2	22.3	1.5	7.4	1.8	135.5	1.8	0.7	15.4	1.9	0.5	0.3	1.7	4.1	5.4	5.4	5.7	29.2	0.8	1.6	2.7	18.8	2.5	1.3	2.1	4.2	3.5	7.6	8.4	26.2	10.3	0.0	12.5	4.7	0.2	1.5	12.1	3.6	12.2	6.1	4.0	2.1	12.1	0.9	0.5	6.7	0.4	5.5	5.1	19.6	3.0	2.9	72.0	6.6	3.0	8.9	0.2	3.2	23.1	10.7	4.9	2.0	2.1	24.9	6.1
PPP1R37	LRRC68	ENSG00000104866	"Protein phosphatase 1 regulatory subunit 37"	O75864	19	45091396-45148077	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"RT4: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041500	Approved		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041500: AB_10795122"	"unprognostic (8.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.89e-3)"	"unprognostic (7.72e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (2.04e-4)"	10.4	26.9	11.3	5.8	12.8	4.8	13.0	7.9	16.7	17.9	1.2	14.3	12.1	15.7	3.2	19.8	13.1	5.3	14.8	12.3	4.7	18.2	14.0	11.7	5.2	6.6	4.9	13.5	16.4	7.2	39.3	5.3	6.6	20.0	3.6	8.0	18.4	8.8	20.9	21.3	14.6	4.1	1.8	14.0	28.3	16.5	6.7	5.7	20.4	5.4	3.1	21.7	16.9	10.8	26.2	25.4	9.2	13.4	11.6	7.8	18.4	18.8	10.6	12.8	14.6	11.5	14.2	7.1	13.4	10.0	11.8	20.1	6.3	14.4	3.6	9.3	15.7	6.1	13.6	14.3	14.4	6.4	10.1	10.0	11.1	12.1	7.7	13.7	10.4	9.6	10.8	5.5	7.1	34.2	13.5	8.9	8.7	18.7	15.1	16.3	10.9	5.3	8.4	69.5	28.2	13.0	16.0	33.2	29.3	4.7	21.3	9.4	16.4	15.2	18.2	9.1	17.0	9.3	6.3	5.3	19.7	6.4	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.8	7.9	16.7	12.3	4.7	6.6	4.9	6.6	1.8	6.7	10.8	9.4	6.4	3.4	8.5	8.1	7.6	11.1	6.8	13.1	48.6	16.9	11.7	6.2	15.7	5.6	3.7	39.6	21.1	9.7	21.9	7.9	17.9	8.8	9.8	12.1	10.3	30.6	4.8	18.9	9.8	19.0	9.8	30.5	10.9	0.0	12.1	11.0	7.4	17.9	77.4	15.2	27.7	10.2	6.4	6.3	7.0	12.2	6.2	12.4	5.6	4.4	22.7	9.2	11.6	14.3	12.0	23.4	12.4	13.1	10.6	25.6	18.2	5.9	44.1	19.7	10.3	10.1	21.6	23.9	14.3	9.5	18.3	10.4	16.0	22.3	11.4
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682725	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 3019.3"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 5332.3"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"spinal cord: 38.2"	"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA		18000		"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	4.8	0.4	0.5	0.5	0.6	0.2	1.9	0.3	0.9	67.8	0.2	7.8	4.0	0.4	0.6	334.0	7.9	10.0	0.4	0.6	0.2	5.8	0.7	6.3	0.1	0.5	0.3	0.6	3.2	0.0	0.6	2.4	0.4	230.6	4.8	0.0	23.5	1.9	0.3	11.1	2.5	0.1	0.2	0.4	3019.3	1.4	0.5	0.4	0.4	0.0	15.0	629.0	167.7	0.5	10.7	0.7	0.0	0.0	2.1	6.8	10.6	4.9	1.1	2.1	1.8	0.1	22.4	0.0	0.4	0.4	8.1	2.1	0.0	0.4	1.3	0.6	0.0	0.0	45.7	0.0	0.1	0.0	1.5	6.0	7.8	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.7	5.8	1.7	0.6	1.2	17.6	1.2	0.7	0.0	0.9	1.0	61.7	0.2	0.5	5.1	15.6	3.5	0.3	0.2	0.2	1.0	1.5	1.7	2.7	0.0	1.9	0.1	0.0	2.9	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	0.9	0.6	0.2	0.5	0.3	0.4	0.2	0.5	0.5	0.2	3.2	1.5	1.6	7.7	0.9	26.0	120.0	0.0	0.0	3.9	2.7	1.2	71.4	894.2	1.8	0.0	2.3	0.0	1.9	7.9	3.2	0.3	1.3	0.1	1.1	275.1	0.0	0.3	1.2	5.0	3.3	5332.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	12.9	179.0	0.6	1.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	57.1	0.2	0.0	13.4	238.7	0.3	0.4	994.9	0.0	0.0	0.0	48.9	0.0	0.5	13.1	1.3	28.5	4.6	0.0	0.9	1241.5
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
RALGAPA2	"AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2"	ENSG00000188559	"Ral GTPase activating protein catalytic subunit alpha 2"	Q2PPJ7	20	20389530-20712644	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 212.2;Microglial cells: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 91.5;SCLC-21H: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042707, HPA043622"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA042707: AB_2678124, HPA043622: AB_2678585"	"unprognostic (7.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (3.77e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.33e-2)"	16.7	6.5	4.6	6.1	6.2	20.6	15.0	10.8	7.6	9.6	5.7	12.2	10.3	8.7	3.7	8.8	10.8	11.3	7.9	4.3	4.8	10.2	27.3	25.2	6.4	6.9	8.0	7.4	17.0	13.1	14.5	17.6	7.5	13.1	12.6	13.4	15.1	5.5	34.4	16.9	10.5	7.0	2.8	7.5	18.3	10.1	13.1	8.0	21.1	21.0	5.4	12.6	8.4	9.5	7.0	4.4	9.2	4.7	5.1	3.6	10.1	1.8	2.0	2.1	3.0	3.8	9.5	3.2	6.1	3.0	10.6	7.1	9.4	8.6	4.0	16.1	4.6	11.1	2.5	6.7	1.8	14.0	6.4	3.1	6.4	3.5	1.7	3.9	13.1	14.9	2.2	6.0	3.8	4.9	5.6	18.5	3.8	22.8	3.9	7.6	6.2	4.5	7.4	91.5	51.4	4.5	6.9	5.2	6.1	8.9	3.6	13.7	3.3	3.7	3.6	2.7	2.6	3.5	2.6	1.8	3.1	9.1	5.4	4.4	1.1	3.6	0.8	0.4	1.2	1.1	0.5	0.8	0.5	0.8	1.0	1.1	4.4	2.7	1.0	1.2	1.0	0.3	4.6	6.2	10.8	7.6	4.3	4.8	6.9	8.0	7.5	2.8	13.1	9.5	90.7	6.4	42.5	212.2	9.7	10.6	10.1	25.9	6.8	47.8	13.5	7.7	9.1	41.5	27.0	14.7	27.1	10.6	14.6	24.7	1.9	23.9	28.9	61.0	16.4	80.1	24.6	10.7	87.3	24.9	4.9	7.6	51.5	123.0	8.2	97.3	67.1	47.4	12.8	52.2	122.0	20.7	40.7	18.3	10.3	7.3	1.8	13.0	8.8	145.2	18.2	8.8	10.3	122.2	111.1	19.5	21.0	6.8	4.8	20.5	20.6	12.5	43.1	13.5	13.1	16.4	9.7	12.3	11.1	15.3	16.6	11.2	14.3	19.7	30.6	25.0
RBM5	"H37, LUCA-15, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088919-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	70.6	53.9	42.2	44.2	45.4	63.5	69.8	48.4	49.6	96.2	47.9	74.8	37.4	74.6	64.0	57.5	85.8	40.1	58.0	41.1	52.5	66.2	58.1	61.8	66.8	46.5	42.5	120.2	73.1	45.2	84.7	60.1	46.2	85.2	47.7	90.5	63.9	47.2	63.6	81.6	72.1	53.7	40.9	95.2	64.8	62.9	44.1	62.5	80.8	36.4	69.5	66.6	73.2	62.5	31.1	37.3	132.6	58.2	54.3	78.1	31.3	91.9	54.8	67.0	46.9	37.6	34.7	72.4	31.0	60.3	65.6	26.8	90.4	44.5	71.5	67.5	33.2	91.0	136.5	34.2	66.7	84.1	71.0	70.1	49.8	72.7	71.3	114.5	71.9	72.5	63.3	47.4	63.7	27.3	85.6	56.9	47.9	52.3	42.3	46.3	57.9	37.6	48.7	152.1	19.0	43.8	75.6	32.8	46.2	89.5	30.2	79.9	82.0	44.3	45.9	61.7	53.7	64.8	103.2	76.4	32.9	50.8	52.3	54.3	21.4	29.2	24.8	22.2	23.3	20.5	22.2	25.9	18.4	19.6	27.9	22.3	39.0	22.9	22.6	13.9	28.5	17.0	42.2	45.4	48.4	49.6	41.1	52.5	46.5	42.5	46.2	40.9	44.1	62.5	70.1	70.5	103.3	108.7	69.9	32.0	39.8	31.1	27.3	94.4	43.9	44.2	44.5	25.8	68.2	38.6	183.5	52.5	77.0	51.3	11.7	27.3	128.2	52.4	67.9	67.9	73.5	40.2	100.8	20.9	26.2	54.4	74.5	47.8	68.9	85.1	60.3	40.0	32.4	94.2	107.1	53.7	50.8	42.2	48.4	246.2	64.3	56.4	44.4	96.5	66.9	43.2	75.2	117.6	136.0	30.8	45.8	57.9	64.5	49.5	42.4	11.3	84.0	126.1	32.9	62.4	57.1	57.8	33.0	31.1	34.0	81.7	68.1	52.2	44.7	55.5
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 50.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 64.1;Alveolar cells type 2: 77.7;Excitatory neurons: 33.3;Proximal enterocytes: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 85.7;hTCEpi: 73.6;RT4: 126.9"	"Low region specificity"	"Detected in all"							HPA060938	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA060938: AB_2684391"	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	6.5	8.8	17.9	7.5	31.7	2.3	8.4	3.6	27.6	6.8	7.1	6.2	8.5	7.7	5.3	4.8	9.8	6.5	21.8	21.4	7.3	11.2	2.4	50.5	14.9	4.2	10.3	25.8	8.0	9.6	14.2	11.2	4.1	7.7	2.5	5.6	6.4	23.0	16.5	5.5	21.2	6.5	0.8	12.6	8.3	8.1	22.8	8.9	18.5	13.6	16.7	10.4	4.5	15.1	6.8	13.2	10.4	16.7	12.4	8.7	14.0	9.2	12.0	14.2	10.7	34.2	6.6	85.7	13.8	13.3	18.5	13.2	5.0	51.5	6.8	7.4	3.0	9.3	17.8	9.7	6.0	5.5	18.5	11.3	73.6	14.8	7.4	9.8	10.4	6.1	2.3	8.2	9.5	19.7	3.5	8.8	11.0	19.7	9.2	4.7	16.8	5.9	10.1	126.9	6.8	12.5	7.1	21.2	14.5	7.7	4.0	14.0	12.8	17.7	12.8	32.0	10.6	20.7	21.5	30.2	17.2	7.9	14.0	2.9	0.6	0.8	1.7	1.0	1.1	5.1	0.4	0.8	0.6	4.3	0.6	0.6	0.1	2.9	1.1	1.8	0.9	0.8	17.9	31.7	3.6	27.6	21.4	7.3	4.2	10.3	4.1	0.8	22.8	15.1	4.1	64.1	77.7	13.1	7.6	2.9	2.5	5.2	2.8	31.1	2.9	3.2	10.2	5.7	9.1	7.3	4.2	14.7	4.5	0.2	1.9	2.1	0.8	1.9	4.8	6.2	6.0	1.3	33.3	3.7	8.5	5.5	6.1	3.2	4.5	2.4	7.9	1.9	14.3	16.8	13.1	5.8	0.0	2.5	2.6	0.8	6.2	3.5	1.8	5.6	1.5	7.3	8.2	7.1	1.8	4.1	2.6	6.4	4.2	1.2	57.2	6.2	3.1	6.1	0.0	7.2	4.2	0.9	1.9	0.5	0.6	5.6	2.5	2.9	2.8	0.9
RPGRIP1	"CORD13, LCA6, RGI1, RPGRIP"	ENSG00000092200	"RPGR interacting protein 1"	Q96KN7	14	21280083-21351301	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Cone-rod dystrophy, Disease variant, Glaucoma, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	80	"retina: 185.3;testis: 59.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 231.4;Early spermatids: 177.3;Late spermatids: 108.9;Rod photoreceptor cells: 117.5;Spermatocytes: 51.7"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.3;granulocytes: 8.8;monocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"RT4: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042955, HPA060190"	Supported	Supported				NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042955: AB_2678239, HPA060190: AB_2684218"	"unprognostic (9.02e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.83e-2)"	0.2	0.1	0.5	0.7	0.3	1.2	0.6	0.8	0.6	0.3	0.4	0.5	0.9	0.2	0.0	0.2	0.1	0.3	0.2	0.4	0.3	0.2	0.8	0.5	0.5	0.4	0.2	0.1	0.1	0.2	0.1	1.2	0.6	0.4	0.6	185.3	0.1	0.1	0.1	0.5	0.8	0.0	0.1	1.5	0.2	59.6	0.5	0.1	0.3	0.2	0.3	0.5	0.1	0.3	0.3	0.8	0.8	0.4	0.0	0.0	1.1	0.3	0.0	0.0	0.4	0.5	0.5	1.1	0.2	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.5	0.4	0.8	0.2	0.0	0.9	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.7	0.1	0.0	0.3	0.3	0.5	1.2	0.5	0.3	0.4	0.7	0.9	0.0	3.8	0.6	0.5	0.7	0.8	0.2	0.6	0.3	0.5	0.3	0.2	0.2	0.8	0.6	0.9	0.9	1.0	0.4	0.6	0.2	0.7	3.7	0.0	0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.1	0.1	0.0	8.8	0.3	0.0	0.0	0.0	1.0	0.5	0.3	0.8	0.6	0.4	0.3	0.4	0.2	0.6	0.1	0.5	0.3	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.3	1.0	0.0	0.0	0.0	231.4	0.9	0.0	0.0	0.0	0.0	177.3	0.1	0.1	0.6	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.9	0.0	1.2	0.0	0.0	2.7	0.9	108.9	1.8	0.8	0.0	1.0	0.5	4.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	117.5	0.0	0.1	0.1	51.7	2.2	0.0	0.1	1.5	0.1	0.1	0.0	0.1
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011481	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"skin 1: 9.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 10.0;Ionocytes: 10.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.3;NK-cells: 2.0;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 9.5;hTCEpi: 12.1;MCF7: 8.3;RT4: 20.6;SCLC-21H: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	0.5	0.1	0.0	0.9	0.1	0.4	4.4	0.0	0.1	1.2	0.1	2.4	5.6	1.3	1.9	3.6	1.7	1.1	0.6	0.0	0.2	1.9	1.8	1.6	1.3	0.1	0.1	0.3	3.2	2.1	1.3	0.3	0.1	1.7	1.7	0.0	3.1	0.9	0.0	9.2	4.7	1.1	0.0	0.8	2.6	1.1	0.2	1.6	1.9	0.0	2.4	2.3	2.4	0.0	3.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.9	0.0	1.8	0.0	0.4	9.5	0.0	6.5	0.0	0.0	0.6	0.0	1.7	0.0	0.3	0.0	0.0	0.3	12.1	1.5	5.9	0.0	0.0	0.0	1.6	0.0	0.8	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	2.5	20.6	8.2	0.0	0.2	4.3	0.0	0.2	0.1	0.0	0.2	0.0	4.3	0.0	0.0	4.0	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	1.1	2.3	0.7	1.2	0.1	1.0	2.2	1.6	0.0	2.0	0.0	0.1	1.5	0.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.0	1.1	0.0	2.7	5.9	3.5	6.1	6.2	0.0	5.8	3.9	2.6	7.2	3.3	1.8	0.0	0.6	1.1	2.7	3.9	10.0	1.3	2.8	0.7	0.5	2.4	0.4	0.0	7.5	0.2	0.4	1.1	3.2	0.0	0.4	0.0	3.7	0.0	0.0	0.0	6.0	10.2	0.0	0.3	2.0	0.0	0.2	1.8	0.0	0.0	0.0	1.0	0.0	0.1	6.3	4.5	0.0	1.1	3.8	9.7	2.9	3.6	0.0	0.0	0.0	0.5	8.4	6.2	5.6	9.1	0.3	1.2	0.1	4.1	4.4
SEMA5A	"SEMAF, semF"	ENSG00000112902	"Semaphorin 5A"	Q13591	5	9035033-9546075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 1189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004632	Approved					NA	NA		13000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA004632: AB_1079905"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.15e-2)"	"prognostic favorable (3.66e-8)"	"unprognostic (8.51e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.01e-2)"	4.6	1.2	7.8	2.7	9.1	0.0	6.8	5.6	23.6	13.0	3.6	9.5	2.9	8.9	2.2	3.1	2.9	5.4	9.5	35.4	17.0	11.6	4.9	11.1	4.7	10.9	11.1	1.7	4.4	1.9	2.3	7.0	17.1	2.9	7.5	7.0	2.1	4.9	1.3	4.4	5.3	2.4	8.3	6.3	1.9	1.6	16.4	1.7	1.9	3.1	3.7	5.8	3.8	13.4	0.0	0.0	15.0	0.0	10.1	14.1	0.0	24.2	64.2	4.7	2.5	0.0	0.1	0.0	0.0	37.1	0.3	21.6	0.0	1.4	2.4	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.1	3.6	0.7	5.3	21.6	10.5	0.0	0.0	0.0	0.0	5.7	0.7	0.0	0.0	1.5	13.2	1.1	0.0	0.0	0.9	1.8	66.7	3.1	0.3	0.2	0.0	19.9	5.1	0.0	0.0	0.0	23.0	0.5	0.0	0.5	0.0	0.0	0.0	21.4	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	9.1	5.6	23.6	35.4	17.0	10.9	11.1	17.1	8.3	16.4	13.4	8.0	150.6	5.6	63.6	0.3	9.2	6.4	30.8	8.0	2.8	1.6	49.0	37.0	22.8	14.3	1.8	0.0	1.8	9.6	23.9	0.0	3.4	32.6	6.3	151.5	6.4	5.4	0.0	60.6	2.3	1.2	27.8	0.5	9.3	1.3	1.8	5.3	4.3	1.3	247.3	53.1	10.9	0.0	0.0	5.2	50.5	10.2	0.8	33.8	134.9	0.1	44.8	0.0	1189.7	152.3	1.2	8.0	14.7	0.0	8.2	16.9	14.4	2.0	3.6	39.5	4.3	40.5	0.6	0.5	11.4	4.8	1.9	1.4	29.0	20.5	14.1
SEPTIN8	"KIAA0202, SEP2, SEPT8"	ENSG00000164402	"Septin 8"	Q92599	5	132750819-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 393.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 14.1;Cytotrophoblasts: 31.0;Extravillous trophoblasts: 12.1;Fibroblasts: 9.5;Hofbauer cells: 12.1;Smooth muscle cells: 8.8;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: AB_2797226"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	26.9	19.5	192.8	18.0	273.3	8.3	22.2	279.1	238.2	28.2	111.6	26.3	26.2	18.8	18.5	34.0	21.4	25.2	33.0	188.3	218.5	34.8	13.0	26.2	14.9	319.9	262.0	25.2	23.3	23.9	22.3	44.3	304.7	20.5	26.9	74.6	33.4	20.6	10.9	49.7	25.8	21.3	238.1	14.8	26.8	6.9	250.4	18.0	32.3	12.4	18.6	36.1	31.1	393.6	55.8	26.4	37.3	76.7	50.8	49.5	122.0	58.9	56.2	54.7	66.5	46.6	39.2	0.3	51.1	57.3	32.4	42.3	70.5	96.4	59.9	71.3	50.8	54.4	35.5	40.5	37.2	19.4	76.0	35.9	30.6	25.3	35.8	53.5	77.4	47.7	84.6	10.6	29.7	53.0	63.3	18.2	19.8	33.7	17.0	57.4	43.5	4.7	32.0	141.1	50.0	31.0	50.0	11.5	32.9	107.4	100.6	25.4	80.9	60.6	39.2	15.1	42.5	14.3	14.3	2.0	38.7	28.6	46.5	0.5	1.0	0.0	2.0	0.6	2.0	0.4	1.6	2.5	1.2	0.1	0.4	1.0	0.0	0.2	0.3	0.0	1.9	1.0	192.8	273.3	279.1	238.2	188.3	218.5	319.9	262.0	304.7	238.1	250.4	393.6	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	31.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	12.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	10.1	0.6	0.0	0.0	0.0
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815948-70881184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	12.0	12.7	15.8	18.0	17.4	6.8	13.0	15.2	16.3	17.6	11.0	16.7	16.0	14.4	18.8	27.9	15.3	12.6	6.4	14.7	16.4	15.5	22.9	10.7	18.1	18.6	16.7	9.0	18.5	21.0	9.4	10.0	17.4	17.5	17.9	10.8	14.3	12.4	9.6	30.4	22.8	13.9	17.4	16.1	12.3	14.0	17.7	17.9	20.1	6.0	20.1	25.0	14.7	19.8	26.9	35.2	33.2	38.1	8.9	11.5	22.1	15.5	16.4	16.5	21.4	38.4	57.8	24.2	18.0	15.8	15.9	44.1	28.8	31.0	23.5	39.1	15.6	2.5	17.5	46.2	33.6	10.6	20.9	21.8	51.4	22.1	57.6	34.6	10.4	22.3	7.2	20.4	23.6	29.6	13.2	7.1	15.0	35.4	19.5	16.6	25.2	9.1	26.3	112.1	22.6	27.5	30.9	46.6	28.5	25.9	24.3	7.5	20.3	14.8	38.7	11.6	30.1	8.4	12.6	11.0	14.7	19.3	10.7	1.1	18.2	14.0	18.0	34.6	16.5	7.2	11.5	14.7	16.2	8.7	8.5	13.5	15.0	18.8	44.9	8.9	11.8	12.4	15.8	17.4	15.2	16.3	14.7	16.4	18.6	16.7	17.4	17.4	17.7	19.8	3.8	16.0	6.4	32.3	11.0	12.2	17.8	21.4	8.0	6.3	15.8	9.8	6.3	27.1	23.2	46.0	20.9	7.3	16.0	41.5	3.9	36.2	2.9	30.2	13.3	7.3	25.1	4.4	48.7	37.6	13.8	10.1	6.6	46.1	14.7	23.1	7.1	44.5	27.6	15.2	38.8	21.2	22.4	43.1	16.1	5.2	11.5	25.7	7.2	35.6	22.7	9.8	25.7	41.7	43.8	55.6	18.8	20.3	5.9	26.0	53.5	12.0	26.6	9.7	6.6	13.3	19.0	20.0	34.0	15.9	22.7	6.3	11.1	18.2	20.9	25.3
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SHISA5	"hShisa5, SCOTIN"	ENSG00000164054	"Shisa family member 5"	Q8N114	3	48467798-48504826	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042295	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA042295: AB_10794794"	"unprognostic (3.52e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.72e-6)"	"unprognostic (3.82e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-2)"	97.5	71.8	74.2	68.3	71.9	65.0	82.2	58.8	92.2	99.6	113.0	82.1	60.6	91.4	45.3	140.6	94.9	70.6	75.0	72.3	88.9	94.3	115.0	101.7	80.1	76.8	73.6	86.3	58.3	48.0	70.2	138.4	72.0	107.9	39.5	13.7	69.1	69.8	22.8	60.1	74.5	67.1	70.8	114.3	73.5	35.5	87.6	84.4	76.8	31.7	66.9	116.8	98.3	65.2	71.0	141.9	82.4	132.0	153.1	194.7	417.7	115.3	209.0	254.3	187.9	157.4	175.6	97.7	123.2	200.9	240.9	91.7	91.5	148.3	70.7	116.4	63.6	89.2	91.2	128.2	256.7	61.9	164.0	200.9	169.3	205.7	141.7	141.7	193.2	129.0	56.6	115.6	138.2	154.1	70.4	111.1	150.4	101.2	113.0	48.2	36.7	133.4	130.5	446.6	24.6	13.8	74.9	79.1	155.6	136.8	91.5	91.2	153.6	90.5	100.8	155.2	112.0	87.0	76.3	85.8	128.2	118.3	90.2	205.9	301.6	252.5	320.7	267.5	283.4	165.0	264.1	293.8	167.3	222.6	210.9	219.4	910.2	138.7	306.9	126.7	345.7	500.0	74.2	71.9	58.8	92.2	72.3	88.9	76.8	73.6	72.0	70.8	87.6	65.2	69.8	41.7	39.4	12.1	55.8	27.8	73.0	52.2	114.4	22.7	29.6	29.8	17.3	51.5	37.6	64.4	16.7	279.7	56.3	43.0	11.7	79.4	4.2	29.2	49.8	79.4	37.8	22.9	10.8	104.3	229.9	57.4	36.2	31.2	34.8	41.5	66.0	88.0	103.0	6.7	11.0	48.3	14.2	57.5	27.3	5.7	49.0	47.7	46.2	18.7	46.5	30.1	101.0	10.6	10.4	80.2	31.2	39.1	54.5	50.2	64.9	43.3	38.0	5.0	32.9	22.1	43.9	5.1	8.8	85.9	32.1	120.5	74.0	49.9	40.3	50.5
SHROOM1	"APXL2, KIAA1960"	ENSG00000164403	"Shroom family member 1"	Q2M3G4	5	132822141-132830659	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 116.9;prostate: 73.9;urinary bladder: 62.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.0;Hepatocytes: 79.2;Proximal enterocytes: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037690, HPA037691"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA037690: AB_2675613, HPA037691: AB_2675614"	"unprognostic (2.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.22e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.26e-3)"	9.3	2.4	25.2	2.6	32.0	0.2	8.2	28.9	26.9	12.6	10.4	20.5	6.1	11.3	2.1	5.1	8.4	6.7	7.6	20.2	23.6	10.7	116.9	10.5	0.6	42.1	30.9	5.6	16.2	4.9	6.8	11.8	33.3	73.9	11.1	3.4	7.0	15.2	1.7	1.5	16.6	3.9	26.1	2.3	10.9	1.7	31.2	0.6	6.9	1.3	0.5	62.4	9.3	55.7	8.6	5.1	0.9	0.8	1.4	4.0	9.0	9.1	7.7	7.0	7.8	11.2	5.7	1.5	12.5	4.9	3.8	0.8	3.1	5.7	4.3	9.5	11.0	0.3	8.7	10.5	4.1	0.7	3.1	1.7	3.0	4.9	3.0	4.8	4.8	0.1	7.3	8.1	6.1	4.8	0.2	4.0	1.4	6.7	8.1	0.5	0.0	0.8	1.2	24.4	5.7	1.5	8.8	0.7	4.9	4.5	5.2	2.9	4.5	8.1	11.7	1.1	11.5	9.2	6.8	0.1	7.9	0.0	2.5	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	25.2	32.0	28.9	26.9	20.2	23.6	42.1	30.9	33.3	26.1	31.2	55.7	18.3	25.6	22.3	18.9	1.8	1.3	15.4	2.3	3.4	3.7	9.3	5.5	2.2	30.0	11.3	9.2	10.4	6.8	1.0	135.0	1.9	6.0	0.9	7.1	17.3	18.1	22.8	2.7	3.0	10.7	4.8	6.1	33.6	15.1	8.2	9.0	25.0	79.2	6.6	16.8	1.0	28.6	0.0	8.7	5.5	1.1	4.7	4.6	0.0	23.4	8.1	19.9	3.1	6.6	37.5	7.1	53.6	4.9	3.6	31.6	65.5	3.5	9.1	13.3	26.3	2.8	5.1	7.6	5.1	1.8	2.0	2.9	2.5	1.4	35.5	17.3
SLC16A5	"MCT5, MCT6"	ENSG00000170190	"Solute carrier family 16 member 5"	O15375	17	75087727-75106162	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 92.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Collecting duct cells: 88.3;Early spermatids: 42.2;Proximal enterocytes: 40.9;Respiratory ciliated cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.2;neutrophil: 34.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 34.9;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"A549: 65.9;OE19: 71.5;RPTEC TERT1: 68.8;RT4: 139.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.43e-3)"	"unprognostic (8.07e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	6.5	1.4	1.1	4.8	1.1	8.7	7.2	1.2	1.2	9.4	5.0	15.2	34.0	8.5	4.4	11.2	16.1	8.2	13.9	1.0	1.7	92.8	3.3	24.6	3.4	2.2	2.2	8.1	4.7	4.6	2.7	10.8	1.7	15.0	10.3	0.1	7.9	12.5	9.4	15.9	24.9	4.2	1.9	10.6	26.0	6.5	2.4	1.9	14.3	4.6	3.9	18.5	11.1	1.8	14.2	65.9	1.2	0.1	3.2	4.2	22.0	7.7	19.8	7.7	5.4	16.9	39.6	0.0	9.2	24.1	1.0	39.7	3.2	10.8	2.9	0.0	0.2	5.1	33.5	8.9	14.9	0.0	0.2	10.1	12.8	7.8	0.1	0.1	15.8	0.7	1.1	0.2	0.5	2.3	0.5	7.1	5.0	71.5	0.2	1.6	0.0	0.5	68.8	139.8	0.0	0.4	19.4	4.5	9.7	11.0	32.0	7.1	5.7	0.1	0.1	0.5	0.1	0.2	0.0	0.0	0.3	4.3	4.3	4.1	13.2	3.5	0.5	5.0	0.3	1.4	0.6	0.1	3.9	0.3	1.4	0.6	34.9	1.0	2.6	0.1	0.8	4.4	1.1	1.1	1.2	1.2	1.0	1.7	2.2	2.2	1.7	1.9	2.4	1.8	4.4	38.5	34.5	0.0	0.9	2.5	7.7	10.1	6.2	0.0	5.6	6.1	5.5	7.2	23.5	88.3	0.0	18.5	0.5	17.1	5.9	6.4	42.2	9.7	1.5	5.0	6.7	0.4	0.2	1.3	3.7	3.7	11.7	6.1	7.0	3.9	12.8	0.4	6.5	0.0	0.3	13.2	4.1	8.5	1.8	31.8	0.6	5.5	7.2	3.7	7.9	0.2	3.1	0.0	0.1	1.0	23.8	0.0	0.2	11.3	40.9	1.9	45.4	0.0	0.0	0.8	2.1	0.3	1.5	3.6	1.3	19.6	1.4	1.1	11.8	25.5
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 609.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 289.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.8	1.1	0.2	0.3	0.2	0.0	1.2	0.1	0.4	0.5	0.5	5.1	0.4	2.2	0.2	1.7	0.9	0.3	0.3	0.1	0.6	4.4	609.9	0.3	0.2	0.2	0.3	0.2	6.6	0.2	0.1	2.2	0.1	1.3	1.3	0.1	0.8	0.5	10.2	2.6	0.5	5.4	0.2	1.2	0.2	0.3	0.7	1.4	0.3	2.6	0.8	2.0	0.2	0.3	0.0	0.0	0.1	0.0	17.7	2.2	3.4	2.3	5.6	2.0	1.8	1.1	4.3	0.0	3.5	7.8	0.0	1.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.2	0.7	0.5	0.0	4.2	0.1	0.1	1.4	0.1	0.0	0.0	0.2	0.0	43.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	14.6	0.0	0.0	86.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.1	0.6	0.2	0.3	0.1	0.2	0.7	0.3	0.1	0.0	0.0	2.6	0.5	0.8	0.0	2.2	3.4	0.0	0.1	0.0	1.5	11.5	0.2	1.8	0.0	2.5	0.0	1.9	0.0	0.0	0.2	0.4	0.2	1.2	0.0	5.3	0.6	0.0	0.7	1.2	0.0	0.2	0.0	1.6	3.9	289.5	0.5	0.0	2.2	0.4	2.0	6.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	1.2	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.0	0.1	2.8	0.6	0.8	0.4	2.7	1.3	0.1
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098809-27166981	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 76.5;stomach 1: 65.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	9.6	10.7	6.1	10.4	14.7	11.5	9.0	2.8	10.8	10.9	0.2	18.6	29.3	10.9	8.0	11.0	7.6	16.9	13.7	2.3	5.3	5.8	2.4	13.2	7.0	13.8	4.7	7.0	8.6	20.7	8.2	21.9	11.2	9.0	13.6	4.5	76.5	19.4	4.6	10.5	19.0	10.7	0.5	11.6	65.9	10.1	10.4	6.3	9.5	4.9	6.7	15.1	9.2	2.4	32.3	10.7	9.9	10.1	21.8	15.7	60.8	25.9	38.5	21.7	23.5	13.0	20.0	14.4	21.9	33.4	10.5	38.9	9.8	62.4	13.4	17.4	9.4	21.9	7.1	5.5	66.1	13.1	16.0	19.7	29.5	36.5	50.7	15.8	36.3	9.8	6.3	13.4	32.3	18.7	6.8	6.4	14.0	38.2	21.9	11.8	9.0	6.7	10.9	46.3	11.4	3.7	21.5	28.4	12.6	10.0	13.3	7.9	39.9	23.0	9.4	21.7	14.5	12.6	8.6	4.3	24.6	14.1	13.5	0.0	0.6	0.6	0.7	0.3	1.5	0.1	0.8	0.7	0.2	0.3	0.5	0.6	2.0	0.1	0.6	0.0	0.3	0.8	6.1	14.7	2.8	10.8	2.3	5.3	13.8	4.7	11.2	0.5	10.4	2.4	13.5	6.4	14.8	6.5	7.9	31.2	17.9	14.6	13.1	7.4	21.7	23.2	13.5	7.2	8.3	11.0	0.0	40.3	11.9	81.5	0.0	9.1	26.5	13.8	15.9	9.7	12.5	0.4	14.1	12.5	19.4	12.7	160.0	26.5	27.3	7.5	6.8	1.2	12.9	20.2	14.1	15.0	4.1	5.7	5.1	14.4	9.3	12.7	7.2	8.4	4.3	8.2	12.3	4.0	4.6	28.1	43.1	13.2	4.8	9.6	38.9	1.2	5.9	3.8	6.6	20.8	9.8	3.6	4.4	15.0	25.1	52.9	9.8	4.8	18.3	18.3
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792790-85806683	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.7;urinary bladder: 14.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1;urothelial cancer: 18.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7"	"Region enhanced"	"Detected in many"		"thalamus: 22.6"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		28000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.1	0.2	1.0	0.9	4.4	0.0	3.2	2.2	1.9	1.2	0.1	5.5	3.5	1.0	2.5	1.9	0.5	1.4	1.5	0.2	2.0	0.1	0.9	3.3	0.0	0.6	2.3	0.0	0.2	0.0	0.1	0.9	0.9	7.6	6.8	4.8	27.7	2.2	0.0	5.6	5.7	0.4	0.3	0.1	1.5	0.3	5.7	0.2	0.3	0.1	0.1	14.7	1.4	0.4	0.0	2.9	0.1	0.5	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.9	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	28.8	0.0	3.3	2.7	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	24.2	1.9	0.2	0.0	0.0	0.0	101.4	1.0	1.2	0.5	0.1	0.1	1.7	0.5	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.4	2.2	1.9	0.2	2.0	0.6	2.3	0.9	0.3	5.7	0.4	0.1	0.0	1.8	0.0	0.0	3.8	5.0	22.8	0.0	41.7	5.3	1.5	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	4.3	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	2.7	0.0	2.2	2.2	0.0	0.2	0.0	0.4	1.7	16.2	0.0	0.6	0.0	9.6	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.4	0.0	1.5	0.0	0.1	41.6	2.0	0.0	0.0	0.8	0.0	0.1	3.8	2.4	0.0	0.2	0.1	0.5	4.5
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.5;urinary bladder: 16.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.6	0.1	1.0	0.0	1.2	0.2	0.4	0.8	3.1	0.4	0.6	0.3	0.0	0.3	0.2	6.5	0.3	1.1	1.7	1.0	1.1	0.2	0.5	0.1	0.4	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.4	0.1	0.7	4.0	0.7	0.3	0.5	0.5	3.6	16.4	1.7	1.5	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.2	0.8	3.1	1.0	1.1	0.0	0.0	0.0	0.4	0.7	1.5	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894152-76898144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.0	0.3	1.2	0.7	1.4	0.0	1.3	0.0	2.8	1.0	0.7	7.7	5.5	0.3	0.8	6.2	1.1	1.3	0.0	1.8	0.1	7.7	19.1	1.6	0.0	0.5	0.0	0.0	5.8	6.9	0.4	0.6	0.6	0.8	6.3	0.2	2.4	2.7	0.0	1.5	8.1	0.2	0.0	0.0	4.6	0.0	0.0	0.2	2.4	0.0	2.3	6.0	2.2	1.1	3.9	0.1	0.3	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.9	2.6	0.0	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.5	19.4	0.1	0.0	0.0	1.7	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.0	2.8	1.8	0.1	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.5	1.9	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	4.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.1	1.1	0.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.5	6.1
SPIDR	KIAA0146	ENSG00000164808	"Scaffold protein involved in DNA repair"	Q14159	8	47260878-47736306	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 122.4;Excitatory neurons: 255.4;Inhibitory neurons: 214.4;Microglial cells: 216.4;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027201, HPA041582"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA027201: AB_10603774, HPA041582: AB_2677563"	"unprognostic (5.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.72e-3)"	"unprognostic (7.99e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.35e-2)"	21.4	16.5	17.2	16.2	17.1	15.1	19.1	20.9	19.9	19.6	16.2	16.1	11.0	16.6	14.8	23.6	18.3	20.9	12.4	17.3	15.5	13.5	15.1	19.0	16.6	16.6	15.1	23.6	18.1	11.8	17.8	18.5	16.3	18.3	14.5	18.0	17.7	10.6	13.9	20.3	13.4	11.8	13.9	20.5	17.7	10.6	15.2	12.3	19.7	4.1	12.0	17.3	16.1	15.9	16.4	24.2	16.5	28.7	19.6	24.9	15.0	22.8	18.1	16.5	25.5	13.4	39.4	31.5	22.6	19.8	16.9	8.5	18.3	17.3	23.7	9.1	15.6	21.5	23.0	25.7	21.9	16.0	13.3	15.9	13.5	13.7	19.9	20.0	12.4	19.7	16.9	11.2	19.9	38.8	30.3	40.5	19.6	38.2	6.5	15.2	10.1	2.2	22.4	55.6	9.0	19.5	35.2	25.7	12.3	17.4	23.9	33.0	20.4	12.0	17.8	17.8	13.4	12.7	25.1	21.8	14.2	22.3	12.0	4.6	10.6	3.1	9.3	6.5	9.4	7.1	4.1	5.5	8.6	6.0	4.4	3.9	4.4	7.9	7.7	1.3	8.8	5.5	17.2	17.1	20.9	19.9	17.3	15.5	16.6	15.1	16.3	13.9	15.2	15.9	25.8	35.3	33.7	122.4	22.2	10.7	16.6	17.8	30.7	11.2	20.1	18.0	19.5	12.8	18.0	12.9	18.8	17.8	15.7	8.8	7.9	8.2	8.5	18.1	20.4	21.4	11.5	12.4	255.4	8.8	11.5	21.7	26.0	21.0	12.6	20.6	10.8	8.3	11.1	13.5	214.4	9.7	10.2	33.1	11.3	7.6	14.6	27.4	8.8	216.4	24.9	8.7	15.5	207.6	141.4	7.1	10.1	14.7	16.6	15.1	6.0	4.9	26.5	12.2	6.6	17.5	16.9	21.7	29.7	27.6	8.7	16.4	15.1	10.9	12.3	18.6
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor Kazal type 1"	P00995	5	147824572-147831671	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"pancreas: 53063.4"	"Group enriched"	"Detected in many"	9	"Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"CACO-2: 417.2;RT4: 1139.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	NA	NA		8000000		"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favorable (2.15e-5)"	8.8	1.5	0.1	36.4	0.1	6.8	4.1	0.3	1.2	3.1	0.3	428.2	394.4	5.5	0.8	2.9	1.3	111.9	12.0	0.2	0.2	142.5	491.8	2.7	2.7	0.1	0.1	25.6	53063.4	0.0	1.9	3.2	0.2	4.4	441.3	0.6	12.8	1.4	1.2	21.1	403.9	14.1	0.0	2.5	1475.2	0.9	0.3	0.4	1.0	0.0	0.3	995.6	10.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	417.2	0.3	0.1	6.8	0.0	0.8	0.9	2.2	0.0	0.0	3.9	0.0	0.0	0.0	107.0	0.3	0.0	3.9	0.0	2.1	0.0	3.0	5.8	0.0	0.0	0.0	0.3	0.0	0.3	0.8	1.3	2.1	138.9	0.8	0.8	0.0	2.5	0.0	1139.0	0.5	1.7	0.0	0.2	0.1	5.4	0.1	0.0	0.0	0.1	13.7	1.1	3.8	2.2	5.9	3.0	16.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.2	0.2	0.2	0.1	0.1	0.2	0.0	0.3	0.6	0.0	0.0	3.6	0.0	9.7	0.0	15.1	0.3	0.0	0.0	5.5	0.8	0.1	1451.2	11.1	377.0	0.0	0.0	0.0	280.8	86.1	1286.7	0.1	0.3	0.4	9.4	517.2	18.7	1.0	50621.7	0.1	1.9	1580.5	5.0	4.5	2.0	39.3	3385.8	0.1	0.0	0.2	2087.4	0.0	30.9	0.0	0.2	0.0	13.7	0.0	0.0	269.8	0.0	0.0	0.0	0.1	16750.7	563.8	0.0	1.3	173.5	1457.1	1.6	0.7	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1365.3	649.1
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 4257.2;esophagus: 19480.4;vagina: 6062.0"	"Cell type enriched"	"Detected in some"	11	"Squamous epithelial cells: 987.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4"	"Not detected"	"Not detected"							HPA044467	Enhanced					NA	NA		5200		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	4.0	3.5	0.0	0.1	0.0	0.0	3.0	0.0	0.0	4257.2	0.0	2.6	0.1	3.5	0.0	19480.4	3.4	38.1	7.4	0.0	0.0	2.6	5.8	1.7	0.0	0.0	0.0	4.4	8.8	0.0	11.0	0.7	0.0	3.4	0.1	0.0	3157.9	0.0	5.0	7.5	4.2	1.7	0.0	3.4	15.2	2.1	0.0	1.4	2.3	0.0	2399.3	65.1	6062.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	3.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	12.6	0.0	0.0	0.3	2.7	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	7.4	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	5.9	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.2	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.4	0.0	0.1	2.1	0.0	0.0	0.0	1.0	0.0	0.0	987.1	0.0	7.5	0.4	0.1	0.0	89.6
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.5;fallopian tube: 20.4;liver: 60.8;prostate: 16.8;seminal vesicle: 18.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Region enriched"	"Detected in single"	11	"midbrain: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	23.5	0.0	20.4	0.0	0.0	0.0	0.0	0.3	60.8	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.1	0.0	18.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787682	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.8;testis: 2.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Muller glia cells: 2.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"								"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 294.5;Paneth cells: 343.4;Proximal enterocytes: 415.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 7.9;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 87.3;HaCaT: 70.3;MCF7: 104.3;RT4: 138.1"	"Region enriched"	"Detected in many"	13	"cerebellum: 20.5"	"Low region specificity"	"Detected in some"			"HPA002375, HPA027761"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (4.13e-4)"	5.6	18.1	2.6	7.5	2.7	0.4	16.6	3.6	4.2	18.1	3.5	72.8	77.5	5.7	10.6	91.0	15.1	7.1	4.9	2.7	2.4	28.5	55.3	8.2	3.2	2.4	2.2	11.5	30.6	21.3	4.4	3.4	2.7	37.9	59.7	0.5	45.4	9.8	1.2	73.9	72.0	4.0	2.0	1.5	24.2	2.0	2.5	7.9	15.3	0.7	13.0	16.5	41.0	2.6	87.3	0.4	6.2	5.8	0.4	4.7	35.7	1.6	8.8	2.8	2.2	52.0	34.8	0.1	13.3	2.8	17.9	70.3	1.1	50.3	1.6	14.9	0.7	0.3	0.4	35.1	10.9	0.1	0.7	3.5	41.7	4.8	12.2	7.0	8.9	2.1	3.4	18.6	1.3	104.3	1.3	0.7	4.8	55.3	20.4	3.6	0.8	2.2	29.4	138.1	2.1	3.5	0.1	25.9	14.6	2.2	60.7	0.3	12.5	0.2	1.2	0.7	1.8	0.1	1.4	1.3	0.3	0.4	5.7	0.4	0.1	0.0	0.6	0.0	2.3	0.6	0.8	0.1	0.7	0.1	2.3	1.4	0.1	7.9	0.0	2.2	2.5	0.8	2.6	2.7	3.6	4.2	2.7	2.4	2.4	2.2	2.7	2.0	2.5	2.6	6.7	9.6	14.4	0.3	2.4	40.5	59.8	171.4	42.7	0.6	33.8	30.1	6.9	38.6	87.2	29.5	0.0	16.9	2.3	294.5	25.4	137.5	1.2	9.0	3.6	10.1	85.8	4.4	1.5	101.0	3.0	4.5	55.5	13.4	8.9	5.2	7.5	29.6	1.8	0.0	1.2	147.5	91.6	4.1	9.4	0.9	4.7	1.8	19.6	0.0	12.5	1.0	1.0	0.5	1.8	139.4	343.4	1.9	1.4	92.6	415.7	125.0	44.9	0.8	0.0	1.7	7.9	0.6	2.6	86.0	61.8	12.4	3.3	5.7	173.2	117.0
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.5"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA004199: AB_1080156, HPA076871: AB_2732324"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.0	0.4	7.5	0.0	11.0	0.1	0.1	0.0	16.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.1	12.7	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	1.1	0.4	0.0	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.8	3.8	0.0	0.0	0.0	0.0	0.3	0.2	0.4	10.8	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.6	0.6	0.0	1.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	6.2	17.0	0.3	2.8	0.5	0.7	0.0	1.0	0.0	0.0	0.0	2.7	6.6	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	0.0	16.5	12.7	8.0	0.0	0.0	0.0	0.1	3.8	0.4	0.0	0.0	0.0	8.8	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.3	0.0	0.0	3.7	2.1	0.7	0.0	0.0	0.0	0.3	45.0	0.1	0.4	0.1	0.0	0.0	281.4	0.0	0.6	0.1	3.1	0.3	0.0	3.4	0.0	0.0	0.1	0.0	279.7	0.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	8.4	0.0	0.7	0.0	127.2	13.9	0.1	0.0	0.0	0.3	1.7	0.0	0.2	0.1	0.1	0.0	0.0	0.4	3.8	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SYT9		ENSG00000170743	"Synaptotagmin 9"	Q86SS6	11	7238778-7469043	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;retina: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.47e-1)"	"unprognostic (9.41e-2)"		"unprognostic (1.39e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.31e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.22e-4)"	0.0	2.0	9.1	0.0	9.2	0.0	0.8	11.7	5.9	0.4	1.4	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.3	4.7	7.6	2.0	3.6	0.0	0.0	9.9	11.8	0.1	1.3	0.9	1.5	0.0	9.6	1.0	0.0	7.6	0.0	3.6	0.0	0.1	0.1	0.1	8.1	0.0	0.1	0.9	15.9	0.0	1.1	0.0	0.0	0.2	0.3	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	17.9	3.2	13.2	0.0	0.0	0.0	0.4	0.0	0.0	20.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.2	11.7	5.9	4.7	7.6	9.9	11.8	9.6	8.1	15.9	11.7	0.0	0.0	0.0	48.6	0.5	0.0	0.1	0.0	0.0	13.6	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.2	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	3.3	9.8	0.0	0.0	0.3	0.0	23.5	0.0	0.0	0.0	5.6	0.0	2.0	0.0	55.3	139.2	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	3.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBX6		ENSG00000149922	"T-box transcription factor 6"	O95947	16	30085793-30091924	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4;Urothelial cells: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 4.1;RT4: 6.9;U-266/70: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.1	1.9	3.3	0.7	3.9	0.5	1.4	3.1	4.1	3.6	2.4	1.8	1.2	1.1	0.7	13.8	1.7	0.8	1.3	3.1	3.3	3.2	1.9	1.4	0.8	3.7	3.7	1.8	4.3	1.0	1.9	0.3	3.9	3.3	0.3	1.7	2.8	1.2	2.0	3.5	1.7	0.4	3.4	2.4	4.7	1.8	4.0	0.9	2.8	0.5	1.5	4.4	7.3	4.5	0.6	0.7	0.4	0.7	1.0	0.5	0.5	0.2	0.1	0.0	0.1	0.9	2.9	1.2	1.5	0.1	0.1	0.8	0.3	0.5	0.0	0.9	0.5	0.8	1.4	0.7	0.7	0.1	1.7	0.2	0.8	0.1	0.3	0.6	0.4	2.7	0.1	2.9	0.0	2.6	0.5	0.3	0.6	4.1	0.6	2.0	0.0	2.1	0.0	6.9	0.9	1.3	0.1	0.5	0.8	0.3	1.2	1.2	0.3	0.8	0.4	0.4	0.0	6.9	1.7	0.2	0.8	1.2	0.2	1.2	0.6	0.2	0.4	0.6	0.3	0.3	0.2	0.3	0.3	1.2	0.4	0.4	0.8	0.3	0.2	0.2	0.5	0.3	3.3	3.9	3.1	4.1	3.1	3.3	3.7	3.7	3.9	3.4	4.0	4.5	1.0	0.0	0.6	2.6	2.7	1.1	3.4	4.2	4.0	1.9	1.2	1.4	0.5	0.0	3.7	1.8	8.4	1.7	0.5	0.7	0.0	0.8	0.1	0.9	0.8	1.9	0.0	3.2	0.2	1.2	0.8	1.1	3.6	1.0	0.0	1.1	0.4	0.4	0.5	0.0	0.4	1.2	4.1	0.8	1.7	0.2	0.9	1.2	0.0	1.9	0.6	1.9	2.1	0.0	2.7	3.5	1.6	1.2	0.2	3.2	2.6	0.7	3.0	3.4	6.6	2.7	1.4	2.6	3.9	6.2	1.0	2.3	0.8	0.5	1.6	9.4
THEM6	"C8orf55, DSCD75"	ENSG00000130193	"Thioesterase superfamily member 6"	Q8WUY1	8	142727223-142736927	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 82.4;RT4: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023255	Uncertain		Approved	"Nuclear speckles,Cytosol"	"Secreted - unknown location"	NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"		"HPA023255: AB_1845782"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (6.66e-7)"	"unprognostic (7.02e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (4.49e-4)"	14.3	17.2	15.8	4.4	13.9	5.3	15.6	14.4	18.3	9.6	12.0	13.3	11.5	6.9	3.5	21.0	9.4	7.3	16.6	16.1	15.4	21.6	47.0	10.6	6.5	20.7	17.2	4.4	23.1	15.7	12.5	8.3	16.7	12.5	5.1	1.4	16.3	10.3	12.4	16.6	11.6	3.5	15.0	11.0	15.6	3.7	15.9	6.8	14.2	7.2	4.1	17.2	11.5	14.2	28.5	23.1	3.5	23.9	10.9	3.8	16.6	14.3	11.8	21.5	14.9	14.2	41.5	11.9	31.8	5.4	8.0	64.4	10.2	31.0	3.5	9.9	28.2	9.1	12.3	28.9	11.9	5.3	9.2	5.5	10.9	4.2	6.0	4.3	18.4	16.6	4.3	5.9	3.7	82.4	21.7	1.3	5.4	53.0	74.5	24.9	2.4	27.4	25.9	114.0	53.1	20.8	21.9	64.7	18.6	3.2	31.9	4.3	10.7	9.2	6.7	26.8	2.5	3.8	5.6	5.2	9.5	25.7	11.6	7.2	4.9	2.6	10.9	9.2	16.6	5.1	11.6	14.1	4.7	6.7	13.6	12.9	0.7	11.1	9.0	3.6	11.6	9.1	15.8	13.9	14.4	18.3	16.1	15.4	20.7	17.2	16.7	15.0	15.9	14.2	35.4	9.6	5.8	6.2	6.7	3.6	7.5	5.7	2.8	10.4	24.7	25.3	7.4	11.5	7.8	18.4	6.2	18.3	11.5	16.6	5.9	13.7	3.3	5.5	3.0	14.6	31.8	11.6	11.3	11.6	10.1	4.8	7.7	9.0	0.0	6.6	19.2	20.8	11.4	16.8	7.8	13.5	6.1	3.1	1.4	15.7	2.8	3.9	5.4	2.8	2.3	13.5	16.5	11.6	7.3	9.4	9.0	4.1	3.7	10.7	29.0	16.2	2.4	11.3	0.0	6.1	4.3	2.7	5.7	18.4	7.7	3.4	10.3	8.2	22.4	25.1
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274197-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 573.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	231.0	120.9	118.0	84.1	135.0	96.1	165.5	124.8	123.6	146.8	112.1	143.1	152.6	119.7	92.9	333.4	97.3	135.5	123.3	109.4	131.2	123.5	170.8	175.1	55.4	194.5	144.0	93.5	240.3	125.6	50.2	172.7	150.7	97.6	140.7	15.2	155.1	89.5	219.1	185.3	174.6	127.1	139.8	65.9	212.3	25.4	134.1	41.9	158.0	185.2	106.8	172.9	215.1	144.2	183.9	66.4	3.5	47.1	404.3	170.6	188.7	175.5	217.9	103.4	117.7	169.8	449.0	40.6	123.3	263.0	194.6	305.3	59.8	399.9	100.4	151.0	23.5	264.6	41.8	205.6	183.3	2.4	252.4	161.1	370.7	210.4	265.6	108.4	111.8	6.7	169.0	75.0	182.9	6.1	2.8	46.5	2.5	382.3	60.4	5.7	28.3	33.1	142.1	573.4	2.2	3.1	58.0	214.7	122.8	36.6	56.3	39.8	168.4	182.4	50.1	84.9	64.8	35.9	45.2	17.7	179.9	41.0	105.5	352.9	136.4	298.5	107.9	172.7	91.8	77.1	98.0	89.1	93.3	61.9	64.3	70.2	167.1	66.7	221.9	25.9	116.1	190.1	118.0	135.0	124.8	123.6	109.4	131.2	194.5	144.0	150.7	139.8	134.1	144.2	47.6	73.7	25.6	20.9	37.2	81.7	96.9	85.0	51.2	2.0	28.8	26.0	26.4	78.6	66.9	69.9	0.0	139.1	51.8	266.8	13.7	175.5	0.6	45.6	42.6	50.8	22.7	66.3	2.4	281.2	146.8	61.9	110.6	78.4	50.0	16.1	28.9	50.4	104.9	0.0	2.5	67.9	52.9	45.1	50.2	2.8	54.0	69.6	46.2	14.0	22.0	22.9	48.4	5.0	35.2	294.3	177.3	59.5	30.3	151.8	204.4	37.7	34.8	1.9	13.1	35.7	45.0	1.4	12.5	86.5	101.2	282.1	41.3	9.9	69.1	299.8
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 59.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 19.3"	"Cell line enhanced"	"Detected in many"		"RT4: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.8	8.8	7.0	2.2	7.8	1.2	11.4	9.2	8.4	6.0	27.5	4.2	11.1	2.7	7.1	4.2	4.9	6.8	26.3	6.4	6.5	30.8	12.3	8.5	4.5	7.2	7.5	5.2	4.2	59.7	6.5	2.9	7.2	3.9	3.7	7.0	13.3	5.9	6.6	11.1	6.3	2.1	6.9	3.4	10.2	27.1	7.5	5.4	6.3	5.8	6.8	7.4	3.2	8.5	6.2	6.4	8.9	9.7	8.3	6.6	6.0	5.1	7.5	6.1	6.6	4.6	5.1	6.9	2.9	3.5	7.6	5.9	4.8	5.1	5.4	17.1	4.1	4.4	5.4	5.1	13.2	1.6	0.7	7.8	8.5	7.7	13.5	6.7	2.2	13.2	8.7	5.0	6.5	9.4	2.3	14.2	10.6	14.5	3.9	7.0	3.8	12.2	18.9	33.1	8.1	5.6	5.3	4.4	8.3	11.7	16.0	22.9	1.6	5.8	1.8	5.1	2.2	6.5	12.1	6.6	7.9	5.5	8.0	1.1	2.6	4.5	8.1	4.5	6.8	2.9	18.5	15.6	2.9	3.6	9.6	10.8	0.4	2.4	3.5	4.2	19.3	4.0	7.0	7.8	9.2	8.4	6.4	6.5	7.2	7.5	7.2	6.9	7.5	8.5	4.0	3.2	18.5	17.3	6.2	5.5	6.2	8.8	7.4	11.2	14.0	12.8	21.7	7.2	10.1	29.5	16.7	18.6	10.2	5.7	23.5	4.2	67.8	7.0	4.3	3.5	0.0	3.4	28.3	4.0	5.9	5.9	7.7	3.7	5.7	7.0	2.2	5.4	5.1	10.1	25.6	4.6	24.4	4.1	4.5	33.5	9.3	3.9	7.2	7.5	3.6	13.4	11.3	13.0	33.3	2.7	3.2	4.9	5.5	4.2	20.9	10.3	18.6	17.3	6.6	6.5	6.6	123.5	37.4	6.2	5.4	40.1	17.4	7.0	6.0	7.6
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TRAFD1	FLN29	ENSG00000135148	"TRAF-type zinc finger domain containing 1"	O14545	12	112125538-112153604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 117.6;Spermatocytes: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039254, HPA039266"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039254: AB_10805358, HPA039266: AB_10795142"	"unprognostic (7.80e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (1.07e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (3.92e-5)"	17.1	14.6	15.9	30.4	21.5	30.1	20.3	21.2	18.9	21.2	24.7	40.6	16.7	16.8	15.6	32.0	15.4	17.7	22.3	15.1	17.3	15.7	13.5	26.3	37.1	22.4	20.0	18.7	11.8	15.7	11.7	19.0	23.0	22.0	20.6	18.7	19.0	19.8	12.9	35.9	20.3	25.9	20.5	31.3	17.2	29.1	20.1	32.6	13.8	11.4	40.4	29.9	21.7	30.2	23.8	26.2	41.8	40.8	28.8	27.3	22.1	27.2	38.8	36.5	29.4	29.5	21.9	27.4	22.6	28.9	15.7	49.0	42.0	26.3	24.2	47.3	40.1	44.4	37.7	16.3	50.0	27.1	67.7	34.4	43.5	27.1	35.7	37.2	32.6	16.6	50.1	16.9	23.6	41.2	31.5	39.0	35.4	27.8	31.8	43.8	25.6	46.8	24.3	89.5	36.4	27.3	57.4	55.7	15.1	30.8	35.8	38.7	22.1	17.2	12.2	17.1	14.3	40.3	36.2	29.3	18.5	21.6	19.1	323.7	96.1	226.1	45.1	86.8	30.1	56.7	43.1	40.3	50.1	60.2	39.4	36.6	188.2	70.8	93.1	33.5	63.7	101.2	15.9	21.5	21.2	18.9	15.1	17.3	22.4	20.0	23.0	20.5	20.1	30.2	10.7	19.2	13.1	6.8	12.4	12.2	7.4	18.5	30.7	7.0	14.7	11.8	10.9	5.7	18.9	12.9	25.0	20.1	8.5	15.4	5.9	21.3	1.7	9.0	14.3	11.3	15.6	9.0	8.4	20.8	15.6	15.1	15.3	7.5	12.0	10.0	7.9	5.7	14.8	15.2	12.2	10.3	30.5	11.9	9.9	3.7	11.8	14.0	7.2	7.5	117.6	9.9	19.6	10.6	28.6	25.8	15.5	12.8	8.7	22.7	13.0	6.3	10.2	10.9	0.0	5.6	8.8	75.6	36.0	22.0	15.2	26.4	14.0	10.0	9.4	14.4
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225890	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.0;Cardiomyocytes: 262.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	26.0	13.1	23.0	17.1	26.2	18.2	18.0	28.5	27.7	13.7	27.8	27.1	34.5	12.2	10.4	29.3	19.8	26.9	168.9	24.2	19.5	20.1	15.3	24.1	22.8	24.4	30.3	8.5	13.1	32.2	17.7	15.3	21.6	15.4	25.4	96.7	44.1	13.1	262.4	45.1	42.0	16.8	19.1	22.2	61.0	12.1	26.0	17.9	31.4	202.6	22.6	33.8	18.4	21.4	22.2	19.2	37.9	16.4	25.6	24.9	48.9	29.5	33.5	19.0	20.6	12.8	30.7	43.9	15.1	75.2	20.4	10.7	26.5	68.8	20.6	39.6	18.8	30.4	19.9	35.6	12.8	34.6	22.9	21.4	28.9	41.9	38.0	28.1	38.6	11.6	15.7	34.4	24.4	9.2	3.7	18.1	16.4	60.4	14.8	16.1	14.1	36.8	26.3	165.3	23.8	27.9	11.3	16.3	16.2	31.4	14.6	29.3	39.6	16.6	19.2	99.0	17.4	25.7	23.0	38.9	18.2	30.2	16.4	0.9	1.3	0.5	0.6	2.4	0.5	2.4	0.9	0.7	1.5	3.6	0.3	0.9	0.6	1.0	1.4	2.5	0.4	0.7	23.0	26.2	28.5	27.7	24.2	19.5	24.4	30.3	21.6	19.1	26.0	21.4	27.4	32.1	32.4	173.0	23.9	38.0	16.3	32.1	30.1	22.7	18.5	17.7	262.0	24.3	38.1	14.7	100.1	23.0	13.9	61.4	1.9	10.8	1.1	53.3	21.8	23.9	22.8	6.5	62.0	12.3	18.3	14.0	81.1	70.0	10.8	11.5	6.8	10.3	15.7	33.7	81.3	39.5	26.4	15.7	33.4	3.0	1.8	23.3	24.9	97.4	17.9	27.8	4.1	105.1	64.8	24.2	37.1	2.6	5.4	18.5	97.9	10.2	80.6	139.9	32.9	15.9	29.9	1.0	3.9	27.5	43.2	15.7	7.5	4.6	35.6	27.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.1;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.4	12.1	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;intestine: 16.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.6	0.0	2.1	0.6	3.5	2.6	0.6	3.0	2.4	0.3	0.2	13.2	7.0	0.3	0.2	0.3	0.2	0.3	0.2	1.6	2.8	1.9	0.1	0.3	0.3	4.2	3.4	0.0	0.1	1.4	0.5	0.3	4.1	0.5	16.6	0.4	0.3	0.1	0.1	0.7	7.9	0.5	2.7	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.6	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.5	3.0	2.4	1.6	2.8	4.2	3.4	4.1	2.7	3.1	6.6	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627108-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 121.7;RT4: 153.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	29.6	18.2	7.2	4.9	7.5	0.6	34.2	7.2	8.9	26.9	26.8	40.0	19.7	20.5	14.8	46.8	39.5	16.7	8.6	7.4	9.0	36.5	70.2	11.3	3.0	8.7	9.3	53.4	20.2	34.7	36.9	20.0	8.2	18.9	33.1	6.2	52.6	10.3	4.6	9.7	18.5	7.2	8.9	8.7	14.8	74.9	9.6	4.2	19.3	5.3	6.8	32.2	24.1	12.0	24.8	23.0	80.6	42.2	28.7	16.6	30.4	12.9	17.3	20.3	47.6	54.9	37.7	0.0	53.3	12.2	16.9	19.9	0.3	19.7	25.8	0.1	33.3	3.8	14.9	62.0	17.1	0.1	2.5	30.2	9.3	19.5	6.6	34.4	49.3	0.0	0.0	0.1	21.7	19.8	0.1	0.3	121.7	35.4	18.4	0.0	35.5	0.0	33.0	153.5	4.7	20.3	11.6	10.0	18.5	61.9	16.6	3.3	12.7	16.0	24.4	24.3	8.6	0.1	0.2	0.3	13.4	0.0	11.5	0.3	0.0	0.1	0.3	0.0	1.1	0.1	0.8	0.3	0.0	0.1	2.1	1.2	0.3	0.1	0.1	0.1	0.0	0.3	7.2	7.5	7.2	8.9	7.4	9.0	8.7	9.3	8.2	8.9	9.6	12.0	147.0	3.2	10.1	14.4	2.3	7.1	41.0	75.7	29.0	0.6	72.5	46.1	8.2	50.1	89.4	93.8	0.0	28.7	1.1	94.9	23.5	80.3	422.5	54.0	21.4	37.4	33.6	4.8	0.9	12.6	40.7	25.6	21.9	19.2	0.0	684.8	47.5	104.0	4.5	0.0	0.8	47.9	193.3	10.2	3.1	1708.3	32.9	3.1	10.6	1.0	1.0	48.2	0.0	9.5	0.4	18.7	55.5	35.7	0.3	33.0	43.5	43.8	193.9	1.9	19.7	17.1	43.1	20.9	32.4	23.3	5.4	13.5	2.5	49.4	94.3	89.7
TXNDC17	"MGC14353, TRP14, TXNL5"	ENSG00000129235	"Thioredoxin domain containing 17"	Q9BRA2	17	6640985-6644541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 182.9"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 785.8;Proximal tubular cells: 814.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022931	Approved					NA	NA		820000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022931: AB_1858479"	"unprognostic (8.94e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.97e-2)"	"unprognostic (5.02e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.88e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.86e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.09e-2)"	"unprognostic (9.01e-2)"	25.9	45.3	16.7	22.6	17.3	21.8	28.0	17.7	24.0	35.5	18.5	54.1	56.8	20.4	40.3	182.9	16.1	27.0	31.3	17.8	18.5	62.3	69.8	23.2	22.1	17.3	17.3	13.3	40.4	24.5	27.6	15.0	17.5	32.2	44.7	7.4	47.5	14.6	21.7	27.7	38.8	20.4	18.2	41.9	54.5	15.5	17.2	25.8	20.7	10.1	27.0	68.7	58.5	18.7	130.8	154.4	62.1	134.1	38.1	54.4	29.1	65.4	56.4	59.2	57.0	84.8	44.0	27.8	62.4	50.6	62.3	200.0	67.6	223.5	73.2	93.0	109.3	33.1	138.6	153.3	43.3	54.1	70.7	55.1	83.6	72.7	72.3	58.2	79.8	88.2	45.1	13.3	83.1	91.8	55.1	69.7	90.3	91.9	123.9	53.2	41.4	69.5	126.7	253.3	28.8	74.9	65.9	66.7	54.6	42.1	63.3	48.2	59.8	48.8	61.7	55.7	117.2	20.0	47.8	43.1	98.9	56.9	57.1	77.2	105.0	93.6	35.3	117.3	37.2	54.9	41.7	42.4	115.8	47.5	32.2	37.8	180.9	35.5	120.9	109.3	66.9	56.7	16.7	17.3	17.7	24.0	17.8	18.5	17.3	17.3	17.5	18.2	17.2	18.7	91.8	93.0	157.2	3.9	66.9	189.3	185.3	785.8	330.6	18.1	141.5	162.6	110.3	175.8	236.4	125.0	2.1	180.7	76.6	560.2	389.4	326.8	362.5	110.0	81.6	99.6	135.1	70.7	3.9	451.8	291.6	84.9	181.0	126.9	50.0	92.2	88.2	371.7	245.0	40.4	3.6	316.4	221.8	114.9	83.7	303.2	74.9	118.9	113.8	1.9	170.2	86.8	80.3	4.0	5.3	534.5	378.6	67.0	112.5	169.9	420.3	814.9	142.9	26.8	26.3	58.5	103.9	34.6	116.4	500.1	143.3	104.9	67.7	151.0	332.1	300.0
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 22.0;intestine: 79.5;stomach 1: 32.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.8;Gastric mucus-secreting cells: 3.6;Intestinal goblet cells: 1.0;Paneth cells: 1.4;Proximal enterocytes: 3.9;Squamous epithelial cells: 4.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	143	"RT4: 523.3"														"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.5	79.5	0.1	0.0	14.6	0.0	22.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.5	0.0	0.9	0.0	0.0	0.9	53.1	1.9	0.0	0.0	32.7	1.5	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	523.3	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.9;liver: 20.1;urinary bladder: 30.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 4.5;Club cells: 1.0;Ionocytes: 2.0;Paneth cells: 2.5;Proximal enterocytes: 1.3;Squamous epithelial cells: 1.1"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	64	"RT4: 121.4"															NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"						"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	2.8	0.0	0.0	1.9	0.0	6.5	0.0	0.0	0.0	1.8	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.5	0.0	0.0	0.1	4.3	1.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	30.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.4	0.2
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671898-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	370	"kidney: 458.6;liver: 195.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 7.5;Proximal tubular cells: 6.6"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"A549: 1.4;RT4: 1.2"															NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"										"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	458.6	195.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.2;urinary bladder: 205.7;vagina: 52.4"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.3	0.1	0.3	0.5	0.4	31.8	0.2	0.1	0.0	0.0	0.0	43.2	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.2	6.8	0.0	0.1	4.2	0.2	0.1	20.7	0.1	0.0	0.1	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	205.7	52.4	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.3	0.2	0.3	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205143	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 33.8;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 147.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA031799, HPA031800"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	10.2	0.0	0.4	0.1	1.6	0.2	0.2	0.3	0.6	4.8	0.0	0.0	0.1	0.5	0.0	3.5	7.9	8.0	1.8	0.4	0.0	10.2	0.1	1.2	0.0	0.1	0.0	0.0	6.5	0.0	0.2	7.6	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	33.8	0.6	0.0	3.7	0.0	0.2	17.0	88.8	1.4	0.3	0.1	17.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	40.6	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	36.5	147.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.3	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	1.5	0.0	0.2	0.3	0.6	32.2	0.0	0.5	0.2	0.4	0.5	24.3	198.3	0.0	0.0	3.5	0.4	0.1	0.0	15.6	3.5	25.1	9.4	0.9	0.0	0.0	1.9	0.7	11.1	4.0	11.2	80.9	2.5	0.5	0.0	0.5	0.5	1.7	1.2	0.2	24.4	0.3	3.1	1.5	0.0	1.1	1.8	0.0	1.1	0.2	0.0	0.5	0.5	0.8	0.2	0.0	0.4	0.9	0.2	10.9	27.8	1.2	0.0	0.5	4.6	0.2	0.5	0.3	0.0	1.5	0.7	0.1	0.0	46.3
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"urinary bladder: 70.1"	"Group enriched"	"Detected in some"	7	"Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 144.4;RT4: 160.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.2	70.1	2.4	0.2	4.0	0.4	0.1	0.4	0.0	0.1	26.2	0.0	0.0	0.0	0.1	0.2	9.0	0.0	0.2	0.4	0.2	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	144.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	160.9	0.0	0.1	0.3	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.9	0.0	0.4	0.6	1.0	0.0	0.0	3.2	0.0	0.0	10.5	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.5	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	9.6	0.1	0.4	0.0	6.9
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 67.3;lymphoid tissue: 76.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA011403	Approved					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"		"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011403: AB_2668503"																		11.0	5.4	11.4	16.0	11.0	45.2	11.3	12.1	13.1	6.1	10.2	10.2	12.4	10.2	8.5	67.3	11.4	9.6	6.2	10.7	9.3	5.6	7.4	11.2	28.2	11.5	9.6	8.3	10.5	9.7		8.3	10.1	12.6	10.6	6.9	13.8	22.5	23.1	22.0	12.0	7.0	5.6	25.0	8.7	3.9	9.4	18.4	29.3	6.5	76.8	17.9		12.6	10.8	16.2	6.9	12.3	3.3	1.1	23.7	19.3	24.2	24.1	29.4	5.6	17.8	12.1	9.5	7.6	2.6	34.1	0.8	9.1	6.6	13.4	19.9	4.3	32.1	9.9	13.9	10.7	12.9	11.4	13.3	6.9	6.4	5.4	10.9	15.7	11.5	27.7	8.7	43.9	12.0	17.9	2.8	5.2	3.4	9.3	3.7	18.0	13.4	41.6	8.8	9.5	10.9	5.2	9.9	11.9	5.7	10.1	5.1	12.7	5.6	8.2	8.0	27.1	9.5	7.7	3.5	19.1	9.4	0.1	2.5	2.0	4.8	1.3	1.9	3.0	2.0	1.7	1.0	3.0	3.4	1.8	4.1	0.7	1.4	5.8	2.0	1.1	11.4	11.0	12.1	13.1	10.7	9.3	11.5	9.6	10.1	5.6	9.4	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VPS18	"KIAA1475, PEP3"	ENSG00000104142	"VPS18 core subunit of CORVET and HOPS complexes"	Q9P253	15	40894450-40903975	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040701	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"HPA040701: AB_10794145"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.69e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.61e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.06e-2)"	8.6	11.8	9.2	7.3	9.9	21.3	7.4	12.0	10.3	7.5	8.0	9.7	6.8	11.3	8.7	9.2	8.3	7.7	12.9	9.2	10.8	9.8	10.7	9.0	8.8	11.5	10.3	7.5	5.9	11.2	9.6	6.2	12.9	8.7	4.1	3.8	8.3	8.3	13.0	9.5	9.0	8.2	9.1	11.9	9.6	6.2	11.3	7.5	7.9	9.5	7.2	9.8	6.1	12.1	9.9	23.1	11.1	19.1	35.5	15.1	15.2	20.3	29.4	24.5	29.9	29.5	5.9	5.3	19.0	24.3	31.1	25.7	23.4	23.0	10.3	12.2	15.8	23.5	22.2	17.0	31.3	19.8	30.2	26.2	11.9	24.6	13.6	11.5	26.0	11.8	16.5	13.1	20.9	13.0	13.4	21.8	14.7	10.1	15.7	27.1	12.6	9.9	20.0	52.3	12.8	12.8	14.6	28.4	13.7	13.5	17.7	22.0	25.8	24.8	12.9	25.0	13.4	13.0	20.9	14.4	27.2	21.5	12.5	7.3	10.9	13.1	10.1	7.4	8.3	8.3	5.2	7.8	11.1	5.8	5.4	5.8	12.0	7.8	10.6	4.8	9.8	9.0	9.2	9.9	12.0	10.3	9.2	10.8	11.5	10.3	12.9	9.1	11.3	12.1	3.3	3.2	7.2	2.0	7.5	2.4	2.3	7.7	4.0	9.0	4.2	2.3	6.7	5.7	10.4	7.3	6.2	7.1	11.0	12.0	3.9	16.7	1.1	6.8	3.7	6.9	11.9	1.3	4.0	7.7	4.6	5.0	12.2	8.2	7.0	8.1	7.5	10.8	21.4	6.7	4.1	6.4	10.2	10.9	6.6	1.8	7.2	9.5	8.8	2.8	13.2	6.8	12.3	1.5	3.1	11.5	5.9	9.8	4.0	3.2	10.3	11.4	5.4	7.1	6.6	4.1	4.5	5.8	6.2	8.0	2.0	10.8	6.9	7.5	5.8	5.8
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"WASP like actin nucleation promoting factor"	O00401	7	123681943-123749003	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 282.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 138.3;U-2197: 128.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	20.4	24.7	19.2	12.8	22.2	5.6	21.7	13.5	42.4	29.1	13.6	42.4	37.2	27.1	18.3	29.5	18.7	28.4	18.2	43.0	20.4	44.1	46.8	19.9	7.8	18.0	19.1	35.1	29.5	40.0	13.0	34.6	17.4	25.3	37.9	24.9	22.3	24.0	24.7	18.0	41.5	23.6	13.5	17.0	30.1	22.5	20.9	10.3	35.2	28.7	11.0	38.7	22.5	18.4	34.4	24.8	26.7	23.0	41.2	42.4	34.7	23.3	38.7	16.9	21.7	20.5	42.2	3.5	18.1	35.3	36.0	25.1	50.1	25.7	25.9	6.0	19.9	3.0	19.6	22.2	44.7	4.6	2.9	34.2	47.0	25.0	42.2	37.9	29.5	3.6	15.5	6.6	40.6	20.7	6.0	6.1	50.1	36.5	22.4	3.6	21.6	7.7	35.6	138.3	32.9	48.1	32.1	95.0	63.0	41.4	18.6	4.5	33.8	44.9	12.6	128.1	23.2	7.2	2.7	7.5	38.8	3.8	36.7	2.4	1.7	0.8	1.7	1.7	1.4	2.0	1.1	1.0	1.5	1.3	1.4	1.5	0.7	2.5	3.0	1.9	0.6	0.6	19.2	22.2	13.5	42.4	43.0	20.4	18.0	19.1	17.4	13.5	20.9	18.4	71.2	86.6	61.1	36.9	11.5	60.4	48.9	44.4	46.1	32.9	67.6	57.1	69.8	52.9	53.7	53.3	20.9	41.6	12.6	200.2	52.8	52.6	26.2	58.0	53.1	43.9	67.9	5.9	55.9	54.1	52.4	62.6	50.0	68.8	3.8	35.0	56.4	61.9	12.7	26.9	51.2	105.1	40.7	13.8	25.1	9.3	48.1	15.6	30.2	34.7	14.0	60.9	6.2	42.7	48.7	70.6	113.4	64.7	14.0	104.4	108.0	96.0	49.5	32.4	19.7	54.1	75.3	17.2	21.3	54.9	68.3	81.3	13.1	76.0	74.8	282.3
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WASP homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Approved		Supported	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	7.7	4.8	4.3	3.9	4.4	29.7	7.2	6.1	4.7	6.6	8.8	6.8	4.6	5.5	2.8	7.2	6.1	2.9	5.8	4.3	3.9	7.0	8.8	7.8	5.5	4.5	4.3	7.2	7.5	6.1	5.4	4.6	4.3	7.7	4.0	4.0	6.6	3.5	17.7	9.0	7.3	3.3	3.8	8.5	6.2	3.7	4.3	5.1	6.6	7.8	4.7	7.5	6.4	5.8	4.0	4.1	2.5	3.6	7.9	5.5	4.2	5.5	5.5	6.0	5.9	2.6	7.2	8.7	6.7	5.2	5.6	8.8	7.7	4.5	3.9	2.9	4.4	5.0	4.5	3.9	8.0	3.6	5.7	5.4	6.0	2.8	5.9	6.0	4.3	4.1	4.6	11.3	6.0	3.1	3.0	5.2	1.0	5.0	2.4	4.4	5.3	2.5	10.4	16.1	2.3	1.9	8.5	5.5	5.8	5.1	3.7	7.7	6.8	7.9	2.7	5.3	6.3	12.0	7.3	4.2	5.6	4.9	5.0	2.6	0.5	0.5	1.2	0.4	1.0	1.0	1.1	0.8	0.3	1.1	1.0	1.0	1.3	2.3	0.4	0.9	1.0	0.4	4.3	4.4	6.1	4.7	4.3	3.9	4.5	4.3	4.3	3.8	4.3	5.8	36.6	16.0	17.3	18.9	37.1	26.5	42.8	6.6	34.1	16.2	16.7	17.7	15.6	17.2	7.6	20.2	14.6	14.5	47.3	18.1	5.9	8.9	6.9	19.6	13.9	23.2	6.7	31.5	10.1	10.3	16.6	18.7	23.9	29.4	10.8	12.6	19.2	13.8	19.9	23.5	15.9	19.4	6.1	15.8	41.4	5.5	17.4	25.4	19.6	15.0	19.3	17.9	61.8	14.1	23.4	13.0	15.5	23.7	24.1	49.0	16.8	11.2	7.1	18.0	32.9	24.5	19.5	29.8	31.1	29.2	25.1	25.4	36.1	15.5	13.8	75.1
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;thyroid gland: 16.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	8.9	0.1	14.3	0.0	0.8	36.7	13.9	3.5	0.3	3.3	0.3	10.1	2.1	1.0	2.6	0.1	0.4	17.9	4.2	1.0	0.0	0.3	0.1	0.6	2.4	0.3	1.4	0.0	1.4	0.2	2.2	4.2	0.3	11.9	0.3	13.5	0.2	0.8	0.7	6.8	2.7	0.1	1.9	0.2	10.0	0.0	16.8	0.4	0.1	2.5	1.3	7.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.9	14.3	36.7	13.9	17.9	4.2	0.6	2.4	2.2	2.7	10.0	7.2	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
ZBTB7C	"ZBTB36, ZNF857C"	ENSG00000184828	"Zinc finger and BTB domain containing 7C"	A1YPR0	18	48026672-48410752	"Predicted intracellular proteins, Transcription factors"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Basal squamous epithelial cells: 45.5;Distal enterocytes: 52.5;Excitatory neurons: 48.8;Gastric mucus-secreting cells: 49.5;Oligodendrocyte precursor cells: 51.3;Squamous epithelial cells: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"RT4: 42.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.83e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.52e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.89e-2)"	5.3	11.2	7.8	2.0	3.9	0.4	6.1	3.6	5.4	8.4	0.0	14.5	1.8	1.7	17.2	40.8	14.0	3.4	1.6	4.6	8.1	1.9	0.9	4.5	0.6	7.6	6.6	6.5	1.0	5.2	1.8	3.7	4.3	3.2	13.4	6.3	14.7	3.9	1.7	22.4	2.9	2.1	5.0	9.2	13.8	9.2	14.7	0.3	16.7	1.6	3.8	11.0	19.5	4.8	0.0	0.0	1.5	1.2	0.2	0.4	0.8	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.5	0.0	1.7	2.7	0.1	0.4	0.2	0.3	1.3	0.2	3.2	0.1	0.0	0.0	0.4	0.1	0.7	0.2	0.4	0.0	0.0	1.2	0.0	0.1	0.6	0.7	1.7	0.5	0.5	8.6	0.0	0.1	0.0	9.7	1.3	42.7	5.4	6.9	0.6	0.3	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.5	0.0	0.1	0.2	0.0	2.7	0.1	0.2	1.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.2	0.0	0.0	7.8	3.9	3.6	5.4	4.6	8.1	7.6	6.6	4.3	5.0	14.7	4.8	0.5	6.4	1.5	47.0	0.1	6.1	5.3	11.6	45.5	1.2	6.0	8.4	3.1	12.8	9.5	1.8	0.0	13.7	0.1	52.5	0.0	1.0	9.6	4.8	1.8	2.9	4.8	0.0	48.8	4.0	0.8	3.4	49.5	6.7	0.0	1.0	0.0	0.6	1.5	1.7	7.0	30.8	6.1	2.1	0.8	4.4	3.7	0.4	3.6	22.5	0.1	1.0	0.0	51.3	2.1	1.2	14.6	12.0	0.0	7.5	3.5	0.0	7.6	2.5	13.1	8.8	11.9	0.9	0.9	96.9	8.8	12.6	0.2	6.6	18.3	13.7
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465072-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"									"HPA055553, HPA071427"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055553: AB_2682848, HPA071427: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.0	0.1	1.6	0.1	1.1	0.4	0.1	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	1.9	0.0	0.0	0.0	0.1	1.2	1.9	0.1	0.1	0.1	0.6	0.1	1.1	0.1	0.0	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.9	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.2	0.1	0.0	1.6	1.1	0.8	1.2	1.0	1.9	1.2	1.9	1.1	0.4	1.8	0.8	0.4	0.0	1.8	0.3	0.2	1.7	1.1	0.1	0.0	2.6	0.3	0.5	0.8	0.0	0.7	0.0	6.2	1.9	1.4	0.3	0.0	0.0	2.1	0.5	1.6	0.7	0.0	0.0	0.8	0.0	1.3	0.8	0.0	0.5	3.8	2.8	0.7	0.2	0.4	3.3	2.2	0.0	0.0	0.3	4.7	2.1	0.6	0.7	1.8	1.9	0.0	1.4	1.0	9.0	0.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1	1.5	2.4	0.0	1.6	0.7	2.2	1.5	0.0	0.6	0.3	0.7	0.9	0.0	0.9
ZC3H12A	"FLJ23231, MCPIP1, Regnase-1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474580-37484377	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 136.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.8;RT4: 61.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Cytoplasmic bodies"	Nucleoplasm	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	28.9	28.0	2.4	17.3	2.3	136.3	15.1	3.6	4.1	9.1	2.7	16.3	14.1	6.6	4.6	45.4	14.3	36.0	12.1	2.5	3.8	15.7	23.3	40.0	13.6	4.1	3.7	6.0	12.4	2.5	9.2	3.7	4.1	29.5	7.9	0.3	22.9	5.2	10.8	51.5	20.1	5.7	3.0	15.5	23.5	5.2	3.7	5.7	6.5	3.2	15.5	39.0	21.4	2.8	7.8	5.5	0.6	3.5	2.7	4.0	6.2	5.5	48.8	3.5	4.5	6.1	17.2	8.7	22.8	5.3	37.8	16.8	2.2	35.4	2.0	17.8	3.2	2.3	20.9	9.7	3.9	4.6	3.5	8.6	17.8	30.0	5.3	7.9	3.9	4.4	4.3	14.1	3.1	9.4	3.5	8.3	4.2	10.4	4.8	5.2	2.2	5.1	8.8	61.2	1.6	1.1	11.0	17.4	1.3	5.3	6.0	5.1	4.1	10.3	5.7	7.7	8.5	11.2	4.5	6.6	23.5	9.7	2.0	1.2	1.4	4.0	3.1	1.4	3.3	3.1	1.3	1.9	1.7	3.9	0.7	1.5	5.6	3.5	1.2	1.5	2.0	1.7	2.4	2.3	3.6	4.1	2.5	3.8	4.1	3.7	4.1	3.0	3.7	2.8	19.1	16.0	36.2	1.6	56.9	195.9	149.8	300.7	242.4	0.4	93.6	69.8	4.2	61.5	117.6	11.0	0.0	3.7	78.1	71.5	0.0	79.5	16.9	67.6	20.8	32.2	63.9	0.4	0.1	73.9	10.0	41.0	66.3	102.2	42.6	5.0	5.3	11.4	9.7	0.0	0.1	77.3	69.2	10.5	232.8	2.7	0.9	71.2	48.0	1.0	14.0	0.9	9.2	0.5	0.9	55.4	73.2	1.2	52.1	127.9	59.5	0.6	58.4	4.5	6.6	52.7	36.1	1.6	1.3	217.6	225.2	11.8	76.6	9.5	62.2	81.9
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZNF223		ENSG00000178386	"Zinc finger protein 223"	Q9UK11	19	44051367-44067999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.4"									"HPA067823, HPA079175"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Mitochondria	"HPA067823: AB_2685906, HPA079175: "	"unprognostic (6.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-4)"	3.2	3.8	2.9	3.5	2.8	2.0	5.5	3.9	3.7	3.6	2.3	4.5	4.0	3.3	5.9	3.0	3.9	3.8	4.9	2.4	3.3	3.9	2.6	3.9	3.6	2.8	2.7	4.0	2.8	4.9	4.1	5.5	3.0	6.5	5.7	4.5	3.6	4.8	2.1	4.9	4.4	3.9	2.5	4.9	4.9	3.2	3.4	2.7	6.3	1.6	4.3	3.9	3.0	3.0	2.8	1.5	5.9	1.4	3.8	4.7	0.1	4.2	4.6	3.7	5.3	2.8	4.6	0.0	3.9	3.3	2.2	2.6	0.0	4.7	3.9	0.1	4.5	5.6	5.0	3.9	2.8	0.3	0.1	4.6	3.7	3.1	3.0	5.2	4.2	0.1	0.2	0.0	4.2	2.2	0.0	2.1	4.4	1.9	2.1	0.0	2.4	1.3	4.5	23.4	3.6	8.5	7.3	0.9	2.9	7.5	4.1	5.2	4.2	3.5	3.3	1.9	1.6	2.7	5.0	0.0	1.5	0.1	3.4	15.0	4.9	7.8	2.4	5.9	3.5	3.2	3.8	1.9	5.4	3.3	7.4	3.2	0.4	6.2	2.7	6.6	3.6	2.4	2.9	2.8	3.9	3.7	2.4	3.3	2.8	2.7	3.0	2.5	3.4	3.0	2.4	0.0	1.1	4.2	1.3	0.0	0.6	0.0	1.2	3.6	1.7	1.4	0.9	2.8	0.0	1.8	2.1	2.1	0.9	2.2	3.9	2.3	3.8	1.4	1.0	1.8	0.0	3.0	6.1	0.5	0.8	1.8	2.0	1.5	0.0	1.8	3.3	0.4	1.7	3.3	5.0	2.8	0.0	2.4	0.0	1.0	1.5	1.3	0.0	1.9	1.7	1.2	3.1	4.5	3.4	1.4	1.5	1.9	0.3	0.6	2.3	1.1	0.7	1.6	0.0	0.7	1.4	1.9	2.1	1.9	0.0	1.0	0.7	1.3	1.7	0.7
ZNF316	"ENST00000305834, MZF-3"	ENSG00000205903	"Zinc finger protein 316"	A6NFI3	7	6637318-6658279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.74e-1)"	"unprognostic (2.82e-3)"	"unprognostic (9.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.43e-3)"	16.1	15.2	13.3	18.0	12.2	20.7	13.4	9.9	13.8	19.1	11.6	19.7	13.0	18.6	17.1	15.4	17.6	8.9	13.0	12.6	10.3	15.0	16.6	15.7	16.3	14.5	11.6	16.4	17.2	21.0	17.9	11.0	11.2	17.5	8.3	8.9	13.7	8.8	26.1	19.7	17.8	12.7	10.3	28.2	15.6	12.8	11.7	13.2	23.4	6.6	12.1	17.0	14.8	13.2	26.6	23.0	28.5	27.3	15.0	7.7	17.2	20.5	9.8	9.0	9.3	21.6	18.6	35.3	13.7	15.0	35.5	26.6	14.0	13.9	8.6	10.8	15.7	24.3	39.6	12.3	16.2	30.6	26.7	11.0	14.4	14.0	16.8	18.1	8.0	16.0	46.0	17.1	10.3	44.2	11.6	38.7	16.0	18.1	17.0	21.0	21.9	15.3	9.1	59.5	32.9	53.7	15.0	55.0	16.7	24.1	31.8	33.2	15.2	17.8	35.2	25.5	28.1	37.3	37.7	27.5	14.0	25.0	36.4	0.7	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.5	0.2	0.6	0.2	0.1	13.3	12.2	9.9	13.8	12.6	10.3	14.5	11.6	11.2	10.3	11.7	13.2	9.6	6.4	9.3	15.7	8.6	0.0	3.1	0.0	12.5	13.3	12.8	11.8	9.0	10.0	3.7	14.7	10.4	3.4	10.1	13.2	3.9	4.6	1.0	10.3	9.2	8.4	16.7	4.8	9.8	6.0	2.0	6.5	15.8	11.4	1.3	12.0	9.3	13.6	7.3	18.5	9.8	9.9	0.0	10.3	0.0	0.9	6.5	13.1	0.0	7.5	9.7	5.0	9.2	7.5	9.2	6.1	6.6	7.2	10.8	7.6	5.7	3.8	1.5	7.5	0.0	11.5	8.4	4.3	3.2	15.7	0.0	2.2	7.6	12.5	9.4	5.3
ZNF320	"DKFZp686G16228, ZFPL"	ENSG00000182986	"Zinc finger protein 320"	A2RRD8	19	52860851-52897693	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 105.9;U-266/84: 56.1"									"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: AB_2732685"	"unprognostic (3.33e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.47e-4)"	"unprognostic (8.90e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.75e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.61e-3)"	4.9	6.3	4.5	6.6	5.8	5.0	10.4	8.9	5.5	8.9	5.1	9.0	6.9	10.0	9.8	5.1	10.5	7.3	7.2	4.9	4.9	10.7	1.5	5.9	6.7	4.5	3.9	13.4	6.8	12.3	6.5	11.1	4.7	10.3	9.7	13.0	6.3	8.0	7.0	9.1	5.3	7.8	2.5	7.5	7.8	5.3	4.7	6.3	10.8	3.6	6.4	9.5	7.1	7.3	11.2	0.5	16.8	28.1	3.8	6.2	19.8	8.0	7.3	10.5	12.7	6.7	3.8	12.5	10.3	6.9	9.3	3.1	0.1	5.7	7.4	0.1	3.6	12.6	16.6	0.1	7.8	0.8	14.2	10.7	4.8	12.2	2.6	4.8	7.8	5.5	12.9	0.8	7.7	0.0	16.1	9.8	20.4	0.2	9.5	12.0	15.3	14.1	10.2	105.9	13.3	26.4	0.3	7.0	2.9	23.3	10.0	1.3	9.0	4.4	11.0	2.7	12.2	14.1	56.1	9.3	0.3	0.2	9.8	3.2	2.1	1.8	3.2	2.6	2.9	2.2	1.8	2.4	2.5	3.2	3.4	3.5	3.5	7.9	2.4	3.7	2.0	2.5	4.5	5.8	8.9	5.5	4.9	4.9	4.5	3.9	4.7	2.5	4.7	7.3	0.6	3.2	1.7	13.7	2.8	1.9	5.8	3.4	1.2	8.3	0.2	0.1	13.2	14.3	5.9	1.8	10.4	10.5	2.9	9.0	0.0	0.3	6.7	1.9	1.0	4.5	10.7	4.2	10.2	0.0	6.3	5.0	6.1	2.8	1.3	0.6	6.8	0.8	4.3	16.8	10.1	9.0	4.1	3.2	3.9	2.7	4.4	1.6	3.6	3.7	2.4	5.6	9.2	17.6	12.4	0.1	6.3	2.6	0.5	9.4	4.1	0.2	4.4	12.4	0.0	9.2	3.2	5.6	5.8	5.3	4.3	7.7	1.8	0.4	7.3	7.5
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031378-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 26.9;Rod photoreceptor cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	6.3	13.4	3.2	3.7	3.9	8.0	6.5	5.7	3.7	6.5	8.8	5.5	5.2	7.0	8.7	6.6	6.0	3.5	6.0	3.4	5.5	5.1	4.1	5.6	4.3	3.9	3.7	6.8	18.0	5.6	12.4	4.4	3.9	11.8	4.3	24.6	7.1	4.5	4.1	7.8	5.2	4.3	2.9	4.4	6.4	7.2	4.3	4.0	6.7	4.4	4.1	5.0	6.5	4.8	4.6	3.7	8.2	13.0	5.6	7.2	2.8	5.2	3.9	3.7	5.9	3.2	2.7	3.1	1.6	5.6	4.0	3.4	4.8	4.5	6.4	3.2	11.8	9.5	9.2	6.0	2.6	0.0	8.5	7.3	3.6	5.4	7.9	7.1	4.9	3.7	2.6	14.0	6.8	2.6	9.3	5.2	3.0	2.4	6.3	4.9	9.5	5.4	5.5	22.2	4.8	5.0	8.1	4.4	2.6	5.8	3.9	3.7	7.0	3.1	4.7	3.7	5.5	7.2	10.7	7.5	7.2	0.8	6.1	0.9	1.1	1.3	1.4	1.3	1.0	1.9	0.8	0.8	0.9	1.2	1.5	1.1	1.0	0.6	0.6	0.6	1.2	0.8	3.2	3.9	5.7	3.7	3.4	5.5	3.9	3.7	3.9	2.9	4.3	4.8	6.2	16.0	10.0	8.1	8.0	2.0	3.3	3.4	3.4	9.8	3.8	3.2	6.0	2.8	11.6	9.2	16.7	2.7	6.4	3.7	3.9	3.5	14.7	11.9	6.4	5.7	10.2	2.5	9.4	1.6	5.8	5.8	6.6	9.0	12.6	7.8	3.9	1.3	2.3	26.9	6.7	4.9	4.1	4.1	1.3	12.4	3.7	3.2	3.6	9.4	3.8	7.7	10.3	9.0	6.9	2.1	5.2	4.5	4.0	3.6	2.0	2.7	11.6	30.7	6.6	7.1	6.4	10.0	8.4	2.2	2.3	4.9	6.5	4.2	3.1	3.3
ZNF440	FLJ37933	ENSG00000171295	"Zinc finger protein 440"	Q8IYI8	19	11814273-11835216	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 44.8;Respiratory ciliated cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"RT4: 25.5"									HPA047845	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (2.48e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.57e-4)"	"prognostic favorable (1.18e-4)"	"unprognostic (9.81e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.88e-4)"	3.8	3.9	2.8	3.4	2.5	6.9	6.8	6.3	3.6	6.1	7.4	10.0	5.6	4.4	4.8	9.8	14.5	4.3	3.3	5.0	1.8	4.7	3.7	6.9	4.2	3.7	5.3	3.8	5.5	16.4	2.8	9.7	3.1	6.3	11.1	7.1	7.1	4.3	4.3	15.6	7.1	3.5	1.2	4.3	8.6	6.4	2.4	8.0	4.1	2.2	5.2	11.6	7.1	4.8	6.7	0.0	7.3	8.9	5.4	4.8	19.4	4.6	3.8	5.5	4.7	7.0	5.7	3.7	4.4	4.2	2.7	8.2	3.8	8.9	7.6	0.3	2.5	5.2	4.8	5.6	2.7	0.1	11.5	2.7	5.8	3.4	0.9	3.9	3.1	5.0	19.9	0.3	6.4	2.8	4.7	6.9	5.6	2.3	5.8	3.9	9.5	1.6	4.0	25.5	4.2	3.3	7.2	3.0	5.3	7.8	12.9	10.3	3.3	12.5	2.6	9.2	4.1	6.7	5.2	4.9	5.8	3.3	4.6	12.6	1.4	1.9	1.1	0.9	1.4	1.0	1.4	1.3	1.8	1.1	1.0	1.6	2.5	3.0	2.9	1.1	1.8	0.8	2.8	2.5	6.3	3.6	5.0	1.8	3.7	5.3	3.1	1.2	2.4	4.8	3.9	16.0	7.9	7.2	2.5	2.9	7.6	5.2	8.0	5.5	3.4	2.7	3.0	1.5	14.6	9.2	35.5	31.1	5.8	25.1	3.9	3.6	16.7	44.8	3.8	4.2	6.7	2.1	10.4	3.6	20.7	3.1	15.3	11.9	10.8	3.3	4.2	1.7	4.5	6.7	6.7	12.7	2.0	5.0	2.8	5.7	2.8	3.0	3.6	2.8	2.2	2.0	4.1	10.6	5.8	5.8	15.9	1.9	2.5	5.7	20.8	2.1	74.1	13.1	0.0	3.9	4.1	9.7	3.5	9.0	4.8	29.8	4.6	1.1	12.1	9.8
ZNF587	"FLJ14710, FLJ20813, UBF-fl, ZF6"	ENSG00000198466	"Zinc finger protein 587"	Q96SQ5	19	57849859-57865117	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RT4: 41.5"									"HPA042125, HPA043288, HPA056213"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069"	"unprognostic (1.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-3)"	5.0	5.1	3.9	6.4	3.6	6.8	10.1	4.5	5.3	6.4	5.9	8.5	8.2	5.9	5.6	6.1	6.0	3.7	6.0	3.7	3.8	6.5	6.2	6.2	5.4	2.9	2.9	7.1	9.1	4.9	11.5	8.0	2.9	9.6	13.1	11.4	12.1	6.5	4.5	5.9	7.9	5.5	2.1	6.1	8.9	4.4	3.3	5.4	7.7	4.1	6.8	6.2	7.3	4.7	8.6	7.8	7.0	5.7	7.5	10.9	10.5	7.5	9.5	11.2	9.8	11.2	5.7	5.7	3.9	5.9	4.4	5.1	10.1	11.1	20.8	5.3	21.5	11.1	28.6	8.0	4.3	11.1	10.6	10.8	5.1	11.0	10.4	8.6	12.1	7.8	14.1	7.5	8.4	3.6	6.7	4.1	2.1	2.2	7.1	5.3	6.6	3.8	6.7	41.5	11.1	5.2	8.7	7.9	2.7	9.2	6.8	6.3	5.7	8.3	5.1	2.1	10.7	12.0	9.8	6.0	3.8	4.7	5.0	1.4	0.5	0.4	0.4	0.4	0.4	0.5	0.5	0.4	0.5	0.7	0.4	0.7	1.2	0.5	0.4	0.4	0.7	0.3	3.9	3.6	4.5	5.3	3.7	3.8	2.9	2.9	2.9	2.1	3.3	4.7	6.9	3.2	6.8	13.1	8.4	9.2	13.6	7.3	1.8	20.0	10.4	5.8	7.1	30.0	9.6	7.3	31.3	10.8	7.4	12.2	11.7	9.1	9.5	16.9	10.0	7.8	23.4	3.8	19.9	3.7	9.8	7.3	19.4	22.6	12.7	18.3	12.5	9.4	6.5	20.2	19.3	18.2	4.1	7.1	5.5	1.3	4.7	7.0	0.0	10.3	7.2	7.6	7.2	17.6	14.1	7.6	15.9	9.1	8.7	13.4	14.8	8.5	13.3	24.7	0.0	9.2	6.3	4.2	6.7	5.4	6.7	10.1	8.7	9.5	15.5	15.4
ZNF587B		ENSG00000269343	"Zinc finger protein 587B"	E7ETH6	19	57819721-57846238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 36.2"									"HPA043800, HPA053762, HPA072145"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: "	"unprognostic (4.13e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.70e-2)"	3.6	3.1	1.2	3.4	1.6	9.4	5.3	4.0	1.1	2.5	3.4	4.0	5.7	3.2	2.5	3.8	3.2	2.6	3.1	1.3	0.8	4.0	6.6	3.8	4.8	0.7	0.7	3.3	5.6	3.0	3.0	3.0	0.4	4.0	4.4	2.0	6.0	2.3	9.9	6.9	5.6	2.2	0.1	6.4	4.7	5.3	1.3	2.8	4.0	2.0	5.0	3.7	2.9	0.8	5.6	16.3	6.0	13.0	1.5	1.7	7.0	4.5	3.5	4.4	3.0	9.6	8.9	11.9	2.4	6.1	2.4	4.7	5.9	14.1	10.5	2.0	13.8	8.8	15.3	10.1	5.2	15.4	8.3	5.0	2.7	6.8	7.1	1.2	3.7	8.5	10.3	5.5	2.8	6.2	7.2	2.6	15.7	5.2	7.2	5.9	6.5	5.6	5.3	36.2	3.7	6.2	5.0	6.6	4.3	9.4	9.1	5.5	5.1	6.0	6.9	1.4	6.6	7.7	6.6	9.1	4.9	4.5	6.7	2.0	1.8	0.8	1.1	1.6	1.2	1.2	1.2	1.3	1.1	1.2	1.6	1.5	3.0	1.1	0.9	1.2	1.0	1.8	1.2	1.6	4.0	1.1	1.3	0.8	0.7	0.7	0.4	0.1	1.3	0.8	1.7	6.4	1.5	6.5	3.4	3.2	3.4	2.4	1.2	4.2	2.2	0.6	2.7	4.3	5.4	0.0	0.0	3.5	3.9	1.3	1.9	3.9	4.6	3.1	2.2	2.8	4.2	1.3	11.6	2.0	3.3	2.8	3.1	3.3	0.0	5.8	5.7	3.4	1.4	3.3	12.2	3.7	4.1	2.2	1.0	0.9	0.6	1.9	1.8	4.7	1.8	0.8	2.1	11.1	4.6	2.1	1.4	0.7	2.2	2.9	1.4	3.3	3.2	3.6	6.6	2.3	2.5	4.2	5.8	1.3	3.8	2.5	2.2	4.4	2.4	3.1
ZNF600	"DKFZp686F06123, KR-ZNF1"	ENSG00000189190	"Zinc finger protein 600"	Q6ZNG1	19	52749942-52786807	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 9.1"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.5"	"Group enriched"	"Detected in all"	5	"NK-cells: 45.5;T-cells: 18.9"	"Cell line enhanced"	"Detected in many"		"RT4: 24.6"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (5.19e-6)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.11e-5)"	4.1	3.2	1.4	3.5	1.5	5.5	4.4	9.1	1.9	5.3	2.0	5.7	5.6	3.9	2.6	6.1	4.4	3.0	2.3	1.3	1.4	3.7	4.1	4.9	6.3	1.5	1.6	3.8	5.3	2.5	2.6	3.7	2.2	6.4	5.7	0.7	4.2	3.6	1.2	6.0	8.4	3.1	1.5	9.2	6.0	1.8	1.8	3.4	4.2	1.6	6.3	5.2	6.5	1.9	6.1	0.0	0.1	2.6	3.6	3.4	14.5	4.6	3.8	3.1	7.7	4.8	5.5	6.9	2.0	3.2	6.0	7.1	0.0	4.2	5.3	1.4	2.9	3.9	3.5	3.9	4.3	0.0	9.1	4.7	6.7	3.3	5.4	2.5	1.6	0.1	5.6	0.0	3.4	2.3	0.0	3.6	1.4	5.8	6.6	0.0	0.0	5.4	5.6	24.6	2.6	3.2	6.3	5.0	0.8	9.5	3.1	5.5	4.4	0.8	1.8	0.7	4.5	3.3	5.5	8.3	0.0	0.0	3.4	3.6	2.2	2.9	18.9	1.7	11.2	6.8	6.4	9.9	4.0	6.4	6.2	10.9	0.5	45.5	4.1	0.9	4.0	6.0	1.4	1.5	9.1	1.9	1.3	1.4	1.5	1.6	2.2	1.5	1.8	1.9	4.8	25.6	9.6	1.3	13.3	20.3	18.3	4.9	15.9	0.8	4.9	4.4	3.4	5.7	5.9	5.5	0.0	9.2	25.8	8.9	0.0	6.7	7.4	10.8	4.1	7.1	4.2	5.7	1.6	9.7	9.7	5.0	16.8	23.9	31.7	6.0	3.3	2.2	3.2	0.0	1.3	6.5	2.0	1.9	6.0	1.4	2.8	4.3	1.8	4.7	4.0	1.5	51.5	1.0	4.7	11.6	8.2	1.9	17.0	14.0	12.9	2.9	13.2	1.7	0.0	2.6	4.0	0.5	2.6	13.1	24.3	14.6	19.1	3.3	9.9	27.9
ZNF66	"FLJ16537, ZNF66P"	ENSG00000160229	"Zinc finger protein 66"	Q6ZN08	19	20776304-20809995	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 24.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 8.3;Erythroid cells: 7.4;Granulosa cells: 8.2;Plasma cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 18.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 18.6"	"Cell line enhanced"	"Detected in many"		"RT4: 20.0"															NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"				"unprognostic (4.67e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-2)"	2.2	1.9	12.9	2.5	11.5	7.8	2.4	24.5	22.8	1.4	1.6	2.1	3.0	2.6	3.1	1.9	1.9	2.5	1.4	11.7	4.9	1.9	2.3	1.9	3.7	7.9	2.7	8.9	3.2	1.1	0.5	2.4	10.1	2.3	2.2	10.7	2.6	1.9	3.1	4.8	3.4	1.5	1.4	2.6	4.1	3.2	8.1	2.5	3.4	0.6	2.1	2.7	1.3	18.9	6.6	2.3	4.6	9.6	1.4	1.0	8.1	3.1	0.9	3.2	2.8	4.5	6.5	5.7	13.0	1.4	3.2	2.7	0.5	1.1	2.4	3.8	3.4	5.0	6.2	3.1	0.2	2.9	2.5	1.0	1.7	2.0	1.5	1.6	0.5	3.9	5.5	10.1	1.9	9.1	7.0	4.5	12.2	3.1	2.7	6.1	5.8	4.2	3.5	20.0	6.6	5.8	2.0	4.5	2.0	9.9	8.8	4.2	2.9	5.7	8.0	6.9	5.0	9.4	12.1	5.7	2.1	2.0	3.3	13.0	2.5	3.4	2.7	1.2	2.0	3.3	2.5	2.1	1.1	4.5	3.1	2.9	18.6	4.4	2.2	3.6	2.1	0.8	12.9	11.5	24.5	22.8	11.7	4.9	7.9	2.7	10.1	1.4	8.1	18.9	2.2	3.2	1.1	0.0	8.3	0.1	0.6	0.0	6.2	1.3	1.4	1.7	1.0	0.0	1.3	3.7	2.1	0.6	3.0	0.1	1.9	0.6	0.1	2.4	3.4	2.7	3.0	7.4	0.0	0.6	0.6	2.4	3.1	3.0	1.3	8.2	1.8	0.1	0.4	1.7	0.0	0.1	0.0	1.3	0.5	0.7	1.2	1.7	1.8	0.0	0.2	0.3	1.0	0.0	0.0	0.7	2.6	0.4	6.9	0.4	0.0	0.3	0.0	1.9	0.0	1.2	2.5	3.1	3.5	5.9	0.4	0.1	4.4	3.8	0.4	0.5
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056231	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Excitatory neurons: 56.5;Inhibitory neurons: 59.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	2.3	2.9	0.8	1.8	1.8	1.0	2.7	4.6	1.9	4.1	2.8	4.2	1.1	3.7	3.6	2.1	4.1	1.4	5.2	1.1	1.1	2.8	2.9	2.5	3.2	0.6	0.3	6.3	2.8	2.6	7.8	2.0	1.1	4.0	2.3	14.1	3.4	2.8	3.1	1.7	3.2	2.4	0.5	3.3	3.0	2.4	1.2	3.3	5.8	2.1	3.1	3.9	3.4	2.4	2.0	2.5	5.0	2.4	2.0	1.1	0.0	2.6	1.7	2.8	3.8	5.0	1.5	5.7	2.3	2.4	2.1	1.3	3.2	1.4	2.9	4.6	1.6	4.5	6.2	2.9	1.6	6.1	3.1	2.5	0.6	3.9	1.7	2.2	2.1	2.5	4.7	7.4	2.3	0.5	1.8	0.7	4.0	1.7	2.5	3.1	8.7	1.7	1.2	12.2	3.9	5.0	4.7	1.4	1.2	2.7	1.7	2.3	4.1	1.7	6.4	4.3	3.6	5.6	7.8	3.9	2.3	2.6	1.7	0.0	1.3	0.6	1.1	1.2	1.1	1.0	1.3	1.3	1.0	1.6	1.9	1.7	0.1	1.1	0.8	2.5	0.9	0.6	0.8	1.8	4.6	1.9	1.1	1.1	0.6	0.3	1.1	0.5	1.2	2.4	5.3	9.6	9.6	53.8	11.2	1.9	2.7	4.9	1.2	25.6	3.8	5.2	13.1	7.2	7.9	9.2	33.3	1.8	13.0	2.5	3.9	5.6	8.9	2.7	7.0	6.2	10.3	4.6	56.5	10.0	1.5	5.6	5.1	2.7	7.6	8.1	10.0	5.0	3.7	10.1	59.6	4.2	12.2	5.8	5.8	1.8	3.7	4.7	5.4	38.4	7.6	6.2	4.1	56.3	78.0	6.8	4.2	3.0	4.5	1.7	3.5	3.4	4.8	34.7	6.6	5.5	5.3	2.4	2.8	2.8	3.0	0.7	8.0	3.4	4.4	2.0
ZNF816	ZNF816A	ENSG00000180257	"Zinc finger protein 816"	Q0VGE8	19	52949379-52962911	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 52.6"									HPA042466	Uncertain		Approved	"Nucleoli rim"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim"		"HPA042466: AB_10797497"	"unprognostic (1.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (6.21e-2)"	"unprognostic (5.45e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-2)"	2.8	3.2	2.5	4.6	2.9	3.3	7.9	6.7	3.5	9.5	3.7	9.1	4.8	5.8	8.4	4.3	11.7	5.3	4.6	2.2	2.8	6.0	2.7	5.5	7.7	2.9	2.5	8.4	5.7	6.0	2.9	6.6	3.3	12.5	10.1	5.9	4.6	6.9	1.8	5.2	4.9	4.6	2.3	6.8	10.0	4.4	2.8	9.6	7.2	3.0	8.8	8.2	4.5	3.1	6.5	0.2	5.8	14.5	10.2	11.6	17.0	5.4	5.5	6.8	10.1	4.7	4.1	17.8	11.2	4.8	10.5	3.9	8.5	6.3	6.6	8.9	17.1	8.3	7.0	7.7	3.5	0.0	12.3	5.5	7.8	4.3	7.9	8.0	5.8	8.1	13.4	0.6	8.7	5.3	14.4	9.6	6.8	3.8	8.0	7.9	12.2	8.6	10.7	52.6	4.4	8.1	0.2	9.1	3.6	11.3	5.7	9.6	5.0	5.0	4.9	3.4	6.1	6.0	18.4	16.1	0.6	8.8	6.0	15.2	8.6	17.3	14.4	7.5	19.5	11.3	13.5	14.3	10.0	11.6	18.5	14.5	3.9	21.3	9.6	9.3	13.9	8.9	2.5	2.9	6.7	3.5	2.2	2.8	2.9	2.5	3.3	2.3	2.8	3.1	2.0	3.2	1.5	0.0	2.8	0.9	2.8	4.3	2.2	1.6	1.4	1.3	2.2	2.8	7.0	1.8	6.2	4.9	2.5	1.8	7.9	3.8	3.3	4.8	1.8	2.1	0.0	7.8	0.0	1.6	3.7	1.7	2.0	3.7	7.6	3.8	1.4	0.7	2.4	0.0	0.0	3.2	4.1	1.0	1.7	2.3	1.5	1.8	5.4	0.0	3.7	1.0	8.2	0.0	0.0	2.0	2.5	1.2	1.9	1.4	1.6	0.9	4.8	0.9	0.0	1.3	1.8	1.5	5.0	1.6	1.6	3.6	3.3	2.3	3.3	4.1
ZNF816-ZNF321P	ZNF816-ZNF321	ENSG00000221874	"ZNF816-ZNF321P readthrough"		19	52928475-52962823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 9.8;Syncytiotrophoblasts: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RT4: 9.0"									HPA051271	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA051271: AB_2681415"												"unprognostic (4.18e-2)"						0.2	0.1	0.0	0.3	0.0	0.4	0.8	0.0	0.2	0.7	0.0	0.9	0.0	0.5	0.0	0.2	0.8	0.3	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.5	0.3	0.2	0.2	0.8	0.0	1.7	1.5	0.0	0.4	0.7	0.0	0.2	0.2	0.0	0.0	0.3	1.0	0.1	0.0	0.2	0.2	0.0	0.4	0.6	0.4	0.0	0.3	0.0	0.8	0.2	0.5	0.1	0.5	0.0	0.3	0.5	0.5	0.0	0.3	0.9	0.3	0.4	0.8	0.1	0.8	0.1	0.0	0.5	1.1	0.4	0.1	1.1	0.6	0.0	0.2	0.5	0.0	0.8	0.0	0.3	0.4	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.1	0.0	0.2	9.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.6	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.8	0.0	3.8	0.0	3.4	0.0	1.5	2.4	0.6	4.3	0.0	0.0	0.0	9.8	1.2	4.4	3.9	3.6	1.9	7.3	1.9	1.0	0.0	3.0	0.7	3.6	5.7	1.1	6.6	7.4	4.5	1.5	1.4	0.3	3.7	0.0	0.3	3.6	0.0	1.6	0.0	1.1	0.3	1.8	0.0	1.0	2.9	0.0	4.1	1.0	0.6	3.5	2.5	0.7	1.0	2.7	1.9	1.1	0.0	0.0	0.0	1.3	1.1	1.3	1.6	2.0	0.0	11.2	1.6	1.0	3.0	5.9
ZNF888		ENSG00000213793	"Zinc finger protein 888"	P0CJ79	19	52904417-52923481	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 34.9;Glandular and luminal cells: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 72.9"															NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"				"prognostic unfavorable (5.28e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.31e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.00e-3)"	1.7	1.8	0.9	2.3	0.8	5.0	3.2	1.7	1.1	11.1	1.4	5.3	2.9	4.6	4.8	3.0	8.2	5.1	0.9	0.8	0.9	5.9	0.8	2.9	3.5	0.7	0.7	2.7	5.5	2.2	0.9	4.8	0.8	9.0	8.1	1.0	3.8	6.8	0.4	3.4	2.5	1.5	0.7	2.9	7.6	1.0	0.8	3.4	3.0	0.9	3.5	9.5	3.8	0.9	6.3	0.1	2.0	6.5	1.9	1.1	9.2	4.8	2.9	3.8	6.5	4.6	4.2	6.1	6.4	2.8	4.0	3.7	4.8	3.9	5.9	2.8	7.5	5.3	5.8	4.9	0.9	0.0	8.8	2.2	3.7	3.7	4.5	1.8	2.3	4.0	9.9	0.3	1.0	1.7	6.3	6.7	3.1	0.3	5.2	4.1	3.9	2.9	14.4	72.9	0.9	2.9	0.0	8.4	1.2	4.6	6.3	8.6	3.2	0.8	3.8	1.5	5.4	1.6	3.2	7.2	0.2	4.0	4.4	0.4	0.8	1.0	0.6	0.5	0.8	0.5	0.6	0.8	1.0	0.7	0.7	0.6	0.4	1.3	0.8	2.0	0.9	0.6	0.9	0.8	1.7	1.1	0.8	0.9	0.7	0.7	0.8	0.7	0.8	0.9	1.6	6.4	3.6	1.0	0.7	0.0	0.2	0.2	0.0	0.0	1.7	2.2	1.1	0.0	2.5	9.2	0.0	0.1	2.0	0.1	0.0	2.9	0.0	34.9	5.2	0.7	0.0	0.0	0.8	1.6	0.1	0.8	0.5	41.0	0.0	4.4	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	1.6	0.0	1.0	1.0	0.0	0.0	1.0	0.7	3.3	0.0	0.0	0.7	0.0	0.0	1.6	5.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.3	1.0	1.7	0.0	0.1